https://resources.flatiron.com/real-world-evidence/do-fda-alerts-impact-practice-patternshttps://flatiron.com/hubfs/Imported_Blog_Media/JAMA_paper_1028X880.jpgJAMApaper1028X880JAMApaper1028X8802024-03-29https://resources.flatiron.com/flatiron-stories/welcome-to-the-flatiron-bloghttps://flatiron.com/hubfs/Imported_Blog_Media/blog_intro_2-2.jpgblogintro22blogintro222024-03-29https://resources.flatiron.com/publications/tumor-mutational-burden-and-survival-on-immune-checkpoint-inhibition-in-8000-patients-across-24-cancer-types2025-04-10https://resources.flatiron.com/publications/an-exploratory-analysis-of-real-world-end-points-for-assessing-outcomes-among-immunotherapy-treated-patients-with-advanced-non-small-cell-lung-cancer2024-03-26https://resources.flatiron.com/real-world-evidence/what-is-currently-top-of-mind-for-breast-cancer-industry-expertshttps://flatiron.com/hubfs/webinar-what-is-currently-top-of-mind-for-breast-cancer-industry-experts.pngwebinarwhatiscurrentlytopofmindforbreastcancerindustryexpertswebinarwhatiscurrentlytopofmindforbreastcancerindustryexperts2024-10-09https://resources.flatiron.com/publications/real-world-treatment-patterns-and-survival-outcomes-in-second-and-third-line-settings-in-large-b-cell-lymphoma2025-11-03https://resources.flatiron.com/publications/real-world-clinical-characteristics-and-biomarker-profiles-in-a-japanese-breast-cancer-cohort2025-10-23https://resources.flatiron.com/publications/improving-misclassification-of-icd-9-coding-for-bone-metastases-in-electronic-medical-records-emr-using-technology-enabled-abstraction2024-03-27https://resources.flatiron.com/publications/brain-metastases-treatment-patterns-and-outcomes-in-ros1-positive-nsclc-patients-from-us-oncology-community-centers2024-03-26https://resources.flatiron.com/publications/telemedicine-breast-cancer-covid-192024-03-26https://resources.flatiron.com/publications/comparative-overall-survival-of-plus-an-aromatase-inhibitor-mbc-in-the-us-real-world-setting2024-12-04https://resources.flatiron.com/flatiron-stories/kris-civilhttps://flatiron.com/hubfs/Imported_Blog_Media/kris-jr-2-3.pngkrisjr23krisjr23https://flatiron.com/hubfs/Imported_Blog_Media/KrisCivil_illustration_small-w-watermark.jpgKrisCivilillustrationsmallwwatermarkKrisCivilillustrationsmallwwatermarkhttps://flatiron.com/hubfs/Imported_Blog_Media/FH_KrisCivil_190206_B-3.jpgFHKrisCivil190206B3FHKrisCivil190206B3https://flatiron.com/hubfs/Imported_Blog_Media/kris-jr-1-3.pngkrisjr13krisjr132024-03-29https://resources.flatiron.com/real-world-evidence/realizing-rwes-potential-reproducibility-transparency-and-the-future-of-rwd-analyseshttps://flatiron.com/hubfs/Imported_Blog_Media/Reproducibility-Blog-Post-2.jpgReproducibilityBlogPost2ReproducibilityBlogPost22024-03-29https://resources.flatiron.com/publications/treatment-inequities-mnsclc-actionable-driver-oncogenes-first-line2024-05-23https://resources.flatiron.com/real-world-evidence/machine-learning-nlp-real-world-evidencehttps://flatiron.com/hubfs/the-role-of-machine-learning-and-natural-language-processing-in-real-world-evidence.jpgtheroleofmachinelearningandnaturallanguageprocessinginrealworldevidencetheroleofmachinelearningandnaturallanguageprocessinginrealworldevidencehttps://flatiron.com/hubfs/Imported_Blog_Media/the-role-of-machine-learning-and-natural-language-processing-in-real-world-evidence.jpgtheroleofmachinelearningandnaturallanguageprocessinginrealworldevidencetheroleofmachinelearningandnaturallanguageprocessinginrealworldevidence2024-09-16https://resources.flatiron.com/clinical-research/research-methodology-trial-eligibility-criteria-and-diversity-among-patients-with-advanced-nsclchttps://flatiron.com/hubfs/Learnings%20Trial%20eligibility%20criteria%20and%20diversity%20among%20patients%20with%20advanced%20NSCLC.pngLearningsTrialeligibilitycriteriaanddiversityamongpatientswithadvancedNSCLCLearningsTrialeligibilitycriteriaanddiversityamongpatientswithadvancedNSCLC2024-09-16https://resources.flatiron.com/press/flatiron-health-embarks-on-strategic-partnership-with-sanofi-to-make-clinical-trials-more-efficient-by-streamlining-data-acquisition-at-the-point-of-carehttps://flatiron.com/hubfs/flatiron-press-release-collaboration-announcement-sanofi.pngflatironpressreleasecollaborationannouncementsanofiflatironpressreleasecollaborationannouncementsanofi2024-03-27https://resources.flatiron.com/press/myriad-genetics-and-flatiron-health-partner-to-make-genetic-testing-more-accessible-with-electronic-medical-record-integrationhttps://flatiron.com/hubfs/collaboration-announcement-Myriad-MPI.pngcollaborationannouncementMyriadMPIcollaborationannouncementMyriadMPI2024-10-15https://resources.flatiron.com/publications/analysis-of-the-relationship-between-ebv-positivity-and-baseline-characteristics-treatment-patterns-and-outcomes-in-dlbcl2024-11-06https://resources.flatiron.com/clinical-research/why-is-diversity-in-clinical-trials-essentialhttps://flatiron.com/hubfs/Learnings%20Trial%20eligibility%20criteria%20and%20diversity%20among%20patients%20with%20advanced%20NSCLC.pngLearningsTrialeligibilitycriteriaanddiversityamongpatientswithadvancedNSCLCLearningsTrialeligibilitycriteriaanddiversityamongpatientswithadvancedNSCLC2024-09-16https://resources.flatiron.com/publications/real-world-dosing-patterns-and-outcomes-of-patients-with-metastatic-pancreatic-cancer-treated-with-a-liposomal-irinotecan-regimen-in-the-united-states2024-03-26https://resources.flatiron.com/publications/fairness-by-design-end-to-end-bias-evaluation-for-llm-generated-data2025-07-14https://resources.flatiron.com/publications/rwd-derived-response-in-multiple-myeloma2024-03-26https://resources.flatiron.com/flatiron-stories/getting-to-intellij-zenhttps://flatiron.com/hubfs/Imported_Blog_Media/buddha-2.jpgbuddha2buddha22024-03-29https://resources.flatiron.com/publications/enhanced-cost-effectiveness-analysis-using-ehr-data-for-real-world-value2024-03-26https://resources.flatiron.com/press/nccn-and-flatiron-health-announce-collaboration-to-improve-cancer-care-quality-with-real-world-datahttps://flatiron.com/hubfs/FH_NCCN_PressReleases.pngFHNCCNPressReleasesFHNCCNPressReleases2024-09-05https://resources.flatiron.com/real-world-evidence/rwd-tumor-agnostic-drug-developmenthttps://flatiron.com/hubfs/Imported_Blog_Media/season2_panTumor_01.jpgseason2panTumor01season2panTumor012024-09-16https://resources.flatiron.com/real-world-evidence/near-term-opportunities-rwe-regulatoryhttps://flatiron.com/hubfs/Imported_Blog_Media/Lynn.pngLynnLynn2024-09-16https://resources.flatiron.com/publications/characteristics-and-outcomes-of-patients-pts-with-ntrk-fusion-positive-ntrk-metastatic-/-locally-advanced-la-solid-tumours-receiving-non-trk-inhibitor-trki-standa2024-03-26https://resources.flatiron.com/real-world-evidence/clinico-genomic-data-is-a-game-changer-for-precision-oncology/https://flatiron.com/hubfs/cgdb-blog.jpegcgdbblogcgdbblog2024-03-29https://resources.flatiron.com/publications/immune-checkpoint-inhibitors-patterns-end-of-lifehttps://flatiron.com/hubfs/Imported_Blog_Media/RM_openaccessarticle_thumb_02-Mar-06-2023-06-50-48-1238-AM-Mar-10-2023-04-50-59-7386-AM.jpgRMopenaccessarticlethumb02Mar0620230650481238AMMar1020230450597386AMRMopenaccessarticlethumb02Mar0620230650481238AMMar1020230450597386AM2024-03-26https://resources.flatiron.com/publications/machine-learning-model-for-cancer-biomarker-identification-in-electronic-health-records2024-03-26https://resources.flatiron.com/point-of-care/flatiron-hc-supports-success-in-value-based-carehttps://flatiron.com/hubfs/Imported_Blog_Media/flatironhc-supports-success-in-vbc.pngflatironhcsupportssuccessinvbcflatironhcsupportssuccessinvbc2024-04-02https://resources.flatiron.com/point-of-care/interview-with-carmen-jacobson-and-manda-wood-from-carti-cancer-centerhttps://flatiron.com/hubfs/Imported_Blog_Media/thumbnail_1_-1x.jpgthumbnail11xthumbnail11x2024-04-02https://resources.flatiron.com/real-world-evidence/real-world-data-support-new-drug-applicationhttps://flatiron.com/hubfs/Imported_Blog_Media/season1_clip_kiran_02.jpgseason1clipkiran02season1clipkiran022024-09-16https://resources.flatiron.com/publications/use-of-real-world-data-to-understand-barriers-to-interventional-clinical-trial-enrollment-in-community-oncology-clinics2024-03-26https://resources.flatiron.com/flatiron-stories/supersonic-pipelineshttps://flatiron.com/hubfs/Imported_Blog_Media/DSCF5445_03-2.jpgDSCF5445032DSCF54450322024-04-18https://resources.flatiron.com/publications/racial/ethnic-differences-in-real-world-adverse-events-and-survival-among-patients-receiving-immunotherapy-for-advanced-nsclchttps://flatiron.com/hubfs/_Website%20Files/Resource%20Hub%20-%20Defaults/resource-hub-6.pngresourcehub6resourcehub62024-08-19https://resources.flatiron.com/press/press-release/flatiron-health-research-characterizes-real-world-response-associated-endpoint-in-oncology2024-03-27https://resources.flatiron.com/publications/development-of-a-time-to-treatment-metric-across-an-nci-designated-academic-health-system2024-03-26https://resources.flatiron.com/publications/real-world-treatment-patterns-in-1954-us-patients-with-her2-negative-early-breast-cancer-and-germline-brca-mutations-2021-20252025-12-01https://resources.flatiron.com/publications/complementary-roles-for-tissue-and-blood-based-comprehensive-genomic-profiling-for-detection-of-actionable-driver-alterations-in-advanced-nsclc-12024-03-26https://resources.flatiron.com/publications/machine-learning-framework-risk-prediction-oncologyhttps://flatiron.com/hubfs/Imported_Blog_Media/RM_openaccessarticle_thumb_02-Mar-06-2023-06-50-48-1238-AM-Mar-10-2023-04-50-59-7386-AM.jpgRMopenaccessarticlethumb02Mar0620230650481238AMMar1020230450597386AMRMopenaccessarticlethumb02Mar0620230650481238AMMar1020230450597386AM2024-03-26https://resources.flatiron.com/flatiron-stories/meet-our-changemakers-nathan-hobrath-associate-principal-of-clinical-research-partnershipshttps://flatiron.com/hubfs/Nathan%20Hobrath.pngNathanHobrathNathanHobrath2024-07-11https://resources.flatiron.com/publications/real-world-treatment-patterns-and-clinical-outcomes-in-patients-with-metastatic-neuroendocrine-neoplasms-of-the-lung-nen-l2025-08-13https://resources.flatiron.com/flatiron-stories/a-short-story-of-bootcamp-at-flatiron-health2024-03-29https://resources.flatiron.com/publications/comparing-countries-time-to-treatment-initiation-a-study-of-metastatic-breast-cancer-in-austria-and-the-united-states2025-11-10https://resources.flatiron.com/publications/external-validity-lymphoma-clinical-trials2024-03-26https://resources.flatiron.com/real-world-evidence/the-future-of-ctdna-in-cancer-care-real-world-signals-real-clinical-impacthttps://flatiron.com/hubfs/blog-erin-fidyk-ctDNA.pngblogerinfidykctDNAblogerinfidykctDNA2025-09-29https://resources.flatiron.com/point-of-care/driving-health-equity-in-oncologyhttps://flatiron.com/hubfs/health-equity-coa-2023.jpghealthequitycoa2023healthequitycoa20232024-07-22https://resources.flatiron.com/real-world-evidence/real-world-evidence-oncology-drug-approvals-fdahttps://flatiron.com/hubfs/Imported_Blog_Media/season1_clip_chana_10-1.jpgseason1clipchana101season1clipchana1012024-09-16https://resources.flatiron.com/publications/real-world-characterization-of-advanced-non-small-cell-lung-cancer-in-never-smokers2024-03-26https://resources.flatiron.com/publications/temporally-integrated-framework-for-treatment-intervals-tifti-a-framework-for-extracting-drug-intervals-from-longitudinal-clinic-notes2024-03-26https://resources.flatiron.com/clinical-research/what-are-the-challenges-sponsors-face-today-when-pursuing-a-pmr-pmr-studyhttps://flatiron.com/hubfs/What%20are%20the%20challenges%20sponsors%20face%20today%20when%20pursuing%20a%20PMRPMR%20study.pngWhatarethechallengessponsorsfacetodaywhenpursuingaPMRPMRstudyWhatarethechallengessponsorsfacetodaywhenpursuingaPMRPMRstudyhttps://flatiron.com/hubfs/_Website%20Files/Resource%20Hub%20-%20Defaults/resource-hub-4.pngresourcehub4resourcehub42024-09-16https://resources.flatiron.com/publications/benchmarking-an-electronic-health-records-derived-breast-cancer-cohort-against-national-data-in-germany-implications-for-real-world-research2026-03-10https://resources.flatiron.com/publications/racial-disparities-in-the-use-of-programmed-death-1-checkpoint-inhibitors2024-03-27https://resources.flatiron.com/press/flatiron-health-to-be-a-featured-presenter-at-the-2023-clinical-pathways-congress-cancer-care-business-exchangehttps://flatiron.com/hubfs/FH_CPC_PressReleases.pngFHCPCPressReleasesFHCPCPressReleases2024-04-09https://resources.flatiron.com/press/press-release/dr-shrujal-baxi-memorial-sloan-kettering-medical-oncologist-and-cancer-researcher-joins-flatiron-health2024-03-27https://resources.flatiron.com/real-world-evidence/impact-covid-communityhttps://flatiron.com/hubfs/Imported_Blog_Media/BLOG_IMAGE_Quarantine_1028X880-2.jpgBLOGIMAGEQuarantine1028X8802BLOGIMAGEQuarantine1028X88022024-03-29https://resources.flatiron.com/press/nrg-oncology-and-flatiron-health-announce-collaboration-to-leverage-leading-technology-to-drive-more-efficient-clinical-trialshttps://flatiron.com/hubfs/flatiron-NRG-clinical-pipe.pngflatironNRGclinicalpipeflatironNRGclinicalpipe2025-03-19https://resources.flatiron.com/publications/the-bev1l-study-do-real-world-outcomes-associated-with-the-addition-of-bevacizumab-to-first-line-chemotherapy-in-patients-with-ovarian-cancer2025-05-13https://resources.flatiron.com/clinical-research/improving-clinical-research-from-within-bridging-the-gap-between-research-and-carehttps://flatiron.com/hubfs/CR%20FierceBiotech%20Webinar.pngCRFierceBiotechWebinarCRFierceBiotechWebinarhttps://flatiron.com/hubfs/_Website%20Files/Resource%20Hub%20-%20Webinar/webinar-improving-clinical-research-from-within.pngwebinarimprovingclinicalresearchfromwithinwebinarimprovingclinicalresearchfromwithin2024-09-16https://resources.flatiron.com/publications/machine-learning-research-centric-framework2024-03-26https://resources.flatiron.com/flatiron-stories/perspective-comes-when-you-least-expect-ithttps://flatiron.com/hubfs/Imported_Blog_Media/max-2.jpgmax2max2https://flatiron.com/hubfs/Imported_Blog_Media/Trucks.jpgTrucksTrucks2024-03-29https://resources.flatiron.com/press/press-release/flatiron-health-welcomes-javier-jimenez-as-chief-medical-officerhttps://flatiron.com/hubfs/_Website%20Files/Resource%20Hub%20-%20Defaults/resource-hub-3.pngresourcehub3resourcehub32024-04-26https://resources.flatiron.com/publications/trends-in-checkpoint-inhibitor-therapy-for-advanced-urothelial-cell-carcinoma-at-the-end-of-life-insights-from-real-world-practice2024-03-26https://resources.flatiron.com/real-world-evidence/mantle-cell-lymphoma-treatment-patterns-rwdhttps://flatiron.com/hubfs/Janssen%20MCL.pngJanssenMCLJanssenMCLhttps://flatiron.com/hubfs/_Website%20Files/Resource%20Hub%20-%20Defaults/resource-hub-7.pngresourcehub7resourcehub72024-09-16https://resources.flatiron.com/publications/assessment-of-racialethnic-inequities-in-uptake-of-psma-pet-scans-among-patients-with-metastatic-prostate-cancer-in-the-united-states2025-05-30https://resources.flatiron.com/real-world-evidence/comment-on-real-world-data-assessing-electronic-health-recordshttps://flatiron.com/hubfs/Imported_Blog_Media/Policy-Image-2.jpegPolicyImage2PolicyImage22024-03-29https://resources.flatiron.com/publications/quantifying-bias-in-flatiron-ml-extracted-variables-for-inference-in-clinical-oncology2024-03-26https://resources.flatiron.com/clinical-research/how-is-flatiron-clinical-pipe-evolving-in-2023https://flatiron.com/hubfs/_Website%20Files/Resource%20Hub%20-%20Defaults/resource-hub-9.pngresourcehub9resourcehub9https://flatiron.com/hubfs/_Website%20Files/Video%20Thumbnails%20-%20Large/FH_Website_DemoVideo_ClinicalPipe.pngFHWebsiteDemoVideoClinicalPipeFHWebsiteDemoVideoClinicalPipe2024-09-16https://resources.flatiron.com/real-world-evidence/with-real-world-evidence-the-whole-is-greater-than-the-sum-of-its-partshttps://flatiron.com/hubfs/With%20real-world%20evidence%2c%20the%20whole%20is%20greater%20than%20the%20sum%20of%20its%20parts.pngWithrealworldevidencethewholeisgreaterthanthesumofitspartsWithrealworldevidencethewholeisgreaterthanthesumofitsparts2025-07-13https://resources.flatiron.com/flatiron-storieshttps://flatiron.com/hubfs/_Website%20Files/Resource%20Hub%20-%20Changemakers/Melissa%20Estevez%20May%202024.pngMelissaEstevezMay2024MelissaEstevezMay2024https://flatiron.com/hubfs/article-ngs-testing-reports.pngarticlengstestingreportsarticlengstestingreportshttps://flatiron.com/hubfs/NathanHubbard.pngNathanHubbardNathanHubbardhttps://flatiron.com/hubfs/flatiron-press-release-multinational-network-1.pngflatironpressreleasemultinationalnetwork1flatironpressreleasemultinationalnetwork1https://flatiron.com/hubfs/durham-101.jpgdurham101durham101https://flatiron.com/hubfs/_Website%20Files/Resource%20Hub%20-%20Changemakers/meet-our-changemakers-nick-accomando.pngmeetourchangemakersnickaccomandomeetourchangemakersnickaccomandohttps://flatiron.com/hubfs/Nathan%20Hobrath.pngNathanHobrathNathanHobrathhttps://flatiron.com/hubfs/Using%20machine%20learning.jpegUsingmachinelearningUsingmachinelearninghttps://flatiron.com/hubfs/_Website%20Files/Resource%20Hub%20-%20Defaults/resource-hub-9.pngresourcehub9resourcehub92024-04-17https://resources.flatiron.com/press/press-release/flatiron-health-announces-research-to-be-presented-at-american-society-of-clinical-oncology-2022-annual-meetinghttps://flatiron.com/hubfs/ASCO%20RWE%20Research%20Image.jpgASCORWEResearchImageASCORWEResearchImage2024-04-26https://resources.flatiron.com/point-of-care/navigating-the-future-of-healthcare-and-innovation-in-point-of-care-decisionshttps://flatiron.com/hubfs/AMCCBS%202024.pngAMCCBS2024AMCCBS20242024-04-09https://resources.flatiron.com/point-of-care/the-oncology-care-first-model-a-new-paradigm-in-cancer-care-paymenthttps://flatiron.com/hubfs/Imported_Blog_Media/flatironhc-the-oncology-first-model%20(1).pngflatironhctheoncologyfirstmodel1flatironhctheoncologyfirstmodel12024-04-18https://resources.flatiron.com/publications/hepatic-renal-function-non-small-cell-lung-cancer-real-world-data-trial-data2024-03-26https://resources.flatiron.com/point-of-care/mipshttps://flatiron.com/hubfs/Imported_Blog_Media/Impact-on-MIPS-1028x880-2.jpgImpactonMIPS1028x8802ImpactonMIPS1028x88022024-04-02https://resources.flatiron.com/publications/analytic-considerations-for-constructing-real-world-comparator-cohorts2024-03-26https://resources.flatiron.com/point-of-care/clearview-cancer-institute-achieves-high-concordance-with-nccn-guidelines-using-flatiron-assisthttps://flatiron.com/hubfs/_Website%20Files/Resource%20Hub%20-%20Press%20Releases/flatiron-assist-press-release.pngflatironassistpressreleaseflatironassistpressrelease2024-07-09https://resources.flatiron.com/flatiron-stories/how-to-drive-product-development-with-datahttps://flatiron.com/hubfs/Imported_Blog_Media/first-round-2.pngfirstround2firstround22024-03-29https://resources.flatiron.com/publications/concordance-of-real-world-versus-conventional-progression-free-survival-from-a-phase-3-trial-of-endocrine-therapy-as-first-line-treatment-for-metastatic-breast-ca2024-03-26https://resources.flatiron.com/publications/using-large-language-models-for-scalable-extraction-of-real-world-progression-events-across-multiple-cancer-types2025-07-16https://resources.flatiron.com/publications/real-world-progression-free-survival-2-and-tumor-response-with-cdk4/6is-aromatase-inhibitor-in-patients-with-hr/her2-metastatic-breast-cancer2025-12-01https://resources.flatiron.com/press/press-release/flatiron-health-announces-carolyn-starrett-as-new-ceo2024-04-26https://resources.flatiron.com/publications/performance-new-staging-systems-myeloma2024-03-26https://resources.flatiron.com/publications/ispor-the-fda-and-the-evolving-regulatory-science-of-medical-device-products2024-03-26https://resources.flatiron.com/flatiron-stories/uniqueness-in-postgresql-constraints-versus-indexes2024-03-29https://resources.flatiron.com/publications/organ-dysfunction-advanced-melanoma-immune-checkpoint-inhibitorshttps://flatiron.com/hubfs/Imported_Blog_Media/RM_openaccessarticle_thumb_02-Mar-06-2023-06-50-48-1238-AM-3.jpgRMopenaccessarticlethumb02Mar0620230650481238AM3RMopenaccessarticlethumb02Mar0620230650481238AM32024-03-26https://resources.flatiron.com/publications/real-world-outcomes-of-prophylactic-cranial-irradiation-in-extensive-stage-small-cell-lung-cancer-treated-with-first-line-immunotherapy-and-platinum-etoposide2025-08-13https://resources.flatiron.com/press/press-release/flatiron-health-announces-collaborative-research-to-be-presented-at-asco-2017-annual-meeting2024-03-27https://resources.flatiron.com/publications/impact-of-antibiotics-on-overall-survival-in-patients-with-advanced-non-small-cell-lung-cancer-and-melanoma-treated-with-first-line-immune-checkpoint-inhibition2024-03-26https://resources.flatiron.com/publications/implementation-of-an-ehr-embedded-decision-support-tool-in-community-oncology-practices2024-03-26https://resources.flatiron.com/publications/privacy-preserving-error-analysis-loop-for-ml-based-extraction-of-oncology-ehr-data2025-11-06https://resources.flatiron.com/press/paradigm-health-acquires-flatiron-healths-clinical-research-business-and-forms-strategic-partnership-to-rebuild-clinical-research-ecosystemhttps://flatiron.com/hubfs/Paradigm%20Health-1.pngParadigmHealth1ParadigmHealth12025-12-04https://resources.flatiron.com/publications/real-world-data-sources-for-oncology-in-five-major-european-countries-a-targeted-literature-review2024-11-04https://resources.flatiron.com/press/guardant-health-flatiron-health-announce-integration-of-guardant-genomic-profiling-tests-into-oncoemr-platformhttps://flatiron.com/hubfs/FH_Website_ResourceHubThumbnails_PressReleases_Guardant.pngFHWebsiteResourceHubThumbnailsPressReleasesGuardantFHWebsiteResourceHubThumbnailsPressReleasesGuardant2024-04-09https://resources.flatiron.com/press/flatiron-health-demonstrates-real-world-complexity-of-genitourinary-cancer-care-at-asco-gu-2026https://flatiron.com/hubfs/ascogu26-1.pngascogu261ascogu2612026-03-12https://resources.flatiron.com/publications/natural-language-processing-based-detection-of-transgender-and-gender-non-conforming-patients-in-electronic-health-record-derived-data2024-03-26https://resources.flatiron.com/point-of-care/why-appropriate-use-criteria-matters-and-what-it-means-for-community-oncologyhttps://flatiron.com/hubfs/Imported_Blog_Media/why-appropriate-use-criteria-matters.pngwhyappropriateusecriteriamatterswhyappropriateusecriteriamattershttps://flatiron.com/hubfs/Imported_Blog_Media/In-Line-Graphic-for-AUC-Blog-Post-1.jpgInLineGraphicforAUCBlogPost1InLineGraphicforAUCBlogPost12024-04-02https://resources.flatiron.com/flatiron-stories/the-importance-of-lunchhttps://flatiron.com/hubfs/Imported_Blog_Media/lunch_1030x532-1-2.jpglunch1030x53212lunch1030x532122024-03-29https://resources.flatiron.com/flatiron-stories/learning-to-negotiate-from-a-toddlerhttps://flatiron.com/hubfs/Imported_Blog_Media/2018_1107_rainclouds-stacy.jpg20181107raincloudsstacy20181107raincloudsstacyhttps://flatiron.com/hubfs/Imported_Blog_Media/stacy-boys-2.pngstacyboys2stacyboys22024-03-29https://resources.flatiron.com/publications/trk-fusion-cancer-patient-characteristics-and-survival-analysis-in-the-real-world-setting2024-03-26https://resources.flatiron.com/publications/prevalence-and-incidence-of-ros1-and-ntrk-rearrangements-in-real-world-patients-with-advanced-non-small-cell-lung-cancer-in-the-united-states2024-04-16https://resources.flatiron.com/publications/the-emerging-role-of-real-world-data-in-oncology-care-in-japan2024-03-26https://resources.flatiron.com/publications/age-related-real-world-outcomes-for-patients-pts-with-metastatic-colorectal-cancer-mcrc2024-03-26https://resources.flatiron.com/press/press-release/flatiron-health-and-via-oncology-collaborate-to-embed-via-pathways-into-oncoemr2024-03-27https://resources.flatiron.com/real-world-evidence/flatiron-health-adds-flexibility-to-its-flagship-subscription-dataset-by-scaling-a-key-research-outcome-variable-real-world-responsehttps://flatiron.com/hubfs/_Website%20Files/Resource%20Hub%20-%20Defaults/resource-hub-9.pngresourcehub9resourcehub92024-04-09https://resources.flatiron.com/publications/the-impact-of-missing-deaths-on-survival-analyses-conducted-in-an-oncology-ehr-database2024-03-26https://resources.flatiron.com/publications/real-world-endpoints-recist-progressionhttps://flatiron.com/hubfs/Imported_Blog_Media/RM_openaccessarticle_thumb_02-Mar-06-2023-06-50-48-1238-AM-3.jpgRMopenaccessarticlethumb02Mar0620230650481238AM3RMopenaccessarticlethumb02Mar0620230650481238AM32024-03-27https://resources.flatiron.com/point-of-care/grow-your-practice-not-your-admin-burdenhttps://flatiron.com/hubfs/FH-OncoCloudVirtual-session-thumbnail_grow-your-practice-not-your-admin-burden%20(2).pngFHOncoCloudVirtualsessionthumbnailgrowyourpracticenotyouradminburden2FHOncoCloudVirtualsessionthumbnailgrowyourpracticenotyouradminburden22024-09-16https://resources.flatiron.com/publications/beyond-brca-real-world-outcomes-with-polyadp-ribose-polymerase-inhibitors-among-patients-with-metastatic-castration-resistant-prostate-cancer-and-ho-17703165202072026-02-23https://resources.flatiron.com/real-world-evidence/as-genomic-profiling-becomes-standard-of-care-real-world-genomic-data-comes-of-agehttps://flatiron.com/hubfs/Imported_Blog_Media/BLOG_IMAGECGDB_1028X880.jpegBLOGIMAGECGDB1028X880BLOGIMAGECGDB1028X8802024-03-29https://resources.flatiron.com/publications/evidence-of-low-incidence-of-myelodysplastic-syndrome-mds-in-patients-exposed-to-bendamustine-treatment-for-chronic-lymphocytic-leukemia/small-lymphocytic-lymphom2024-03-27https://resources.flatiron.com/publications/descriptive-comparison-of-patient-characteristics-and-treatment-patterns-in-metastatic-nsclc-us-and-france-cohorts-to-inform-transportability2025-10-22https://resources.flatiron.com/publications/bayesian-additional-evidence-for-decision-making-under-small-sample-uncertainty2024-03-26https://resources.flatiron.com/publications/real-world-progression-treatment-overall-survival-immunotherapyhttps://flatiron.com/hubfs/Imported_Blog_Media/RM_openaccessarticle_thumb_03-1.jpgRMopenaccessarticlethumb031RMopenaccessarticlethumb0312024-03-27https://resources.flatiron.com/clinical-research/whats-the-consequence-of-failure-in-pmc-pmr-studieshttps://flatiron.com/hubfs/Whats%20the%20consequence%20of%20failure%20in%20PMCPMR%20studies.pngWhatstheconsequenceoffailureinPMCPMRstudiesWhatstheconsequenceoffailureinPMCPMRstudieshttps://flatiron.com/hubfs/_Website%20Files/Resource%20Hub%20-%20Defaults/resource-hub-8.pngresourcehub8resourcehub82024-09-16https://resources.flatiron.com/publications/a-novel-predictive-gene-signature-for-liver-metastasis-lm-in-nsclc-using-a-comprehensive-linked-clinical-molecular-database2025-08-13https://resources.flatiron.com/press/press-release/esmo-20192024-03-27https://resources.flatiron.com/publications/analysis-real-world-progression-endpoints-different-cancer-typeshttps://flatiron.com/hubfs/Imported_Blog_Media/RM_openaccessarticle_thumb_02-Mar-06-2023-06-50-48-1238-AM-Mar-10-2023-04-50-59-7386-AM.jpgRMopenaccessarticlethumb02Mar0620230650481238AMMar1020230450597386AMRMopenaccessarticlethumb02Mar0620230650481238AMMar1020230450597386AM2024-04-16https://resources.flatiron.com/publications/early-onset-pancreatic-cancer-research-making-sense-of-confounding-and-bias2024-03-26https://resources.flatiron.com/real-world-evidence/evidence-across-country-bordershttps://flatiron.com/hubfs/Imported_Blog_Media/transportability%20article%20-%20figure%201.jpgtransportabilityarticlefigure1transportabilityarticlefigure1https://flatiron.com/hubfs/Imported_Blog_Media/article-hero.jpegarticleheroarticlehero2024-03-29https://resources.flatiron.com/publications/development-and-validation-of-a-high-quality-composite-real-world-mortality-endpoint2024-03-26https://resources.flatiron.com/publications/authors-response-to-a-letter-in-support-of-real-world-recist2024-03-26https://resources.flatiron.com/publications/laboratory-testing-patterns-in-patients-with-breast-cancer-treated-with-cdk4/6-inhibitors-a-multi-country-electronic-health-record-study-from-the-uk-17606296204072025-10-22https://resources.flatiron.com/publications/real-world-outcomes-for-advanced-non-small-cell-lung-cancer-patients-treated-with-a-pd-l1-inhibitor-beyond-progression2024-03-26https://resources.flatiron.com/publications/tmb-measurement-from-an-fda-approved-assay-and-real-world-overall-survival-on-single-agent-immune-checkpoint-inhibitorshttps://flatiron.com/hubfs/_Website%20Files/Resource%20Hub%20-%20Press%20Releases/flatiron-press-release-4.pngflatironpressrelease4flatironpressrelease42024-03-26https://resources.flatiron.com/flatiron-stories/blackiron-presents-homecoming-2020https://flatiron.com/hubfs/Imported_Blog_Media/Black_iron_632X396_updated.jpgBlackiron632X396updatedBlackiron632X396updatedhttps://flatiron.com/hubfs/Imported_Blog_Media/blackiron-homecoming-4-3.pngblackironhomecoming43blackironhomecoming43https://flatiron.com/hubfs/Imported_Blog_Media/blackiron-homecoming-1-3.pngblackironhomecoming13blackironhomecoming13https://flatiron.com/hubfs/Imported_Blog_Media/blackiron-homecoming-5-3.pngblackironhomecoming53blackironhomecoming532024-03-29https://resources.flatiron.com/publications/a-hybrid-approach-to-scalable-real-world-data-curation-by-machine-learning-and-human-experts2024-03-26https://resources.flatiron.com/press/newcastle-hospitals-agree-new-data-partnerships-to-improve-care-and-treatmenthttps://flatiron.com/hubfs/partnership-announcement-flatiron-health-uk-nuth%20(2)-1.pngpartnershipannouncementflatironhealthuknuth21partnershipannouncementflatironhealthuknuth212025-05-29https://resources.flatiron.com/publications/a-framework-for-evaluating-performance-of-llm-based-extraction-from-the-electronic-health-record-across-different-healthcare-systems2025-11-06https://resources.flatiron.com/publications/mediators-of-racial/ethnic-inequities-in-clinical-trial-participation-among-us-patients-with-cancerhttps://flatiron.com/hubfs/_Website%20Files/Resource%20Hub%20-%20Press%20Releases/flatiron-press-release-4.pngflatironpressrelease4flatironpressrelease42024-03-27https://resources.flatiron.com/point-of-care/the-physician-visit-notehttps://flatiron.com/hubfs/Imported_Blog_Media/visit-note-image-2.jpgvisitnoteimage2visitnoteimage22024-04-02https://resources.flatiron.com/press/flatiron-health-announces-research-to-be-presented-at-international-society-for-pharmacoeconomics-and-outcomes-research-europe-2024-annual-meetinghttps://flatiron.com/hubfs/flatiron-press-release-ISPOR-Europe.pngflatironpressreleaseISPOREuropeflatironpressreleaseISPOREurope2024-11-06https://resources.flatiron.com/publications/racial-disparities-multiple-myeloma-real-world-data2024-03-26https://resources.flatiron.com/point-of-care/decision-support-technology-moves-the-needle-for-oncologistshttps://flatiron.com/hubfs/_Website%20Files/Resource%20Hub%20-%20Illustrations/how-decision-support-technology-moves-the-needle-on-value-based-care-for-oncologists.jpghowdecisionsupporttechnologymovestheneedleonvaluebasedcareforoncologistshowdecisionsupporttechnologymovestheneedleonvaluebasedcareforoncologists2024-04-16https://resources.flatiron.com/publications/real-world-study-of-breast-cancer-epidemiology-and-treatment-patterns-a-pilot-study-to-assess-ehr-derived-data-in-the-united-kingdom2025-10-22https://resources.flatiron.com/publications/comparing-phase-3-go-decisions-ph3-go-between-single-arm-trials-with-real-world-external-control-satrwec-versus-randomized-phase-2-trials-rph22024-03-27https://resources.flatiron.com/publications/adoption-of-immunotherapy-into-real-world-practice-insights-from-the-use-of-checkpoint-inhibitors2024-03-27https://resources.flatiron.com/publications/are-real-world-survival-outcomes-in-metastatic-breast-cancer-transportable-between-the-us-and-austria2025-11-10https://resources.flatiron.com/press/press-release/flatiron-health-announces-strategic-relationships-with-celgene-and-amgen-to-further-advance-personalized-medicine-for-cancer-patients-and-accelerate2024-04-18https://resources.flatiron.com/publications/organ-dysfunction-and-clinical-outcomes-in-patients-treated-with-immune-checkpoint-inhibitors2024-03-26https://resources.flatiron.com/press/press-release/flatiron-health-and-unlimited-systems-announce-partnershiphttps://flatiron.com/hubfs/_Website%20Files/Resource%20Hub%20-%20Defaults/resource-hub-9.pngresourcehub9resourcehub92024-03-29https://resources.flatiron.com/flatiron-stories/terrible-but-fine-how-we-cope-when-the-world-is-endinghttps://flatiron.com/hubfs/Imported_Blog_Media/Terrible-but-fine-final-image-2.jpgTerriblebutfinefinalimage2Terriblebutfinefinalimage22024-03-29https://resources.flatiron.com/real-world-evidence/integrated-evidence-generationhttps://flatiron.com/hubfs/_Website%20Files/Resource%20Hub%20-%20ResearchX/ResearchX-thumbnail-1.jpgResearchXthumbnail1ResearchXthumbnail12025-03-05https://resources.flatiron.com/publications/improving-diversity-clinical-trials-real-world-data2024-03-26https://resources.flatiron.com/publications/prognostic-value-of-patient-reported-outcomes-pros-in-advanced-cancer2024-03-26https://resources.flatiron.com/publications/pd-l1-tumor-proportion-score-and-clinical-benefit-from-first-line-pembrolizumab-in-patients-with-advanced-nonsquamous-versus-squamous-non-small-cell-lung-cancer2024-03-26https://resources.flatiron.com/real-world-evidence/bridging-innovation-and-practice-the-current-and-future-landscape-of-breast-cancer-carehttps://flatiron.com/hubfs/_Website%20Files/Resource%20Hub%20-%20Webinar/webinar-post-asco-2024.pngwebinarpostasco2024webinarpostasco20242024-09-16https://resources.flatiron.com/publications/racial-disparities-in-second-line-2l-treatment-patterns-and-overall-survival-among-real-world-patients-pts-with-hormone-receptor-positive-her2-negative-hrher2-met2024-03-26https://resources.flatiron.com/real-world-evidence/the-future-of-identifying-fit-for-purpose-real-world-evidence-for-regulatory-submissions-a-breakdown-of-the-regan-udall-foundation-for-the-fd-1734015857203https://flatiron.com/hubfs/flatiron-regulatory-submissions-QCARD%20(1).pngflatironregulatorysubmissionsQCARD1flatironregulatorysubmissionsQCARD12024-12-12https://resources.flatiron.com/presshttps://flatiron.com/hubfs/press-release-3.pngpressrelease3pressrelease3https://flatiron.com/hubfs/ascogu26-1.pngascogu261ascogu261https://flatiron.com/hubfs/press-release-2%20(1).pngpressrelease21pressrelease21https://flatiron.com/hubfs/ET-2026%20(2).pngET20262ET20262https://flatiron.com/hubfs/SABCS-2025-overview.pngSABCS2025overviewSABCS2025overviewhttps://flatiron.com/hubfs/_Website%20Files/Resource%20Hub%20-%20Defaults/resource-hub-4.pngresourcehub4resourcehub4https://flatiron.com/hubfs/Paradigm%20Health-1.pngParadigmHealth1ParadigmHealth1https://flatiron.com/hubfs/press-release-2.pngpressrelease2pressrelease2https://flatiron.com/hubfs/ASH-2025.pngASH2025ASH2025https://flatiron.com/hubfs/esmoai25.pngesmoai25esmoai252024-04-17https://resources.flatiron.com/press/press-release/flatiron-health-announces-nature-digital-medicine-publication-of-machine-learning-development-and-evaluation-framework-supporting-prospective-clinichttps://flatiron.com/hubfs/_Website%20Files/Resource%20Hub%20-%20Partner%20Logos/nature-journal-flatiron.pngnaturejournalflatironnaturejournalflatiron2024-03-27https://resources.flatiron.com/point-of-care/managing-clinical-pathwayshttps://flatiron.com/hubfs/Managing%20clinical%20pathways.pngManagingclinicalpathwaysManagingclinicalpathways2024-09-16https://resources.flatiron.com/press/press-release/nebraska-cancer-specialists-selects-flatiron-healths-oncocloudtm-platform-to-maximize-operational-efficiencies-and-optimize-clinician-workflow2024-03-27https://resources.flatiron.com/publications/trends-in-end-of-life-eol-systemic-oncologic-treatment-in-contemporary-clinical-practice-insights-from-real-world-data2024-03-26https://resources.flatiron.com/publications/real-world-outcomes-of-advanced-nsclc-patients-with-common-and-uncommon/complex-egfr-mutation-profiles2024-03-26https://resources.flatiron.com/publications/quantifying-the-value-of-multi-gene-testing-in-resected-early-stage-nsclc2024-03-26https://resources.flatiron.com/point-of-care/strategies-for-sustainable-health-equity-initiativeshttps://flatiron.com/hubfs/Strategies%20for%20sustainable%20health%20equity%20initiatives.pngStrategiesforsustainablehealthequityinitiativesStrategiesforsustainablehealthequityinitiatives2024-09-16https://resources.flatiron.com/press/press-release/protocol-first-joins-flatiron-healthhttps://flatiron.com/hubfs/_Website%20Files/Resource%20Hub%20-%20Defaults/resource-hub-8.pngresourcehub8resourcehub82024-03-29https://resources.flatiron.com/publications/real-world-rw-ctdna-testing-trends-and-associated-outcomes-in-patients-pts-with-early-stage-breast-cancer-ebc2025-05-22https://resources.flatiron.com/publications/real-world-clinical-outcomes-for-advanced/metastatic-non-small-cell-lung-cancer-patients-treated-with-second-line-ramucirumab-plus-docetaxel-post-frontline-platin2024-03-26https://resources.flatiron.com/publications/can-early-us-adoption-of-cancer-drugs-inform-hta-decision-making2024-03-26https://resources.flatiron.com/press/press-release/roche-completes-acquisition-of-flatiron-health2024-03-27https://resources.flatiron.com/real-world-evidence/tools-for-reproducible-real-world-data-analysishttps://flatiron.com/hubfs/Imported_Blog_Media/FH_blog_machine_181029.jpgFHblogmachine181029FHblogmachine1810292024-04-18https://resources.flatiron.com/clinical-research/oncology-trials-a-new-approach-to-improve-accuracy-and-alleviate-burden-associated-with-patient-identificationhttps://flatiron.com/hubfs/_Website%20Files/Resource%20Hub%20-%20Interviews/oncology-trials-interview-with-anosheh-afghahi.pngoncologytrialsinterviewwithanoshehafghahioncologytrialsinterviewwithanoshehafghahi2025-02-18https://resources.flatiron.com/point-of-care/webinar-the-age-of-ai-and-machine-learning-is-here-what-does-that-mean-for-cancer-carehttps://flatiron.com/hubfs/123242%20-%20LinkedIn%20post%20for%20Beckers%20July%20Webinar%20Session_Blog.png123242LinkedInpostforBeckersJulyWebinarSessionBlog123242LinkedInpostforBeckersJulyWebinarSessionBlog2025-01-15https://resources.flatiron.com/publications/using-regression-discontinuity-in-time-design-for-real-world-comparative-effectiveness-a-case-study-for-the-second-line-use-of-pembrolizumab-in-adva-17454350323262025-04-23https://resources.flatiron.com/publications/tumor-mutational-burden-and-pd-l1-expression-as-predictors-of-response-to-immunotherapy-in-nsclc2024-03-26https://resources.flatiron.com/clinical-research/what-role-does-technology-play-in-pmc-pmr-studies-supported-by-flatironhttps://flatiron.com/hubfs/What%20role%20does%20technology%20play%20in%20PMCPMR%20studies%2c%20supported%20by%20Flatiron.pngWhatroledoestechnologyplayinPMCPMRstudiessupportedbyFlatironWhatroledoestechnologyplayinPMCPMRstudiessupportedbyFlatiron2024-09-16https://resources.flatiron.com/real-world-evidence/real-world-outcomes-msi-h-real-world-datahttps://flatiron.com/hubfs/Imported_Blog_Media/season2_panTumor_clip_tamaraSnow_01.jpgseason2panTumorcliptamaraSnow01season2panTumorcliptamaraSnow012024-09-16https://resources.flatiron.com/publications/disparities-in-broad-based-genomic-sequencing-for-patients-with-advanced-non-small-cell-lung-cancer2024-03-26https://resources.flatiron.com/flatiron-stories/when-two-worlds-collide-merging-two-engineering-teams-and-cultureshttps://flatiron.com/hubfs/Imported_Blog_Media/When-Two-Worlds-Collide-171018.pngWhenTwoWorldsCollide171018WhenTwoWorldsCollide1710182024-03-29https://resources.flatiron.com/publications/treatment-patterns-for-advanced-non-small-cell-lung-cancer-after-platinum-containing-therapy-in-us-community-oncology-clinical-practice2024-03-27https://resources.flatiron.com/point-of-care/back-to-the-futurehttps://flatiron.com/hubfs/Imported_Blog_Media/FH_Blog_TeshCvs_180409-2.jpgFHBlogTeshCvs1804092FHBlogTeshCvs18040922024-04-18https://resources.flatiron.com/press/caris-life-sciences-and-flatiron-health-partner-to-create-transformational-real-world-data-offeringhttps://flatiron.com/hubfs/FH_Website_CarisLS_PressReleases.pngFHWebsiteCarisLSPressReleasesFHWebsiteCarisLSPressReleases2024-07-09https://resources.flatiron.com/clinical-research/what-does-diversity-in-clinical-trials-look-like-todayhttps://flatiron.com/hubfs/_Website%20Files/Resource%20Hub%20-%20Defaults/resource-hub-9.pngresourcehub9resourcehub9https://flatiron.com/hubfs/What%20does%20diversity%20in%20clinical%20trials%20look%20like%20today.pngWhatdoesdiversityinclinicaltrialslookliketodayWhatdoesdiversityinclinicaltrialslookliketoday2024-09-16https://resources.flatiron.com/publications/hhv-8-negative-idiopathic-multicentric-castleman-disease-siltuximab2024-03-26https://resources.flatiron.com/publications/carfilzomib-prescribing-patterns-and-outcomes-for-relapsed-or-refractory-multiple-myeloma-a-real-world-analysis2025-04-21https://resources.flatiron.com/press/press-release/leading-real-world-data-and-analytics-organizations-form-industry-coalition-to-advance-policies-to-support-regulatory-use-of-real-world-evidence-22024-03-27https://resources.flatiron.com/press/flatiron-health-announces-quincy-weatherspoon-as-vice-president-and-general-manager-for-point-of-care-businesshttps://flatiron.com/hubfs/quincy-weatherspoon-poc-headshot.pngquincyweatherspoonpocheadshotquincyweatherspoonpocheadshot2024-09-05https://resources.flatiron.com/publications/real-world-measurable-residual-disease-mrd-testing-patterns-and-associated-outcomes-in-patients-with-philadelphia-negative-b-cell-acute-lymphoblastic-leukemia2025-11-03https://resources.flatiron.com/publications/association-between-post-treatment-alpha-fetoprotein-afp-reduction-and-outcomes-in-real-world-us-patients-with-advanced-hepatocellular-carcinoma2024-03-26https://resources.flatiron.com/publications/real-world-evidence-in-support-of-precision-medicine-clinico-genomic-cancer-data-as-a-case-study2024-03-27https://resources.flatiron.com/publications/the-nccn-flatiron-outcomes-database-collaborative-evidence-development-and-quality-improvement-in-oncology2024-03-27https://resources.flatiron.com/real-world-evidence/real-world-clinico-genomic-evidence-can-fill-knowledge-gaps-and-identify-unmet-needs-for-patients-with-lung-cancerhttps://flatiron.com/hubfs/_Website%20Files/Resource%20Hub%20-%20Illustrations/RWE%20can%20fill%20gaps%20for%20lung%20cancer.jpgRWEcanfillgapsforlungcancerRWEcanfillgapsforlungcancer2024-10-14https://resources.flatiron.com/flatiron-stories/how-to-run-engineering-team-meetings-and-not-waste-anyones-timehttps://flatiron.com/hubfs/Imported_Blog_Media/hourglass-2.jpghourglass2hourglass22024-03-29https://resources.flatiron.com/flatiron-stories/crisis-driven-development-or-how-to-be-your-best-when-sht-hits-the-fanhttps://flatiron.com/hubfs/Imported_Blog_Media/Flatiron_Eng_blog_180123-4.jpgFlatironEngblog1801234FlatironEngblog18012342024-03-29https://resources.flatiron.com/flatiron-stories/your-exit-is-not-your-missionhttps://flatiron.com/hubfs/Imported_Blog_Media/week-01_A_0128_V2.jpgweek01A0128V2week01A0128V22024-03-29https://resources.flatiron.com/real-world-evidence/real-world-data-mortality-webinarhttps://flatiron.com/hubfs/Imported_Blog_Media/Real%20world%20data%20vs%20the%20gold%20standard.pngRealworlddatavsthegoldstandardRealworlddatavsthegoldstandard2024-09-16https://resources.flatiron.com/real-world-evidence/ispor-europe-2025-5-key-themes-shaping-the-future-of-heorhttps://flatiron.com/hubfs/thought-leadership-1.pngthoughtleadership1thoughtleadership12025-11-24https://resources.flatiron.com/publications/key-considerations-for-assessing-real-world-comparative-effectiveness-in-the-context-of-the-drug-price-negotiation-program-a-case-study-of-pembrolizumab2025-09-16https://resources.flatiron.com/publications/treatment-patterns-for-metastatic-melanoma-in-us-community-oncology-clinical-practice-a-retrospective-observational-study2024-03-27https://resources.flatiron.com/publications/real-world-treatment-patterns-in-es-sclc-highlight-continued-unmet-medical-need-in-the-era-of-new-therapies-essence-study2025-08-13https://resources.flatiron.com/publications/inequities-advanced-endometrial-cancer-structural-racism2024-05-23https://resources.flatiron.com/point-of-care/glimpsing-the-future-of-value-based-care-through-the-enhancing-oncology-modelhttps://flatiron.com/hubfs/Imported_Blog_Media/Enhancing-Oncology-Model.pngEnhancingOncologyModelEnhancingOncologyModel2024-04-16https://resources.flatiron.com/press/flatiron-health-announces-research-to-be-presented-at-american-society-of-hematology-annual-meeting-and-expositionhttps://flatiron.com/hubfs/flatiron-press-release-ASH.pngflatironpressreleaseASHflatironpressreleaseASH2025-02-25https://resources.flatiron.com/real-world-evidence/responsible-ai-in-action-flatirons-approach-to-ai-fairness-and-bias-assessmenthttps://flatiron.com/hubfs/cleo-ryals.jpgcleoryalscleoryals2025-07-09https://resources.flatiron.com/publications/real-world-characterization-of-advanced-non-small-cell-lung-cancer-in-never-smokers-by-actionable-mutation-status2024-03-26https://resources.flatiron.com/real-world-evidence/postmarket-real-world-data-case-studyhttps://flatiron.com/hubfs/Imported_Blog_Media/season1_clip_albertKraus_02.jpgseason1clipalbertKraus02season1clipalbertKraus022024-09-16https://resources.flatiron.com/real-world-evidencehttps://flatiron.com/hubfs/_Website%20Files/Resource%20Hub%20-%20Defaults/resource-hub-4.pngresourcehub4resourcehub4https://flatiron.com/hubfs/blog-melissa-estevez-data-quality%20(1).pngblogmelissaestevezdataquality1blogmelissaestevezdataquality1https://flatiron.com/hubfs/ESMO-AI-takeaways.pngESMOAItakeawaysESMOAItakeawayshttps://flatiron.com/hubfs/PMWC_REcap_KateEstep_26.pngPMWCREcapKateEstep26PMWCREcapKateEstep26https://flatiron.com/hubfs/ASCO%20GU%20Blog%20Post-3.pngASCOGUBlogPost3ASCOGUBlogPost3https://flatiron.com/hubfs/Arun%20thumbnail-1.jpgArunthumbnail1Arunthumbnail1https://flatiron.com/hubfs/Blog%20Image%20-%20Article%20with%20Author%201.pngBlogImageArticlewithAuthor1BlogImageArticlewithAuthor1https://flatiron.com/hubfs/Endpoints%20Heme%20Webinar%202026-1.pngEndpointsHemeWebinar20261EndpointsHemeWebinar20261https://flatiron.com/hubfs/press-release-3.pngpressrelease3pressrelease32025-07-13https://resources.flatiron.com/flatiron-stories/this-is-how-we-clinicalhttps://flatiron.com/hubfs/Imported_Blog_Media/5-2.png5252https://flatiron.com/hubfs/Imported_Blog_Media/This_is_how_we_clinical_1028X880.jpgThisishowweclinical1028X880Thisishowweclinical1028X880https://flatiron.com/hubfs/Imported_Blog_Media/3-2.png3232https://flatiron.com/hubfs/Imported_Blog_Media/1-2.png1212https://flatiron.com/hubfs/Imported_Blog_Media/4-2.png4242https://flatiron.com/hubfs/Imported_Blog_Media/2-2.png22222024-03-29https://resources.flatiron.com/real-world-evidence/treatment-gaps-in-prostate-and-bladder-carehttps://flatiron.com/hubfs/ASCO%20GU%20Blog%20Post-3.pngASCOGUBlogPost3ASCOGUBlogPost32026-03-26https://resources.flatiron.com/clinical-research/value-in-leveraging-prospective-data-vs-retrospective-data-in-pmc-pmr-studieshttps://flatiron.com/hubfs/Whats%20the%20value%20in%20leveraging%20prospective%20data%20vs.%20retrospective%20data%20in%20PMCPMR%20studies.pngWhatsthevalueinleveragingprospectivedatavsretrospectivedatainPMCPMRstudiesWhatsthevalueinleveragingprospectivedatavsretrospectivedatainPMCPMRstudies2024-09-16https://resources.flatiron.com/publications/real-world-evidence-from-germany-representativeness-analysis-and-mortality-endpoint-validation-in-electronic-health-record-derived-oncology-cohorts2026-03-10https://resources.flatiron.com/publications/validation-of-international-classification-of-diseases-coding-for-bone-metastases-in-electronic-health-records-using-technology-enabled-abstraction2024-03-27https://resources.flatiron.com/publications/digital-health-applications-in-oncology-an-opportunity-to-seize2024-03-26https://resources.flatiron.com/real-world-evidence/real-world-evidence-for-oncology-innovation-in-europehttps://flatiron.com/hubfs/FT%20Intl%20Webinar.jpegFTIntlWebinarFTIntlWebinar2025-08-19https://resources.flatiron.com/publications/real-world-survival-of-relapsed-compared-to-de-novo-stage-iv-diagnosis-of-advanced-non-small-cell-lung-cancer2024-03-26https://resources.flatiron.com/publications/real-world-rw-first-line-1l-treatment-tx-patterns-and-overall-survival-rwos-in-patients-pts-with-locally-advanced/metastatic-urothelial-carcinoma-la-17703109726212026-02-23https://resources.flatiron.com/press/press-release/flatiron-assist-epics-app-orchard2024-03-27https://resources.flatiron.com/publications/real-world-outcomes-plasma-tumor-dna-cancer2024-03-26https://resources.flatiron.com/publications/trial-eligibility-criteria-and-diversity-among-patients-with-advanced-non-small-cell-lung-cancerhttps://flatiron.com/hubfs/_Website%20Files/Resource%20Hub%20-%20Press%20Releases/flatiron-press-release-4.pngflatironpressrelease4flatironpressrelease42024-03-26https://resources.flatiron.com/publications/response-progression-endpoints-nsclc2024-05-17https://resources.flatiron.com/point-of-care/coa-insights-how-technology-enhances-value-based-care-initiativeshttps://flatiron.com/hubfs/Hematology%20Oncology%20Associates%20of%20Central%20New%20York%20Interview%20Thumbnail.pngHematologyOncologyAssociatesofCentralNewYorkInterviewThumbnailHematologyOncologyAssociatesofCentralNewYorkInterviewThumbnail2024-09-16https://resources.flatiron.com/publications/performance-assessment-and-validation-of-real-world-response-data-generated-using-a-deep-learning-based-natural-language-processing-model2025-04-17https://resources.flatiron.com/point-of-care/the-precision-medicine-ecosystemhttps://flatiron.com/hubfs/_Website%20Files/Resource%20Hub%20-%20Defaults/resource-hub-9.pngresourcehub9resourcehub9https://flatiron.com/hubfs/_Website%20Files/Resource%20Hub%20-%20Videos/Without%20Play%20Button/EOM-Panel-video-thumb.jpgEOMPanelvideothumbEOMPanelvideothumb2024-09-16https://resources.flatiron.com/press/press-release/flatiron-health-announces-strategic-collaboration-with-the-national-cancer-institute-to-explore-use-of-real-world-evidence-in-clinical-trial-design2024-03-27https://resources.flatiron.com/flatiron-stories/empathy-in-engineeringhttps://flatiron.com/hubfs/Imported_Blog_Media/180803_empathy-1.jpg180803empathy1180803empathy1https://flatiron.com/hubfs/Imported_Blog_Media/0*I1A0TRjJiX4lr3V8-2.jpeg0I1A0TRjJiX4lr3V820I1A0TRjJiX4lr3V822024-03-29https://resources.flatiron.com/clinical-research/what-are-future-expectations-for-ensuring-diversity-in-clinical-trialshttps://flatiron.com/hubfs/What%20are%20future%20expectations%20for%20ensuring%20diversity%20in%20clinical%20trials.pngWhatarefutureexpectationsforensuringdiversityinclinicaltrialsWhatarefutureexpectationsforensuringdiversityinclinicaltrials2024-09-16https://resources.flatiron.com/publications/a-platform-to-prospectively-link-real-world-clinico-genomic-imaging-and-outcomes-data-for-patients-with-lung-cancer-12024-03-26https://resources.flatiron.com/real-world-evidence/webinar-how-breakthrough-rwe-is-powering-a-new-era-of-blood-cancer-researchhttps://flatiron.com/hubfs/Endpoints%20Heme%20Webinar%202026-1.pngEndpointsHemeWebinar20261EndpointsHemeWebinar20261https://flatiron.com/hubfs/Endpoints%20Heme%20Webinar%202026.pngEndpointsHemeWebinar2026EndpointsHemeWebinar20262026-01-29https://resources.flatiron.com/publications/association-of-real-world-agreement-between-her2-expression-and-erbb2-amplification-with-trastuzumab-therapy-benefit-in-advanced-gastric/esophageal-adv-ge-cancer-2024-03-26https://resources.flatiron.com/clinical-research/how-are-pmc-pmr-studies-different-for-sites-compared-to-traditional-studieshttps://flatiron.com/hubfs/_Website%20Files/Resource%20Hub%20-%20Defaults/resource-hub-8.pngresourcehub8resourcehub8https://flatiron.com/hubfs/How%20are%20PMCPMR%20studies%20different%20for%20sites%2c%20compared%20to%20traditional%20studies.pngHowarePMCPMRstudiesdifferentforsitescomparedtotraditionalstudiesHowarePMCPMRstudiesdifferentforsitescomparedtotraditionalstudies2024-09-16https://resources.flatiron.com/publications/treatment-patterns-and-predictors-of-survival-after-first-line-therapy-in-large-b-cell-lymphoma-in-a-real-world-us-cohort2024-11-06https://resources.flatiron.com/press/flatiron-health-announces-research-to-be-presented-at-iaslc-2025-world-conference-on-lung-cancer-hosted-by-the-international-association-for-the-study-of-lung-cancerhttps://flatiron.com/hubfs/wclc-2025.pngwclc2025wclc20252025-08-13https://resources.flatiron.com/press/press-release/flatiron-health-expands-technology-partnerships-with-oncology-care-model-practices2024-03-27https://resources.flatiron.com/publications/circulating-tumor-dna-ctdna-changes-in-patients-with-lung-cancer-from-a-real-world-prospective-clinico-genomic-pcg-study2024-03-26https://resources.flatiron.com/publications/assessing-missing-antineoplastic-therapy-prior-to-electronic-health-record-ehr-derived-first-line-of-therapy-after-advanced-non-small-cell-lung-ansclc-diagnosishttps://flatiron.com/hubfs/_Website%20Files/Resource%20Hub%20-%20Press%20Releases/flatiron-press-release-4.pngflatironpressrelease4flatironpressrelease42024-03-26https://resources.flatiron.com/publications/sociodemographic-uptake-novel-therapies-acute-myeloid-leukemia2024-03-26https://resources.flatiron.com/publications/association-of-baseline-body-mass-index-bmi-with-overall-survival-os-in-patients-pts-with-metastatic-non-small-cell-lung-cancer-mnsclc-treated-with-nivolumab-n-an2024-03-26https://resources.flatiron.com/point-of-care/interview-with-pamela-swackhamer-from-hematology-oncology-associates-of-central-new-yorkhttps://flatiron.com/hubfs/_Website%20Files/Resource%20Hub%20-%20Headshots/Interview-with-Pamela-Swackhamer-Hematology-Oncology-Associates-Central-New-York.pngInterviewwithPamelaSwackhamerHematologyOncologyAssociatesCentralNewYorkInterviewwithPamelaSwackhamerHematologyOncologyAssociatesCentralNewYork2024-04-02https://resources.flatiron.com/real-world-evidence/precision-medicine-real-world-cancer-clinichttps://flatiron.com/hubfs/Imported_Blog_Media/season1_clip_Razelle_02.jpgseason1clipRazelle02season1clipRazelle022024-09-16https://resources.flatiron.com/publications/identification-of-resistance-mechanisms-to-egfr-treatment-in-the-real-world-using-a-clinicogenomic-database2024-03-27https://resources.flatiron.com/publications/supporting-optimal-value-based-and-sustainable-cancer-care-delivery2024-03-26https://resources.flatiron.com/publications/real-world-utilization-of-egfr-tki-therapies-and-treatment-outcomes-in-patients-with-advanced-egfr-sensitizing-mutation-positive-nsclc2024-03-26https://resources.flatiron.com/point-of-care/case-study-flatiron-assist-hematology-oncology-associates-central-new-yorkhttps://flatiron.com/hubfs/_Website%20Files/Resource%20Hub%20-%20Case%20Studies/hematology-oncology-associates-of-central-new-york-case-study-flatiron.pnghematologyoncologyassociatesofcentralnewyorkcasestudyflatironhematologyoncologyassociatesofcentralnewyorkcasestudyflatironhttps://flatiron.com/hubfs/decision-support.jpgdecisionsupportdecisionsupport2024-04-09https://resources.flatiron.com/press/world-cancer-day-unlocking-the-power-of-rwd-to-answer-questions-for-people-with-cancerhttps://flatiron.com/hubfs/1K%20Pubs%20Social%20Media%20Clip%20-%20Aaron%20Cohen%20-%20World%20Cancer%20Day.mp4/medium.jpg1K Pubs Social Media Clip - Aaron Cohen - World Cancer Day1K Pubs Social Media Clip - Aaron Cohen - World Cancer Dayhttps://flatiron.com/hubfs/1K%20Pubs%20Social%20Media%20Clip%20-%20Aaron%20Cohen%20-%20World%20Cancer%20Day.mp4195nonohttps://flatiron.com/hubfs/Screenshot%202025-01-30%20at%205.48.54%20PM.pngScreenshot20250130at54854PMScreenshot20250130at54854PM2025-02-25https://resources.flatiron.com/flatiron-stories/part-1-financial-toxicityhttps://flatiron.com/hubfs/Imported_Blog_Media/bills_1030x532.jpgbills1030x532bills1030x5322024-03-29https://resources.flatiron.com/publications/real-world-use-of-radiation-brain-lung-cancer2024-03-26https://resources.flatiron.com/publications/carboplatin-cisplatin-shortages-mnsclc2024-05-23https://resources.flatiron.com/clinical-research/how-do-sites-support-pmc-pmr-studies-today-and-how-might-that-look-differentlyhttps://flatiron.com/hubfs/How%20do%20sites%20support%20PMCPMR%20studies%20today%20and%20how%20might%20that%20look%20differently%2c%20working%20with%20Flatiron.pngHowdositessupportPMCPMRstudiestodayandhowmightthatlookdifferentlyworkingwithFlatironHowdositessupportPMCPMRstudiestodayandhowmightthatlookdifferentlyworkingwithFlatiron2024-09-16https://resources.flatiron.com/publications/disease-control-with-folfiri-plus-ziv-aflibercept-zfolfiri-beyond-folfiri-plus-bevacizumab-case-series-in-metastatic-colorectal-cancer-mcrc2024-03-26https://resources.flatiron.com/clinical-research/what-can-sponsors-do-to-enable-more-diversity-in-clinical-trialhttps://flatiron.com/hubfs/_Website%20Files/Resource%20Hub%20-%20Defaults/resource-hub-3.pngresourcehub3resourcehub3https://flatiron.com/hubfs/What-can-sponsors-do-to-enable-more-diversity-in-clinical-trials.jpgWhatcansponsorsdotoenablemorediversityinclinicaltrialsWhatcansponsorsdotoenablemorediversityinclinicaltrials2024-09-16https://resources.flatiron.com/publications/treatment-patterns-duration-and-outcomes-of-pemetrexed-maintenance-therapy-in-patients-with-advanced-nsclc-in-a-real-world-setting2024-03-26https://resources.flatiron.com/publications/structuring-gdpr-compliant-private-networks-to-enable-llm-extracted-oncology-data-on-pseudonymized-patient-ehr-data-in-europe2025-11-06https://resources.flatiron.com/flatiron-stories/not-all-roads-are-pavedhttps://flatiron.com/hubfs/Imported_Blog_Media/181026_hands2.jpg181026hands2181026hands22024-03-29https://resources.flatiron.com/real-world-evidence/clinico-genomic-research-developmenthttps://flatiron.com/hubfs/Imported_Blog_Media/season1_clip_michaelTaylor_02.jpgseason1clipmichaelTaylor02season1clipmichaelTaylor022024-09-16https://resources.flatiron.com/flatiron-stories/how-precise-is-that-prognosishttps://flatiron.com/hubfs/Imported_Blog_Media/ndi-post-picture-2.pngndipostpicture2ndipostpicture2https://flatiron.com/hubfs/Imported_Blog_Media/NDI-2-1028x880-2.jpgNDI21028x8802NDI21028x88022024-03-29https://resources.flatiron.com/publications/clinical-characteristics-and-treatment-persistence-in-us-patients-node-positive-early-breast-cancer-treated-with-abemaciclib2024-12-04https://resources.flatiron.com/publications/mobile-electronic-prescribing-to-drive-quality2024-03-26https://resources.flatiron.com/publications/delayed-entry-bias-rwdhttps://flatiron.com/hubfs/Imported_Blog_Media/RM_openaccessarticle_thumb_01-4-Mar-10-2023-04-50-59-3127-AM.jpgRMopenaccessarticlethumb014Mar1020230450593127AMRMopenaccessarticlethumb014Mar1020230450593127AM2024-03-26https://resources.flatiron.com/clinical-research/the-history-of-flatiron-clinical-researchhttps://flatiron.com/hubfs/_Website%20Files/Resource%20Hub%20-%20Downloadable%20PDFs/downloadable-pdf-flatiron-1.pngdownloadablepdfflatiron1downloadablepdfflatiron12024-04-02https://resources.flatiron.com/point-of-care/bring-real-world-evidence-to-oncologyhttps://flatiron.com/hubfs/FH-OncoCloudVirtual-session-thumbnail_bring-real-world-evidence-to-oncology%20(2).pngFHOncoCloudVirtualsessionthumbnailbringrealworldevidencetooncology2FHOncoCloudVirtualsessionthumbnailbringrealworldevidencetooncology2https://flatiron.com/hubfs/_Website%20Files/Resource%20Hub%20-%20Defaults/resource-hub-3.pngresourcehub3resourcehub32024-09-16https://resources.flatiron.com/publications/real-world-outcomes-nsclc-pd-1-inhibitorshttps://flatiron.com/hubfs/Imported_Blog_Media/RM_openaccessarticle_thumb_02-Mar-06-2023-06-50-48-1238-AM-3.jpgRMopenaccessarticlethumb02Mar0620230650481238AM3RMopenaccessarticlethumb02Mar0620230650481238AM32024-03-27https://resources.flatiron.com/flatiron-stories/how-i-use-my-experience-building-ad-tech-to-help-fight-cancerhttps://flatiron.com/hubfs/Imported_Blog_Media/dan-1-3.pngdan13dan13https://flatiron.com/hubfs/Imported_Blog_Media/dan-2-3.pngdan23dan23https://flatiron.com/hubfs/Imported_Blog_Media/dan-last-one-3.pngdanlastone3danlastone3https://flatiron.com/hubfs/Imported_Blog_Media/dan-4-3.pngdan43dan43https://flatiron.com/hubfs/Imported_Blog_Media/dan-5-3.pngdan53dan53https://flatiron.com/hubfs/Imported_Blog_Media/dan-3-3.pngdan33dan332024-03-29https://resources.flatiron.com/publications/real-world-outcomes-in-patients-with-locally-advanced-or-metastatic-urothelial-carcinoma-receiving-taxane-monotherapy-following-platinum-and-anti-pd-1/l1-therapy2024-03-26https://resources.flatiron.com/point-of-care/precision-medicine-big-data-webinarhttps://flatiron.com/hubfs/_Website%20Files/Resource%20Hub%20-%20Defaults/resource-hub-8.pngresourcehub8resourcehub8https://flatiron.com/hubfs/Imported_Blog_Media/111679-iflatironhc-precisionmedicine-final-illu.png111679iflatironhcprecisionmedicinefinalillu111679iflatironhcprecisionmedicinefinalillu2024-09-16https://resources.flatiron.com/publications/concordance-of-her2-status-by-ihc/ish-and-erbb2-status-by-ngs-and-analysis-of-real-world-outcomes-in-patients-pts-with-metastatic-breast-cancer-mbc-receiving-firs2024-03-26https://resources.flatiron.com/real-world-evidence/genitourinary-cancer-insights-leveraging-rwehttps://flatiron.com/hubfs/_Website%20Files/Resource%20Hub%20-%20Videos/Without%20Play%20Button/Post%20ASCO%20GU%20Webinar%20Video%20Thumbnail.pngPostASCOGUWebinarVideoThumbnailPostASCOGUWebinarVideoThumbnailhttps://flatiron.com/hubfs/webinar-post-asco-2025.pngwebinarpostasco2025webinarpostasco20252025-03-13https://resources.flatiron.com/press/flatiron-health-announces-research-to-be-presented-at-asco-2025https://flatiron.com/hubfs/ASCO-2025-overview.pngASCO2025overviewASCO2025overview2025-05-23https://resources.flatiron.com/point-of-care/fireside-chat-where-cancer-care-pathways-and-oncology-technology-solutions-are-headedhttps://flatiron.com/hubfs/chat-screenshot.pngchatscreenshotchatscreenshothttps://flatiron.com/hubfs/_Website%20Files/Resource%20Hub%20-%20Defaults/resource-hub-6.pngresourcehub6resourcehub62024-04-02https://resources.flatiron.com/press/press-release/tesh-khullar-joins-flatiron-health-as-vp-of-provider-solutions2024-03-27https://resources.flatiron.com/publications/performance-of-newer-myeloma-staging-systems-in-a-contemporary-large-patient-cohort2024-06-18https://resources.flatiron.com/publications/cancers-with-ntrk-gene-fusions-molecular-characteristics-and-prognosis2024-03-26https://resources.flatiron.com/publications/real-world-insights-into-prostate-cancer-management-using-ehr-derived-data-from-the-uk2025-10-22https://resources.flatiron.com/real-world-evidence/from-data-to-decisions-what-regulatory-grade-real-world-evidence-actually-requireshttps://flatiron.com/hubfs/PMWC_REcap_KateEstep_26.pngPMWCREcapKateEstep26PMWCREcapKateEstep262026-03-12https://resources.flatiron.com/flatiron-stories/how-flatiron-employee-initiatives-are-helping-the-planet-and-the-bottom-linehttps://flatiron.com/hubfs/Imported_Blog_Media/flatiron-blog-green-task-force-632x396-2x.pngflatironbloggreentaskforce632x3962xflatironbloggreentaskforce632x3962x2025-10-27https://resources.flatiron.com/press/press-release/wcc-rcm2024-03-27https://resources.flatiron.com/point-of-care/flatiron-managed-regimens-2020https://flatiron.com/hubfs/Imported_Blog_Media/nccn-1-3.pngnccn13nccn13https://flatiron.com/hubfs/Imported_Blog_Media/BLOG_IMAGE_NCCN_regimen_1028X880.jpgBLOGIMAGENCCNregimen1028X880BLOGIMAGENCCNregimen1028X8802024-04-02https://resources.flatiron.com/publications/considerations-for-use-of-real-world-evidence-in-oncology-lessons-learned-from-friends-of-cancer-research-collaborations2024-03-26https://resources.flatiron.com/clinical-research/what-does-a-pragmatic-approach-to-pmr-pmrs-look-like-for-sponsorshttps://flatiron.com/hubfs/What%20does%20a%20pragmatic%20approach%20to%20PMRPMRs%2c%20look%20like%20for%20sponsors.pngWhatdoesapragmaticapproachtoPMRPMRslooklikeforsponsorsWhatdoesapragmaticapproachtoPMRPMRslooklikeforsponsors2024-10-04https://resources.flatiron.com/publications/real-world-treatment-patterns-in-patients-diagnosed-with-metastatic-castration-resistant-prostate-cancer-in-the-us-2018-20232025-02-10https://resources.flatiron.com/publications/clinical-decision-support-tools-custom-oncology-pathwayshttps://flatiron.com/hubfs/_Website%20Files/Resource%20Hub%20-%20Press%20Releases/flatiron-press-release-4.pngflatironpressrelease4flatironpressrelease42024-03-26https://resources.flatiron.com/publications/real-world-treatment-patterns-and-clinical-outcomes-in-patients-with-emerging-estrogen-receptor-1-esr1-mutated-er-metastatic-breast-cancer-in-the-u.s.-2018-20242025-12-01https://resources.flatiron.com/point-of-care/how-clinical-decision-support-technology-helps-oncologists-keep-pace-with-rapid-changes-to-nccn-guidelineshttps://flatiron.com/hubfs/Imported_Blog_Media/blog-evolution-of-nccn-guidelines-pathways-at-the-point-of-care.pngblogevolutionofnccnguidelinespathwaysatthepointofcareblogevolutionofnccnguidelinespathwaysatthepointofcare2024-04-18https://resources.flatiron.com/publications/pfs-as-a-surrogate-endpoint-for-os-in-real-world-patients-with-ros1-advnsclc-in-the-united-stateshttps://flatiron.com/hubfs/_Website%20Files/Resource%20Hub%20-%20Defaults/resource-hub-6.pngresourcehub6resourcehub62024-08-16https://resources.flatiron.com/publications/demographics-us-patients-with-her2-negative-early-breast-cancer-and-germline-brca-mutations-since-20212024-12-04https://resources.flatiron.com/press/press-release/flatiron-health-announces-research-to-be-presented-at-american-society-of-clinical-oncology-2018-annual-meeting2024-03-27https://resources.flatiron.com/publications/real-world-treatment-patterns-and-time-on-treatment-rwtot-in-recurrent-or-metastatic-head-and-neck-squamous-cell-carcinoma-r/m-hnscc-with-disease-progression-on-o2024-03-26https://resources.flatiron.com/flatiron-stories/data-cityhttps://flatiron.com/hubfs/Imported_Blog_Media/Data-City_1028x880-2.jpgDataCity1028x8802DataCity1028x88022024-03-29https://resources.flatiron.com/publications/fda-approval-ehr-clinical-decision-support-toolshttps://flatiron.com/hubfs/HC%20image-1.webpHCimage1HCimage12024-03-26https://resources.flatiron.com/clinical-research/research-findings-trial-eligibility-criteria-and-diversity-among-patients-with-advanced-nsclchttps://flatiron.com/hubfs/Trial%20eligibility%20criteria%20and%20diversity%20among%20patients%20with%20advanced%20NSCLC.pngTrialeligibilitycriteriaanddiversityamongpatientswithadvancedNSCLCTrialeligibilitycriteriaanddiversityamongpatientswithadvancedNSCLC2024-09-16https://resources.flatiron.com/publications/control-arms-real-world-data-trialshttps://flatiron.com/hubfs/Imported_Blog_Media/RM_openaccessarticle_thumb_02-Mar-06-2023-06-50-48-1238-AM-Mar-10-2023-04-50-59-7386-AM.jpgRMopenaccessarticlethumb02Mar0620230650481238AMMar1020230450597386AMRMopenaccessarticlethumb02Mar0620230650481238AMMar1020230450597386AM2024-03-26https://resources.flatiron.com/flatiron-stories/the-three-questions-you-must-ask-when-running-a-design-sprinthttps://flatiron.com/hubfs/Imported_Blog_Media/Screen-Shot-2017-12-07-at-11_32_12-AM-2.pngScreenShot20171207at113212AM2ScreenShot20171207at113212AM2https://flatiron.com/hubfs/Imported_Blog_Media/FirstMark-blog-post.pngFirstMarkblogpostFirstMarkblogpost2024-03-29https://resources.flatiron.com/flatiron-stories/solving-fundamental-problems-with-cs-fundamentalshttps://flatiron.com/hubfs/Imported_Blog_Media/1*WzsQUKvjQLMQRnxfh5Sw9g-2.png1WzsQUKvjQLMQRnxfh5Sw9g21WzsQUKvjQLMQRnxfh5Sw9g2https://flatiron.com/hubfs/Imported_Blog_Media/FH_blog__190308-2.jpgFHblog1903082FHblog1903082https://flatiron.com/hubfs/Imported_Blog_Media/0*pbdGK5kGKHrPRiOa-2.png0pbdGK5kGKHrPRiOa20pbdGK5kGKHrPRiOa2https://flatiron.com/hubfs/Imported_Blog_Media/0*sM1zQ-T1LglSUgZG-2.png0sM1zQT1LglSUgZG20sM1zQT1LglSUgZG2https://flatiron.com/hubfs/Imported_Blog_Media/0*YrURdh8ybaw49aVQ-2.png0YrURdh8ybaw49aVQ20YrURdh8ybaw49aVQ2https://flatiron.com/hubfs/Imported_Blog_Media/0*_X6NAiltF27Bro2m-2.png0X6NAiltF27Bro2m20X6NAiltF27Bro2m22024-03-29https://resources.flatiron.com/real-world-evidence/machine-learning-bias-analysis-real-world-datahttps://flatiron.com/hubfs/RWE%20-%20Drag%20and%20Drop/figures/fig4_01.pngfig401fig401https://flatiron.com/hubfs/RWE%20-%20Drag%20and%20Drop/figures/fig2_01.pngfig201fig201https://flatiron.com/hubfs/RWE%20-%20Drag%20and%20Drop/figures/fig3_01.pngfig301fig301https://flatiron.com/hubfs/MACS%20with%20Bias%20Analysis%20Model.pngMACSwithBiasAnalysisModelMACSwithBiasAnalysisModel2024-03-29https://resources.flatiron.com/clinical-research/starting-a-study-quicklyhttps://flatiron.com/hubfs/George%20Clinical.pngGeorgeClinicalGeorgeClinical2024-09-16https://resources.flatiron.com/flatiron-stories/confronting-a-history-of-trials-and-tribulations-a-flatiron-hackathon-projecthttps://flatiron.com/hubfs/Imported_Blog_Media/Flatiron_Blog_HackingTrials_1028_2x.jpgFlatironBlogHackingTrials10282xFlatironBlogHackingTrials10282x2024-03-29https://resources.flatiron.com/press/press-release/flatiron-healths-oncoemr-is-top-rated-for-overall-satisfaction-by-klas-2019-medical-oncology-performance-report2024-03-27https://resources.flatiron.com/publications/large-language-models-pdl1-ehr2024-04-16https://resources.flatiron.com/publications/racial-and-ethnic-differences-in-biomarker-testing-for-targetable-alterations-among-patients-with-hr-her2-metastatic-breast-cancer-mbc2025-05-22https://resources.flatiron.com/publications/real-world-evidence-precision-medicine2024-03-27https://resources.flatiron.com/point-of-care/exploring-technology-to-support-clinical-pathwayshttps://flatiron.com/hubfs/_Website%20Files/Resource%20Hub%20-%20Illustrations/exploring-technology-to-support-the-future-of-clinical-pathways-in-oncology-care.jpgexploringtechnologytosupportthefutureofclinicalpathwaysinoncologycareexploringtechnologytosupportthefutureofclinicalpathwaysinoncologycare2024-04-16https://resources.flatiron.com/publications/challenges-and-opportunities-to-updating-prescribing-information-for-longstanding-oncology-drugs2024-03-26https://resources.flatiron.com/publications/real-world-survival-outcomes-in-non-small-cell-lung-cancer-insights-from-uk-ehr2025-08-13https://resources.flatiron.com/press/press-release/flatiron-health-real-world-data-support-fda-approval-of-new-dosing-regimen-for-erbitux-cetuximabhttps://flatiron.com/hubfs/_Website%20Files/Resource%20Hub%20-%20Defaults/resource-hub-4.pngresourcehub4resourcehub42024-04-26https://resources.flatiron.com/clinical-research/reinventing-prospective-study-data-acquisition-and-deliveryhttps://flatiron.com/hubfs/reinventing.pngreinventingreinventing2024-09-16https://resources.flatiron.com/publications/contemporary-management-of-advanced-non-small-cell-lung-cancer-ansclc-in-a-large-real-world-cohort2024-03-27https://resources.flatiron.com/press/flatiron-health-appoints-nathan-hubbard-as-chief-executive-officerhttps://flatiron.com/hubfs/NathanHubbard.pngNathanHubbardNathanHubbard2025-08-06https://resources.flatiron.com/publications/what-remains-matters-real-world-impact-of-measurable-residual-disease-testing-in-multiple-myeloma2025-11-03https://resources.flatiron.com/point-of-care/webinar-evolution-of-nccn-guidelines-pathways-at-point-of-carehttps://flatiron.com/hubfs/ASH-2023-Webinar---Main-event-image.pngASH2023WebinarMaineventimageASH2023WebinarMaineventimagehttps://flatiron.com/hubfs/Imported_Blog_Media/webinar-evolution-of-nccn-guidelines-pathways-at-the-point-of-care.pngwebinarevolutionofnccnguidelinespathwaysatthepointofcarewebinarevolutionofnccnguidelinespathwaysatthepointofcare2024-09-16https://resources.flatiron.com/press/press-release/flatiron-health-announces-rwd-partnership-with-japans-ncchehttps://flatiron.com/hubfs/_Website%20Files/Resource%20Hub%20-%20Press%20Releases/flatiron-press-release-LTHT-Announcement-US.pngflatironpressreleaseLTHTAnnouncementUSflatironpressreleaseLTHTAnnouncementUS2024-04-26https://resources.flatiron.com/publications/mediators-of-racial/ethnic-inequities-in-clinical-trial-participation-among-us-patients-with-cancer-2011-2022https://flatiron.com/hubfs/_Website%20Files/Resource%20Hub%20-%20Defaults/resource-hub-6.pngresourcehub6resourcehub62024-03-26https://resources.flatiron.com/publications/metastatic-patterns-and-outcomes-by-her2-and-hormone-receptor-status-in-patients-with-metastatic-breast-cancerhttps://flatiron.com/hubfs/_Website%20Files/Resource%20Hub%20-%20Press%20Releases/flatiron-press-release-4.pngflatironpressrelease4flatironpressrelease42024-03-26https://resources.flatiron.com/publications/real-world-insights-into-breast-cancer-in-the-uk-findings-from-uk-ehr-derived-data2025-10-22https://resources.flatiron.com/publications/leveraging-machine-learning-to-assess-the-association-of-rash-and-survival-in-patients-with-advanced-nsclc2025-04-17https://resources.flatiron.com/real-world-evidence/ispe-2024-breaking-barriers-in-cancer-researchhttps://flatiron.com/hubfs/event-recap-ispe.pngeventrecapispeeventrecapispe2024-10-24https://resources.flatiron.com/press/lifebit-and-flatiron-health-announce-partnership-to-accelerate-cancer-data-researchhttps://flatiron.com/hubfs/FH_Website_ResourceHubThumbnails_Lifebit.pngFHWebsiteResourceHubThumbnailsLifebitFHWebsiteResourceHubThumbnailsLifebit2024-03-27https://resources.flatiron.com/press/press-release/pcg-study2024-03-27https://resources.flatiron.com/publications/disparities-in-next-generation-sequencing-in-a-population-based-community-cohort-of-patients-with-advanced-non-small-cell-lung-cancer2024-03-27https://resources.flatiron.com/publications/adherence-to-and-determinants-of-guideline-recommended-biomarker-testing-and-targeted-therapy-in-patients-with-gastroesophageal-adenocarcinoma-insights-from-routi2024-03-26https://resources.flatiron.com/publications/letting-the-genie-out-of-its-bottle-examining-the-potential-of-real-world-clinico-genomic-data2024-03-26https://resources.flatiron.com/press/flatiron-health-and-smirta-innovations-announce-partnership-to-enable-oncosmart-for-oncoemr-customershttps://flatiron.com/hubfs/FH_Website_SMIRTA_PressReleases.pngFHWebsiteSMIRTAPressReleasesFHWebsiteSMIRTAPressReleases2024-07-24https://resources.flatiron.com/flatiron-stories/making-the-most-of-your-logs-dns-with-splunkhttps://flatiron.com/hubfs/Imported_Blog_Media/view_events-3.pngviewevents3viewevents3https://flatiron.com/hubfs/_Website%20Files/Resource%20Hub%20-%20Defaults/resource-hub-7.pngresourcehub7resourcehub7https://flatiron.com/hubfs/Imported_Blog_Media/input_lookup-3.pnginputlookup3inputlookup32024-04-18https://resources.flatiron.com/press/press-release/asco2020-real-world-evidence2024-03-27https://resources.flatiron.com/point-of-care/oncoemr-expands-possibilities-of-cancer-carehttps://flatiron.com/hubfs/Imported_Blog_Media/110692-flatironhc-blogimage-illustration-01@2x.png110692flatironhcblogimageillustration012x110692flatironhcblogimageillustration012x2024-04-02https://resources.flatiron.com/press/flatiron-health-welcomes-matthew-reynolds-as-vp-scientific-engagementhttps://flatiron.com/hubfs/MatthewReynolds-NewHire-PressRelease.pngMatthewReynoldsNewHirePressReleaseMatthewReynoldsNewHirePressRelease2024-03-27https://resources.flatiron.com/publications/sex-differences-brain-metastasis-advanced-melanoma-diagnosis2024-05-17https://resources.flatiron.com/publications/rates-of-pd-l1-expression-testing-in-us-community-based-oncology-practices-for-patients-with-metastatic-non-small-cell-lung-cancer-receiving-nivolumab-or-pembroli2024-03-27https://resources.flatiron.com/publications/utilization-of-real-world-evidence-in-regulatory-approvals-for-multiple-myeloma-therapieshttps://flatiron.com/hubfs/publication-summary-2.pngpublicationsummary2publicationsummary22025-12-02https://resources.flatiron.com/clinical-research/illuminating-the-future-of-clinical-research-takeaways-from-dia-2023https://flatiron.com/hubfs/DIA%20Recap%20Image.pngDIARecapImageDIARecapImage2024-04-16https://resources.flatiron.com/publications/racial-ethnic-inequities-clinical-trial-participation-hematologic-malignancies2024-03-26https://resources.flatiron.com/flatiron-stories/flatiron-stands-against-racism2024-03-29https://resources.flatiron.com/point-of-care/contribute-to-development-of-better-treatmentshttps://flatiron.com/hubfs/Imported_Blog_Media/FH-OncoCloudVirtual-session-thumbnail_contribute-to-development-of-better-treatments-1.pngFHOncoCloudVirtualsessionthumbnailcontributetodevelopmentofbettertreatments1FHOncoCloudVirtualsessionthumbnailcontributetodevelopmentofbettertreatments1https://flatiron.com/hubfs/_Website%20Files/Resource%20Hub%20-%20Defaults/resource-hub-8.pngresourcehub8resourcehub82024-09-16https://resources.flatiron.com/publications/implementation-of-the-iom-13-point-care-plan-by-ocm-practices2024-03-27https://resources.flatiron.com/press/press-release/the-american-cancer-society-flatiron-health-announce-recipients-of-third-annual-real-world-data-impact-awardhttps://flatiron.com/hubfs/_Website%20Files/Resource%20Hub%20-%20Partner%20Logos/real-world-data-impact-awards-acs-flatiron.pngrealworlddataimpactawardsacsflatironrealworlddataimpactawardsacsflatiron2024-04-26https://resources.flatiron.com/publications/comparative-overall-survival-of-cdk4/6-inhibitors-plus-an-aromatase-inhibitor-in-hr/her2-metastatic-breast-cancer-in-the-us-real-world-settinghttps://flatiron.com/hubfs/research-summary-1kpubs-cdk46i.pngresearchsummary1kpubscdk46iresearchsummary1kpubscdk46i2025-01-07https://resources.flatiron.com/publications/mediators-of-racial/ethnic-inequities-in-clinical-trial-participation-among-patients-with-cancer-2011-2023https://flatiron.com/hubfs/publication-summary-mediators-of-racial-and-ethnic-inqueities-in-clinical-trial-participation.pngpublicationsummarymediatorsofracialandethnicinqueitiesinclinicaltrialparticipationpublicationsummarymediatorsofracialandethnicinqueitiesinclinicaltrialparticipation2024-11-04https://resources.flatiron.com/press/press-release/initial-analysis-of-tumor-profiling-from-a-prospective-study-by-foundation-medicine-flatiron-health-and-genentech-demonstrates-value-of-tissue-and-lhttps://flatiron.com/hubfs/_Website%20Files/Resource%20Hub%20-%20Defaults/resource-hub-7.pngresourcehub7resourcehub72024-03-29https://resources.flatiron.com/flatiron-stories/flatiron-health-the-next-chapter-begins-todayhttps://flatiron.com/hubfs/Imported_Blog_Media/CEO-First-Day-.jpegCEOFirstDayCEOFirstDay2024-03-29https://resources.flatiron.com/press/flatiron-health-announces-strategic-partnership-with-massive-bio-to-enhance-patient-identification-capabilities-and-serviceshttps://flatiron.com/hubfs/collaboration-announcement-MassiveBio.pngcollaborationannouncementMassiveBiocollaborationannouncementMassiveBio2025-04-07https://resources.flatiron.com/publications/colorectal-cancer-incidence-among-adults-younger-than-50-years-understanding-findings-from-observational-studies-of-lower-gastrointestinal-endoscopy2024-03-26https://resources.flatiron.com/flatiron-stories/typical-day-swe-wfhhttps://flatiron.com/hubfs/Imported_Blog_Media/FH_Blog_Blue_Rocks-2.jpgFHBlogBlueRocks2FHBlogBlueRocks22024-03-29https://resources.flatiron.com/real-world-evidence/asco-2024-reflections-and-highlightshttps://flatiron.com/hubfs/asco-2024-reflections-and-highlights.pngasco2024reflectionsandhighlightsasco2024reflectionsandhighlights2024-07-09https://resources.flatiron.com/publications/characterisation-of-oncology-ehr-derived-real-world-data-in-the-uk-germany-and-japanhttps://flatiron.com/hubfs/Final-BA-ESMO.mp4/medium.jpgFinal-BA-ESMOFinal-BA-ESMOhttps://flatiron.com/hubfs/Final-BA-ESMO.mp4110nono2025-02-12https://resources.flatiron.com/publications/comparative-outcomes-of-nab-paclitaxel-and-paclitaxel-in-platinum-resistant-ovarian-cancer-compass2025-12-18https://resources.flatiron.com/publications/assessment-of-the-application-of-a-90-day-gap-rule-for-mitigating-frontline-treatment-sequence-misclassification-in-electronic-health-records-in-the-united-stateshttps://flatiron.com/hubfs/_Website%20Files/Resource%20Hub%20-%20Defaults/resource-hub-6.pngresourcehub6resourcehub62024-10-30https://resources.flatiron.com/publications/real-world-characteristics-and-survival-outcomes-of-patients-with-mantle-cell-lymphoma-treated-with-covalent-brutons-tyrosine-kinase-inhibitors-in-first-line2024-11-06https://resources.flatiron.com/point-of-care/the-oncology-care-model-roadmap-or-distraction-for-commercial-payers2024-04-02https://resources.flatiron.com/publications/impact-of-flexible-assessment-schedules-on-treatment-effect-bias-in-pragmatic-clinical-trials2024-03-26https://resources.flatiron.com/flatiron-stories/how-to-grow-fast-and-teach-faster-the-opportunities-of-a-modularized-onboarding-framework2024-03-29https://resources.flatiron.com/press/press-release/flatiron-health-announces-research-to-be-presented-at-american-society-of-clinical-oncology-2021-annual-meeting2024-03-27https://resources.flatiron.com/clinical-research/a-pragmatic-approach-to-prospective-evidence-generation-in-clinical-trialshttps://flatiron.com/hubfs/_Website%20Files/Video%20Thumbnails%20-%20Large/josh-buddle-interview-A-pragmatic-approach-to-prospective-evidence-generation-in-clinical-trials.jpgjoshbuddleinterviewApragmaticapproachtoprospectiveevidencegenerationinclinicaltrialsjoshbuddleinterviewApragmaticapproachtoprospectiveevidencegenerationinclinicaltrials2025-05-27https://resources.flatiron.com/publications/rwd-help-validate-generalizability-rct-results2024-03-26https://resources.flatiron.com/publications/assessing-bias-in-llm-extracted-real-world-data-a-health-equity-analysis-of-access-to-care-and-outcomes-in-metastatic-breast-cancer2025-10-22https://resources.flatiron.com/press/press-release/nice-partnership-20202024-03-27https://resources.flatiron.com/publications/implementation-of-a-real-world-data-quality-framework-in-an-nationwide-oncology-electronic-health-record-derived-databasehttps://flatiron.com/hubfs/_Website%20Files/Resource%20Hub%20-%20Press%20Releases/flatiron-press-release-4.pngflatironpressrelease4flatironpressrelease42024-03-26https://resources.flatiron.com/press/press-release/validates-real-world-mortality-endpoint2024-03-27https://resources.flatiron.com/publications/the-real-world-frequency-of-24-hour-urine-protein-electrophoresis-upep-serum-free-light-chain-sflc-and-serum-protein-electrophoresis-spep-testing-in-patients-with2024-03-26https://resources.flatiron.com/real-world-evidence/how-ai-is-transforming-the-clinical-data-journeyhttps://flatiron.com/hubfs/AI%20Data%20Journey.pngAIDataJourneyAIDataJourney2025-03-19https://resources.flatiron.com/real-world-evidence/asco-2025-reflections-and-highlightshttps://flatiron.com/hubfs/blog-neal-meropol-asco-2025-recap.pngblognealmeropolasco2025recapblognealmeropolasco2025recap2025-07-13https://resources.flatiron.com/publications/treatment-dynamics-of-bone-targeting-agents-among-men-with-bone-metastases-from-prostate-cancer-in-the-united-states2024-03-27https://resources.flatiron.com/publications/flatiron-real-world-mortality-endpointhttps://flatiron.com/hubfs/Imported_Blog_Media/RM_openaccessarticle_thumb_01-4-3.jpgRMopenaccessarticlethumb0143RMopenaccessarticlethumb01432024-03-26https://resources.flatiron.com/publications/evaluation-of-real-world-tumor-response-derived-from-electronic-health-record-data-sources-a-feasibility-analysis-in-mnsclc-patients-treated-with-chemotherapyhttps://flatiron.com/hubfs/_Website%20Files/Resource%20Hub%20-%20Publications/publication-summary-evaluation-real-world-tumor-response-dervied-from-EHR.pngpublicationsummaryevaluationrealworldtumorresponsederviedfromEHRpublicationsummaryevaluationrealworldtumorresponsederviedfromEHR2024-08-21https://resources.flatiron.com/clinical-research/scope-summit-2024-advancing-clinical-research-through-collaboration-and-innovationhttps://flatiron.com/hubfs/scope%20summit%202024.pngscopesummit2024scopesummit20242024-04-16https://resources.flatiron.com/press/press-release/flatiron-signs-definitive-agreement-to-acquire-the-assets-of-american-family-archives-chronicles-inc2024-03-27https://resources.flatiron.com/flatiron-stories/crash-a-hackathon-crush-a-plenaryhttps://flatiron.com/hubfs/Imported_Blog_Media/ASCO_632X396-2.jpgASCO632X3962ASCO632X39622024-03-29https://resources.flatiron.com/publications/characterization-cancer-clinical-trials-community-setting2024-05-23https://resources.flatiron.com/publications/persistent-gaps-in-brca-mutation-testing-among-mcrpc-patients-insights-from-us-cancer-practices-2018-20242026-02-23https://resources.flatiron.com/point-of-care/interview-with-vivien-ekuanhttps://flatiron.com/hubfs/_Website%20Files/Resource%20Hub%20-%20Headshots/Interview-with-Vivian-Ekuan-Flatiron-Health.pngInterviewwithVivianEkuanFlatironHealthInterviewwithVivianEkuanFlatironHealth2024-04-02https://resources.flatiron.com/press/flatiron-health-announces-research-to-be-presented-at-ispor-2024https://flatiron.com/hubfs/FH_Website_ResourceHubThumbnails_ISPOR.pngFHWebsiteResourceHubThumbnailsISPORFHWebsiteResourceHubThumbnailsISPOR2024-07-22https://resources.flatiron.com/real-world-evidence/ispor-euhttps://flatiron.com/hubfs/Imported_Blog_Media/ASCO%20RWE%20Research%20Image.jpgASCORWEResearchImageASCORWEResearchImagehttps://flatiron.com/hubfs/Abstract%204%20-%20Sondhi.pngAbstract4SondhiAbstract4Sondhihttps://flatiron.com/hubfs/Abstract%203%20-%20Asfaw.pngAbstract3AsfawAbstract3Asfawhttps://flatiron.com/hubfs/Abstract%202%20-%20Reiss.pngAbstract2ReissAbstract2Reisshttps://flatiron.com/hubfs/Abstract%201%20-%20Xinye.pngAbstract1XinyeAbstract1Xinye2024-03-29https://resources.flatiron.com/publications/technology-enabled-clinical-trials-intentional-capture-of-source-data-in-the-ehr-and-direct-transfer-to-trial-database-in-a-phase-ii-multicenter-trialhttps://flatiron.com/hubfs/_Website%20Files/Resource%20Hub%20-%20Publications/publication-summary-technology-enabled-clinical-trials.pngpublicationsummarytechnologyenabledclinicaltrialspublicationsummarytechnologyenabledclinicaltrials2024-07-23https://resources.flatiron.com/publications/early-onset-gastric-and-colorectal-cancer-in-japan-and-the-us2024-10-10https://resources.flatiron.com/publications/real-world-tumor-response-to-ramucirumab-plus-docetaxel-post-platinum-based-and-immune-checkpoint-inhibitor-therapy-in-advanced-non-small-cell-lung-cancer-patient2024-03-26https://resources.flatiron.com/publications/comparison-of-structured-versus-abstracted-comorbidities-using-oncology-ehr-data-from-cancer-patients-in-the-flatiron-health-network2024-03-27https://resources.flatiron.com/publications/bortezomib-prescribing-patterns-multiple-myeloma2024-03-27https://resources.flatiron.com/publications/unmet-need-in-adults-and-adolescents-and-young-adults-with-b-cell-acute-lymphoblastic-leukemia-b-all-in-the-us-following-a-second-relapse2025-05-30https://resources.flatiron.com/publications/assessing-real-world-data-from-electronic-health-records-for-health-technology-assessment-the-suitability-checklist-a-good-practices-report-of-an-is-1719588422146https://flatiron.com/hubfs/_Website%20Files/Resource%20Hub%20-%20Publications/publication-summary-assessing-real-world-data-from-electronic-health-records-for-health-technology-assessment.pngpublicationsummaryassessingrealworlddatafromelectronichealthrecordsforhealthtechnologyassessmentpublicationsummaryassessingrealworlddatafromelectronichealthrecordsforhealthtechnologyassessment2024-07-23https://resources.flatiron.com/point-of-care/eom-beckers-webinarhttps://flatiron.com/hubfs/_Website%20Files/Video%20Thumbnails%20-%20Large/james-hamrick-beckers-video.jpgjameshamrickbeckersvideojameshamrickbeckersvideohttps://flatiron.com/hubfs/_Website%20Files/Resource%20Hub%20-%20Defaults/resource-hub-9.pngresourcehub9resourcehub92024-09-16https://resources.flatiron.com/publications/tumor-agnostic-drug-developmenthttps://flatiron.com/hubfs/Imported_Blog_Media/RM_openaccessarticle_thumb_01-4-2.jpgRMopenaccessarticlethumb0142RMopenaccessarticlethumb01422024-03-26https://resources.flatiron.com/press/flatiron-health-to-be-a-featured-presenter-at-the-2024-scope-summithttps://flatiron.com/hubfs/SCOPE%202024%20Social%20Promotion-1.pngSCOPE2024SocialPromotion1SCOPE2024SocialPromotion12024-04-02https://resources.flatiron.com/publications/management-and-outcomes-of-rash-peripheral-neuropathy-and-hyperglycemia-during-first-line-treatment-of-locally-advanced/metastatic-urothelial-cancer-17477790933112025-05-30https://resources.flatiron.com/publications/utility-of-automated-data-transfer-for-cancer-clinical-trials-and-considerations-for-implementation2025-02-19https://resources.flatiron.com/publications/real-world-response-rate-clinical-trial-aligned-cohorts-lung-colorectal-breast2024-04-16https://resources.flatiron.com/clinical-research/research-background-trial-eligibility-criteria-and-diversity-among-patients-with-advanced-nsclchttps://flatiron.com/hubfs/Learnings%20Trial%20eligibility%20criteria%20and%20diversity%20among%20patients%20with%20advanced%20NSCLC.pngLearningsTrialeligibilitycriteriaanddiversityamongpatientswithadvancedNSCLCLearningsTrialeligibilitycriteriaanddiversityamongpatientswithadvancedNSCLC2024-09-16https://resources.flatiron.com/real-world-evidence/ispor-2024-highlightshttps://flatiron.com/hubfs/takeaways-from-ispor-2024.pngtakeawaysfromispor2024takeawaysfromispor20242024-05-14https://resources.flatiron.com/real-world-evidence/unlocking-the-power-of-real-world-data-across-the-globe-recent-research-accomplishments-from-flatiron-forum-and-multinational-datahttps://flatiron.com/hubfs/flatiron-forum-global-power-real-world-data.pngflatironforumglobalpowerrealworlddataflatironforumglobalpowerrealworlddata2024-11-12https://resources.flatiron.com/real-world-evidence/data-quality-real-world-evidencehttps://flatiron.com/hubfs/Examples%20of%20validations%20using%20a%20range%20of%20approaches.jpgExamplesofvalidationsusingarangeofapproachesExamplesofvalidationsusingarangeofapproacheshttps://flatiron.com/hubfs/Overview%20of%20Validation%20Approaches.jpgOverviewofValidationApproachesOverviewofValidationApproacheshttps://flatiron.com/hubfs/Data%20quality%202.0%20-%20The%20future%20of%20real-world%20evidence.jpgDataquality20ThefutureofrealworldevidenceDataquality20Thefutureofrealworldevidencehttps://flatiron.com/hubfs/why%20does%20real-world%20evidence%20matter.jpgwhydoesrealworldevidencematterwhydoesrealworldevidencematter2025-02-21https://resources.flatiron.com/publications/data-quality-across-multiple-dimensionshttps://flatiron.com/hubfs/EC-ExtendedCutwCaptions_v1.mp4/medium.jpgEC-ExtendedCutwCaptions_v1A look behind the research, "Raising the bar for real-world data in oncology: approaches to quality across multiple dimensions," published in JCO Clinical Cancer Informatics with Emily Castellanos.https://flatiron.com/hubfs/EC-ExtendedCutwCaptions_v1.mp4360nono2024-09-18https://resources.flatiron.com/press/press-release/the-center-for-cancer-and-blood-disorders-selects-flatiron-health-oncoemr-to-support-its-transition-to-value-based-care2024-03-27https://resources.flatiron.com/publications/electronic-calculation-of-quality-measures-in-the-emr-is-highly-dependent-on-data-capture-in-structured-fields-the-oncology-care-model-ocm-quality-reporting-exper2024-03-27https://resources.flatiron.com/point-of-care/is-healthcare-finally-ripe-for-transformationhttps://flatiron.com/hubfs/Imported_Blog_Media/FH-OncoCloudVirtual-session-thumbnail_thumbnail-is-healthcare-finally-ripe-for-transformation.pngFHOncoCloudVirtualsessionthumbnailthumbnailishealthcarefinallyripefortransformationFHOncoCloudVirtualsessionthumbnailthumbnailishealthcarefinallyripefortransformation2024-09-16https://resources.flatiron.com/publications/hepatitis-b-testing-rates-in-patients-with-chronic-lymphocytic-leukemia-before-and-during-administration-of-anti-cd20-therapy2024-03-26https://resources.flatiron.com/publications/real-world-glucagon-like-peptide-1-use-and-association-with-clinical-characteristics-social-determinants-and-circulating-tumor-dna-positivity-in-pat-17641022820082025-12-01https://resources.flatiron.com/press/adaptive-biotechnologies-and-flatiron-health-announce-integration-of-clonoseq-mrd-testing-into-oncoemrhttps://flatiron.com/hubfs/collaboration-announcement-Adaptive.pngcollaborationannouncementAdaptivecollaborationannouncementAdaptive2025-07-01https://resources.flatiron.com/publications/transportability-of-overall-survival-in-multiple-myeloma-from-the-us-to-germany-a-benchmarking-study2025-11-10https://resources.flatiron.com/press/the-association-of-cancer-care-centers-and-flatiron-health-announce-a-strategic-collaboration-to-improve-study-data-capturehttps://flatiron.com/hubfs/FH_Website_ResourceHubThumbnails_PressReleases_ACCC_2024.pngFHWebsiteResourceHubThumbnailsPressReleasesACCC2024FHWebsiteResourceHubThumbnailsPressReleasesACCC20242024-09-05https://resources.flatiron.com/press/flatiron-health-raises-175-million-series-c-round-to-further-bolster-its-oncologycloud-software-platform-for-providers-and-accelerate-personalized-m2024-04-18https://resources.flatiron.com/flatiron-stories/why-we-love-running-hackathons-at-flatironhttps://flatiron.com/hubfs/Imported_Blog_Media/FH_EngBlog_180227-6.jpgFHEngBlog1802276FHEngBlog18022762024-03-29https://resources.flatiron.com/publications/prognostic-significance-of-cancer-patient-reported-outcomes-in-cancer2024-03-26https://resources.flatiron.com/flatiron-stories/self-compassion-101-for-engineering-managershttps://flatiron.com/hubfs/Imported_Blog_Media/Blog_image_-_Eng_Managers_Self_Compassion_041621-1.jpegBlogimageEngManagersSelfCompassion0416211BlogimageEngManagersSelfCompassion04162112024-03-29https://resources.flatiron.com/real-world-evidence/can-you-trust-real-world-data-extracted-by-a-large-language-model-llmhttps://flatiron.com/hubfs/blog-melissa-estevez-data-quality.pngblogmelissaestevezdataqualityblogmelissaestevezdataqualityhttps://flatiron.com/hubfs/Screenshot%202025-09-18%20at%201.50.15%20PM.pngScreenshot20250918at15015PMScreenshot20250918at15015PM2026-03-17https://resources.flatiron.com/point-of-care/advancing-health-equity-in-cancer-care-with-dora-hugheshttps://flatiron.com/hubfs/_Website%20Files/Resource%20Hub%20-%20Headshots/advancing-health-equity-in-cancer-care-dora-hughes-james-hamrick.pngadvancinghealthequityincancercaredorahughesjameshamrickadvancinghealthequityincancercaredorahughesjameshamrick2024-09-16https://resources.flatiron.com/flatiron-stories/bigger-isnt-always-better2024-03-29https://resources.flatiron.com/publications/effect-of-first-line-pembrolizumab-treatment-in-individuals-with-advanced-non-small-cell-lung-cancer-and-poor-performance-status2024-03-26https://resources.flatiron.com/point-of-care/interview-with-anne-slamhttps://flatiron.com/hubfs/_Website%20Files/Resource%20Hub%20-%20Headshots/Interview-with-Anne-Slam-Eastern-Connecticut-Hematology-and-Oncology.pngInterviewwithAnneSlamEasternConnecticutHematologyandOncologyInterviewwithAnneSlamEasternConnecticutHematologyandOncologyhttps://flatiron.com/hubfs/Imported_Blog_Media/FH_RCM_Q1_ECHO_2.jpgFHRCMQ1ECHO2FHRCMQ1ECHO22024-04-02https://resources.flatiron.com/publications/rwd-prognostic-biomarkerhttps://flatiron.com/hubfs/Imported_Blog_Media/RM_openaccessarticle_thumb_02-Mar-06-2023-06-50-48-1238-AM-Mar-10-2023-04-50-59-7386-AM.jpgRMopenaccessarticlethumb02Mar0620230650481238AMMar1020230450597386AMRMopenaccessarticlethumb02Mar0620230650481238AMMar1020230450597386AM2024-03-26https://resources.flatiron.com/publications/ramucirumab-ram-immune-checkpoint-inhibitors-icis-and-single-agent-chemotherapy-chemo-usage-in-real-world-advanced-non-small-cell-lung-cancer-ansclc-patients-pts-2024-03-26https://resources.flatiron.com/press/the-american-cancer-society-flatiron-health-announce-recipients-of-fourth-annual-real-world-data-impact-awardhttps://flatiron.com/hubfs/social-graphics_RWDIaward-v2%20(1).jpgsocialgraphicsRWDIawardv21socialgraphicsRWDIawardv212024-04-26https://resources.flatiron.com/publications/association-of-programmed-cell-death-ligand-1-expression-status-with-receipt-of-immune-checkpoint-inhibitors-in-patients-with-advanced-non-small-cell-lung-cancer2024-03-26https://resources.flatiron.com/flatiron-stories/what-rock-climbing-taught-me-about-engineeringhttps://flatiron.com/hubfs/Imported_Blog_Media/climbing_rope-2.jpgclimbingrope2climbingrope22024-03-29https://resources.flatiron.com/publications/comparison-of-real-world-response-rate-rwrr-to-recist-based-response-rate-in-patients-with-advanced-non-small-cell-lung-cancer-ansclc2024-03-26https://resources.flatiron.com/point-of-care/coa-insights-leveraging-technology-for-smarter-cancer-care-deliveryhttps://flatiron.com/hubfs/COA%20insights%20-%20leveraging%20technology.pngCOAinsightsleveragingtechnologyCOAinsightsleveragingtechnology2024-09-16https://resources.flatiron.com/press/press-release/abington-hematology-oncology-associates-and-gettysburg-cancer-center-implement-flatiron-health-oncoemr2024-03-27https://resources.flatiron.com/publications/the-bispecific-blind-spot-uncovering-real-world-inequities-in-diffuse-large-b-cell-lymphoma-follicular-lymphoma-and-multiple-myeloma-therapy-access2025-11-03https://resources.flatiron.com/publications/primary-tumor-location-ptl-and-survival-outcomes-in-a-real-world-cohort-of-kras-wild-type-wt-metastatic-colorectal-cancer-mcrc-patients2024-03-26https://resources.flatiron.com/publications/real-world-response-endpoints-in-patients-with-mnsclc-treated-with-chemotherapy-across-real-world-datasetshttps://flatiron.com/hubfs/_Website%20Files/Resource%20Hub%20-%20Press%20Releases/flatiron-press-release-4.pngflatironpressrelease4flatironpressrelease42024-03-26https://resources.flatiron.com/publications/measurement-error-and-bias-in-real-world-oncology-endpoints-when-constructing-external-control-armshttps://flatiron.com/hubfs/publication-summary-large-study-leveraging-flatiron-database-1.pngpublicationsummarylargestudyleveragingflatirondatabase1publicationsummarylargestudyleveragingflatirondatabase12024-08-28https://resources.flatiron.com/publications/re-envisioning-electronic-health-records-to-optimize-patient-centered-cancer-care-quality-surveillance-and-researchhttps://flatiron.com/hubfs/publication-summary-ehr-to-optimize-patient.pngpublicationsummaryehrtooptimizepatientpublicationsummaryehrtooptimizepatient2024-09-03https://resources.flatiron.com/real-world-evidence/clinical-research-clinical-care-integrated-rwe-generationhttps://flatiron.com/hubfs/_Website%20Files/Resource%20Hub%20-%20Press%20Releases/flatiron-press-release-4.pngflatironpressrelease4flatironpressrelease42024-03-29https://resources.flatiron.com/press/canopy-and-flatiron-health-announce-partnership-to-streamline-continuous-care-management-for-oncoemr-customershttps://flatiron.com/hubfs/FH_Website_ResourceHubThumbnails_PressReleases_Canopy_2024%20(1).pngFHWebsiteResourceHubThumbnailsPressReleasesCanopy20241FHWebsiteResourceHubThumbnailsPressReleasesCanopy202412024-05-16https://resources.flatiron.com/real-world-evidence/trends-challenges-tumor-agnostic-drug-developmenthttps://flatiron.com/hubfs/Imported_Blog_Media/season2_panTumor_clip_mikeSpencer_01.jpgseason2panTumorclipmikeSpencer01season2panTumorclipmikeSpencer012024-09-16https://resources.flatiron.com/point-of-care/an-interview-with-dr.-iuliana-shapira-from-regional-cancer-care-associateshttps://flatiron.com/hubfs/_Website%20Files/Resource%20Hub%20-%20Headshots/Interview-with-Iuliana-Shapira-Regional-Cancer-Care-Associates.pngInterviewwithIulianaShapiraRegionalCancerCareAssociatesInterviewwithIulianaShapiraRegionalCancerCareAssociates2024-04-02https://resources.flatiron.com/real-world-evidence/synthetic-control-arms-regulatory-rwehttps://flatiron.com/hubfs/ResearchX%20-%20Beyond%20synthetic%20controls%20thumbnail.pngResearchXBeyondsyntheticcontrolsthumbnailResearchXBeyondsyntheticcontrolsthumbnailhttps://flatiron.com/hubfs/_Website%20Files/Resource%20Hub%20-%20ResearchX/ResearchX-thumbnail-2.jpgResearchXthumbnail2ResearchXthumbnail22024-09-16https://resources.flatiron.com/press/press-release/pfizer-and-flatiron-health-announce-expanded-strategic-collaboration-to-unlock-power-of-real-world-evidence-in-oncology2024-03-27https://resources.flatiron.com/clinical-research/cr-pragmatic-trials-webinarhttps://flatiron.com/hubfs/_Website%20Files/Video%20Thumbnails%20-%20Large/endpoints-webinar-the-pragmatic-shift-designing-trials-that-fit-the-real-world.jpgendpointswebinarthepragmaticshiftdesigningtrialsthatfittherealworldendpointswebinarthepragmaticshiftdesigningtrialsthatfittherealworld2024-12-10https://resources.flatiron.com/publications/real-world-outcomes-in-locally-advanced-or-metastatic-urothelial-carcinoma-following-platinum-and-pd-1/l1-inhibitor-therapy2024-03-26https://resources.flatiron.com/publications/first-line-immune-checkpoint-inhibitor-use-in-cisplatin-eligible-patients-with-advanced-urothelial-carcinoma-a-secular-trend-analysis2024-03-26https://resources.flatiron.com/press/press-release/flatiron-health-and-foundation-medicine-unveil-powerful-oncology-information-resource-to-advance-precision-medicine2024-03-27https://resources.flatiron.com/publications/oncology-practice-setting-classification-us-rwe2024-04-16https://resources.flatiron.com/real-world-evidence/us-adoption-inform-hta-decision-makinghttps://flatiron.com/hubfs/Imported_Blog_Media/researchX_clipsTemplate_pall.jpegresearchXclipsTemplatepallresearchXclipsTemplatepall2024-09-16https://resources.flatiron.com/publications/covid19-visit-rate-disruptions-hematologic-neoplasmshttps://flatiron.com/hubfs/_Website%20Files/Resource%20Hub%20-%20Press%20Releases/flatiron-press-release-4.pngflatironpressrelease4flatironpressrelease42024-03-26https://resources.flatiron.com/publications/aca-medicaid-racial-disparitieshttps://flatiron.com/hubfs/Imported_Blog_Media/RM_openaccessarticle_thumb_02-Mar-06-2023-06-50-48-1238-AM-Mar-10-2023-04-50-59-7386-AM.jpgRMopenaccessarticlethumb02Mar0620230650481238AMMar1020230450597386AMRMopenaccessarticlethumb02Mar0620230650481238AMMar1020230450597386AM2024-03-26https://resources.flatiron.com/publications/representativeness-in-cancer-treatment-trials-in-community-and-academic-settingshttps://flatiron.com/hubfs/_Website%20Files/Resource%20Hub%20-%20Press%20Releases/flatiron-press-release-4.pngflatironpressrelease4flatironpressrelease42024-03-26https://resources.flatiron.com/flatiron-stories/think-yes-before-no-the-improv-comedy-technique-used-at-flatiron-healthhttps://flatiron.com/hubfs/Imported_Blog_Media/07_Think-yes-before-no.jpg07Thinkyesbeforeno07Thinkyesbeforeno2024-03-29https://resources.flatiron.com/real-world-evidence/real-world-data-temporal-htahttps://flatiron.com/hubfs/Imported_Blog_Media/zamumnda-graph.pngzamumndagraphzamumndagraphhttps://flatiron.com/hubfs/HTA%20Temporal%20Considerations.jpgHTATemporalConsiderationsHTATemporalConsiderations2024-03-29https://resources.flatiron.com/clinical-research/how-can-sponsors-balance-eligibility-criteria-and-diversity-goalshttps://flatiron.com/hubfs/Learnings%20Trial%20eligibility%20criteria%20and%20diversity%20among%20patients%20with%20advanced%20NSCLC.pngLearningsTrialeligibilitycriteriaanddiversityamongpatientswithadvancedNSCLCLearningsTrialeligibilitycriteriaanddiversityamongpatientswithadvancedNSCLC2024-09-16https://resources.flatiron.com/publications/feasibility-of-prospective-real-world-studies-to-fulfill-regulatory-commitmentshttps://flatiron.com/hubfs/_Website%20Files/Resource%20Hub%20-%20Defaults/resource-hub-6.pngresourcehub6resourcehub62024-10-30https://resources.flatiron.com/press/press-release/flatiron-health-announces-new-solution-to-support-cancer-care-providers-with-oncology-care-model-participation-requirements2024-03-27https://resources.flatiron.com/clinical-research/why-prospective-real-world-studies-hold-so-much-promise-for-clinical-researchhttps://flatiron.com/hubfs/PRWS_BiopharmaDive_Graphic.pngPRWSBiopharmaDiveGraphicPRWSBiopharmaDiveGraphic2025-05-27https://resources.flatiron.com/publications/cost-effectiveness-of-multi-gene-panel-sequencing-mgps-for-advanced-non-small-cell-lung-cancer-ansclc-patients2024-03-26https://resources.flatiron.com/publications/estimating-survival-parameters-under-conditional-left-truncation2024-03-26https://resources.flatiron.com/publications/initiation-and-adherence-with-bone-targeting-agents-in-us-men-with-bone-metastases-from-prostate-cancer2024-03-27https://resources.flatiron.com/publications/an-observational-study-of-concomitant-immunotherapies-and-denosumab-in-patients-with-advanced-melanoma-or-lung-cancer2024-03-26https://resources.flatiron.com/publications/a-feasibility-analysis-to-align-fit-for-purpose-real-world-data-to-emulate-the-azur-1single-arm-clinical-trial-in-patients-with-mismatch-repair-defi-17720380256402026-02-25https://resources.flatiron.com/real-world-evidence/rwe-case-studieshttps://flatiron.com/hubfs/_Website%20Files/Resource%20Hub%20-%20ResearchX/ResearchX-thumbnail-5.jpgResearchXthumbnail5ResearchXthumbnail52024-09-16https://resources.flatiron.com/publications/ctdna-shed-as-a-tool-to-select-immune-checkpoint-inhibitors-icpi-with-or-without-chemotherapy-for-patients-pts-with-advanced-non-small-cell-lung-cancer-ansclc2024-03-26https://resources.flatiron.com/real-world-evidence/real-world-endpoints-oncologyhttps://flatiron.com/hubfs/Imported_Blog_Media/real-world-endpoints-oncology-1.jpgrealworldendpointsoncology1realworldendpointsoncology1https://flatiron.com/hubfs/_Website%20Files/Resource%20Hub%20-%20Defaults/resource-hub-9.pngresourcehub9resourcehub92024-09-16https://resources.flatiron.com/publications/time-to-treatment-discontinuation-and-real-world-progression-free-survival-as-endpoints-for-comparative-efficacy-analysis-between-entrectinib-trial-and-crizotinib2024-03-27https://resources.flatiron.com/clinical-research/ehr-to-edc-technology-for-cancer-clinical-trialshttps://flatiron.com/hubfs/_Website%20Files/Resource%20Hub%20-%20Webinar/webinar-ehr-to-edc-technology-for-cancer-clinical-trials.pngwebinarehrtoedctechnologyforcancerclinicaltrialswebinarehrtoedctechnologyforcancerclinicaltrials2025-04-23https://resources.flatiron.com/point-of-care/empowering-community-oncology-flatiron-healths-trusted-partner-networkhttps://flatiron.com/hubfs/_Website%20Files/Resource%20Hub%20-%20Press%20Releases/introducing-the-trusted-partner-network.pngintroducingthetrustedpartnernetworkintroducingthetrustedpartnernetwork2024-07-23https://resources.flatiron.com/publications/real-world-evidence-of-male-breast-cancer-patients-treated-with-palbociclib-in-combination-with-endocrine-therapy2024-03-26https://resources.flatiron.com/publications/-retrospective-cohort-study-of-real-world-clinical-outcomes-in-patients-with-cll/sll-previously-treated-with-covalent-btk-inhibitor-cbtki-and-bcl2-17477776813862025-05-23https://resources.flatiron.com/publications/assessing-the-potential-value-of-commercial-mortality-data-combined-with-publicly-available-death-data-for-pharmacoepidemiology-researchhttps://flatiron.com/hubfs/_Website%20Files/Resource%20Hub%20-%20Defaults/resource-hub-6.pngresourcehub6resourcehub62024-10-30https://resources.flatiron.com/publications/comparison-population-characteristics-oncology-databases-seer-npcr-flatironhealthhttps://flatiron.com/hubfs/Imported%20sitepage%20images/hqdefault.jpghqdefaulthqdefault2024-04-18https://resources.flatiron.com/press/flatiron-health-surpasses-1000-research-publicationshttps://flatiron.com/hubfs/press-release-1kpubs.pngpressrelease1kpubspressrelease1kpubs2024-10-09https://resources.flatiron.com/real-world-evidence/real-world-data-machine-learning-large-language-modelshttps://flatiron.com/hubfs/performance-x-fine-tuning-examples.pngperformancexfinetuningexamplesperformancexfinetuningexampleshttps://flatiron.com/hubfs/_Website%20Files/Resource%20Hub%20-%20Illustrations/Optimizing%20real-world%20evidence%20generation%20through%20machine%20Learning%20and%20large%20language%20models.jpgOptimizingrealworldevidencegenerationthroughmachineLearningandlargelanguagemodelsOptimizingrealworldevidencegenerationthroughmachineLearningandlargelanguagemodelshttps://flatiron.com/hubfs/policies-and-procedures.jpgpoliciesandprocedurespoliciesandprocedureshttps://flatiron.com/hubfs/table-with-incorrect-values.giftablewithincorrectvaluestablewithincorrectvalueshttps://flatiron.com/hubfs/chat-gpt-extracting-medical-information-from-ehr-datasets.pngchatgptextractingmedicalinformationfromehrdatasetschatgptextractingmedicalinformationfromehrdatasets2024-07-09https://resources.flatiron.com/clinical-research/how-do-technology-operational-services-complement-each-other-in-pmc-pmr-studieshttps://flatiron.com/hubfs/How%20do%20technology%20and%20operational%20services%20complement%20each%20other%20in%20PMCPMR%20studies%2c%20supported%20by%20Flatiron.pngHowdotechnologyandoperationalservicescomplementeachotherinPMCPMRstudiessupportedbyFlatironHowdotechnologyandoperationalservicescomplementeachotherinPMCPMRstudiessupportedbyFlatiron2024-09-16https://resources.flatiron.com/publications/treatment-patterns-and-outcomes-for-patients-with-advanced-melanoma-in-us-oncology-clinical-practices2024-03-26https://resources.flatiron.com/publications/tolerability-of-first-line-treatment-with-ribociclib-for-metastatic-breast-cancer-using-two-large-us-data-sources2024-12-04https://resources.flatiron.com/publications/development-of-a-dashboard-for-end-of-life-care-at-an-academic-hospital2024-03-26https://resources.flatiron.com/publications/time-to-treatment-initiation-for-patients-with-advanced-cancer-documented-during-the-covid-19-pandemic2024-03-27https://resources.flatiron.com/publications/is-individual-patient-data-essential-for-transportability2024-10-22https://resources.flatiron.com/publications/real-world-application-of-national-comprehensive-cancer-network-nccn-testing-guidelines-in-diffuse-large-b-cell-lymphoma-dlbcl-results-in-underdiagnosis-of-double2024-03-26https://resources.flatiron.com/press/press-release/dayton-physicians-network2024-03-27https://resources.flatiron.com/publications/treatment-duration-and-subsequent-treatments-of-first-line-cdk4/6i-plus-aromatase-inhibitor-for-hr/her2-metastatic-breast-cancer-in-us-routine-clinical-practice2025-10-13https://resources.flatiron.com/publications/measures-of-neighborhood-structural-racism-and-overall-survival-among-patients-with-metastatic-breast-cancerhttps://flatiron.com/hubfs/_Website%20Files/Resource%20Hub%20-%20Press%20Releases/flatiron-press-release-4.pngflatironpressrelease4flatironpressrelease42024-03-26https://resources.flatiron.com/publications/utility-automated-data-transfer-cancer-clinical-trials2024-08-20https://resources.flatiron.com/real-world-evidence/innovative-approaches-to-evidence-generation-that-unlock-key-insights-in-hematologic-cancerhttps://flatiron.com/hubfs/ASH%20Webinar%20Thumbnail.pngASHWebinarThumbnailASHWebinarThumbnail2024-11-20https://resources.flatiron.com/publications/comparative-effectiveness-of-carboplatin-pemetrexed-carbo-pem-with-vs.-without-bevacizumab-bev-in-patients-with-advanced-non-squamous-sq-non-small-cell-lung-cance2024-03-26https://resources.flatiron.com/real-world-evidence/estimating-survival-parameters-under-conditionally-independent-left-truncationhttps://flatiron.com/hubfs/_Website%20Files/Resource%20Hub%20-%20Press%20Releases/flatiron-press-release-4.pngflatironpressrelease4flatironpressrelease42024-03-29https://resources.flatiron.com/real-world-evidence/rwd-cost-effectiveness-analysis-htahttps://flatiron.com/hubfs/Imported_Blog_Media/Akshay.jpegAkshayAkshay2024-09-16https://resources.flatiron.com/press/flatiron-launches-first-of-its-kind-ai-powered-global-prostate-cancer-datasetshttps://flatiron.com/hubfs/press-release-3.pngpressrelease3pressrelease32026-02-18https://resources.flatiron.com/publications/prognostic-value-translocation-patients-relapsed-myeloma-anti-cd382024-03-26https://resources.flatiron.com/real-world-evidence/what-is-integrated-evidencehttps://flatiron.com/hubfs/_Website%20Files/Resource%20Hub%20-%20ResearchX/ResearchX-thumbnail-2.jpgResearchXthumbnail2ResearchXthumbnail22024-09-16https://resources.flatiron.com/publications/an-observational-study-of-concomitant-use-of-emerging-therapies-and-denosumab-or-zoledronic-acid-in-prostate-cancer2024-03-27https://resources.flatiron.com/point-of-care/start-center-for-cancer-care-oncoemr-flatiron-assisthttps://flatiron.com/hubfs/start-cancer-care.pngstartcancercarestartcancercare2024-04-26https://resources.flatiron.com/point-of-care/state-of-community-oncology-2024https://flatiron.com/hubfs/State%20of%20community%20oncology.pngStateofcommunityoncologyStateofcommunityoncology2024-09-16https://resources.flatiron.com/clinical-research/research-learnings-trial-eligibility-criteria-and-diversity-among-patients-with-advanced-nsclchttps://flatiron.com/hubfs/Learnings%20Trial%20eligibility%20criteria%20and%20diversity%20among%20patients%20with%20advanced%20NSCLC.pngLearningsTrialeligibilitycriteriaanddiversityamongpatientswithadvancedNSCLCLearningsTrialeligibilitycriteriaanddiversityamongpatientswithadvancedNSCLC2024-09-16https://resources.flatiron.com/press/willowglade-technologies-and-flatiron-health-partner-to-enhance-patient-engagement-and-practice-operationshttps://flatiron.com/hubfs/partnership-announcement-flatiron-and-willowglade-1.pngpartnershipannouncementflatironandwillowglade1partnershipannouncementflatironandwillowglade12024-11-20https://resources.flatiron.com/publications/molecular-residual-disease-mrd-in-solid-tumors2025-05-22https://resources.flatiron.com/real-world-evidence/advancing-equity-in-cancer-care-unveiling-insights-from-the-2023-real-world-data-impact-awardhttps://flatiron.com/hubfs/advancing-equity-in-cancer-care-1.jpgadvancingequityincancercare1advancingequityincancercare1https://flatiron.com/hubfs/social-graphics_RWDIaward-v2%20(1).jpgsocialgraphicsRWDIawardv21socialgraphicsRWDIawardv212024-09-16https://resources.flatiron.com/publications/inverse-probability-of-treatment-weighting-missingness-confounder-datahttps://flatiron.com/hubfs/_Website%20Files/Resource%20Hub%20-%20Press%20Releases/flatiron-press-release-4.pngflatironpressrelease4flatironpressrelease42024-03-26https://resources.flatiron.com/clinical-research/case-study-prospective-clinicogenomichttps://flatiron.com/hubfs/_Website%20Files/Resource%20Hub%20-%20Case%20Studies/prospective-clinico-genomic-study-flatiron.pngprospectiveclinicogenomicstudyflatironprospectiveclinicogenomicstudyflatiron2025-05-27https://resources.flatiron.com/real-world-evidence/applying-rwe-to-regulatory-applicationshttps://flatiron.com/hubfs/season1_regulatory_08.jpgseason1regulatory08season1regulatory08https://flatiron.com/hubfs/_Website%20Files/Resource%20Hub%20-%20ResearchX/ResearchX-thumbnail-6.jpgResearchXthumbnail6ResearchXthumbnail62024-09-16https://resources.flatiron.com/publications/real-world-disparities-in-daratumumab-utilization-for-patients-with-relapsed-or-refractory-multiple-myeloma-mm2024-03-26https://resources.flatiron.com/publications/approximating-international-myeloma-working-group-uniform-response-criteria-to-derive-response-for-multiple-myeloma-mm-patients-using-data-from-electronic-health-2024-03-26https://resources.flatiron.com/publications/speed-of-adoption-of-immune-checkpoint-inhibitors-of-programmed-cell-death-1-protein-and-comparison-of-patient-ages-in-clinical-practice-vs-pivotal-clinical-trial2024-03-27https://resources.flatiron.com/press/flatiron-health-announces-research-to-be-presented-at-american-society-of-clinical-oncology-2023-annual-meetinghttps://flatiron.com/hubfs/120509_PressRelease.png120509PressRelease120509PressRelease2024-03-27https://resources.flatiron.com/real-world-evidence/accelerating-precision-oncology-research-applications-of-linked-clinical-multiomics-real-world-datahttps://flatiron.com/hubfs/panel-discussion-accelerating-precision-oncology-research-with-linked-clinical-and-multiomic-real-world-data.pngpaneldiscussionacceleratingprecisiononcologyresearchwithlinkedclinicalandmultiomicrealworlddatapaneldiscussionacceleratingprecisiononcologyresearchwithlinkedclinicalandmultiomicrealworlddatahttps://flatiron.com/hubfs/_Website%20Files/Resource%20Hub%20-%20Webinar/panel-discussion-accelerating-precision-oncology-research-with-linked-clinical-and-multiomic-real-world-data.pngpaneldiscussionacceleratingprecisiononcologyresearchwithlinkedclinicalandmultiomicrealworlddatapaneldiscussionacceleratingprecisiononcologyresearchwithlinkedclinicalandmultiomicrealworlddata2024-10-14https://resources.flatiron.com/press/flatiron-health-and-exact-sciences-partner-to-advance-clinical-evidence-generation-for-molecular-residual-disease-testinghttps://flatiron.com/hubfs/flatiron-press-release-EXAS.pngflatironpressreleaseEXASflatironpressreleaseEXAS2025-02-05https://resources.flatiron.com/press/onc.ai-awarded-fda-breakthrough-device-designation-for-serial-ct-response-score-deep-learning-modelhttps://flatiron.com/hubfs/Onc.ai.pngOncaiOncai2025-03-04https://resources.flatiron.com/publications/missing-lab-data-in-electronic-health-records-nsclc-multiple-myelomahttps://flatiron.com/hubfs/_Website%20Files/Resource%20Hub%20-%20Press%20Releases/flatiron-press-release-4.pngflatironpressrelease4flatironpressrelease42024-03-26https://resources.flatiron.com/clinical-research/laying-the-foundation-for-integrated-evidencehttps://flatiron.com/hubfs/_Website%20Files/Events%20Thumbnails/acrp-2023.jpgacrp2023acrp20232024-04-02https://resources.flatiron.com/press/press-release/michael-vasconcelles2024-03-27https://resources.flatiron.com/publications/real-world-outcomes-of-hormone-receptor-positive-hr-her2-negative-her2-metastatic-breast-cancer-mbc-with-high-tumor-mutational-burden-htmb-treated-with-immune-che2024-03-26https://resources.flatiron.com/flatiron-stories/hacking-for-good-improving-access-to-clinical-trialshttps://flatiron.com/hubfs/Imported_Blog_Media/Landing-Page-3.pngLandingPage3LandingPage3https://flatiron.com/hubfs/Imported_Blog_Media/Zoom-Call-3.pngZoomCall3ZoomCall3https://flatiron.com/hubfs/Imported_Blog_Media/image1-3.pngimage13image13https://flatiron.com/hubfs/Imported_Blog_Media/Hackathon-Team-3.jpgHackathonTeam3HackathonTeam3https://flatiron.com/hubfs/Imported_Blog_Media/fight_crc_footer.jpgfightcrcfooterfightcrcfooter2024-03-29https://resources.flatiron.com/publications/real-world-outcomes-of-metastatic-pancreatic-cancer-mpc-patients-pts-treated-with-liposomal-irinotecan-nal-iri-in-the-us2024-03-26https://resources.flatiron.com/publications/accelerating-anticancer-drug-development-opportunities-and-trade-offs2024-03-26https://resources.flatiron.com/publications/effectiveness-of-parp-inhibitor-maintenance-therapy-in-advanced-ovarian-cancer-by-brca1/2-and-hrd-signature-in-real-world-practicehttps://flatiron.com/hubfs/_Website%20Files/Resource%20Hub%20-%20Press%20Releases/flatiron-press-release-4.pngflatironpressrelease4flatironpressrelease42024-03-26https://resources.flatiron.com/publications/validation-of-an-algorithm-to-predict-treatment-discontinuation-status-in-electronic-health-records2024-03-26https://resources.flatiron.com/real-world-evidence/stk11-keap1-mutations-prognostic-biomarkers-real-world-datahttps://flatiron.com/hubfs/Imported_Blog_Media/season1_clip_simonPC_02.jpgseason1clipsimonPC02season1clipsimonPC022024-09-16https://resources.flatiron.com/flatiron-stories/meet-our-changemakers-nick-accomando-chief-risk-and-compliance-officerhttps://flatiron.com/hubfs/_Website%20Files/Resource%20Hub%20-%20Changemakers/meet-our-changemakers-nick-accomando.pngmeetourchangemakersnickaccomandomeetourchangemakersnickaccomando2024-12-10https://resources.flatiron.com/point-of-care/tips-tricks-for-smaller-sized-community-oncology-practicehttps://flatiron.com/hubfs/_Website%20Files/Resource%20Hub%20-%20Headshots/Tips-and-tricks-for-smaller-sized-community-oncology-practices.pngTipsandtricksforsmallersizedcommunityoncologypracticesTipsandtricksforsmallersizedcommunityoncologypractices2024-04-02https://resources.flatiron.com/flatiron-stories/my-coach-my-teacher-my-mentorhttps://flatiron.com/hubfs/Imported_Blog_Media/Martha_Personal_Story_632x396-1.jpgMarthaPersonalStory632x3961MarthaPersonalStory632x39612024-03-29https://resources.flatiron.com/publications/transporting-real-world-evidence-is-it-possible-to-transport-os-estimates-in-her2-mbc-from-us-to-uk2024-10-22https://resources.flatiron.com/point-of-care/enable-precision-medicine-for-every-patienthttps://flatiron.com/hubfs/Imported_Blog_Media/FH-OncoCloudVirtual-session-thumbnail_enable-precision-medicine-for-every-patient.pngFHOncoCloudVirtualsessionthumbnailenableprecisionmedicineforeverypatientFHOncoCloudVirtualsessionthumbnailenableprecisionmedicineforeverypatient2024-09-16https://resources.flatiron.com/publications/end-of-life-systemic-oncology-immunotherapy-era-race-insurance-practicehttps://flatiron.com/hubfs/Imported%20sitepage%20images/hqdefault.jpghqdefaulthqdefault2024-09-19https://resources.flatiron.com/press/press-release/distinguished-oncologist-and-cancer-data-researcher-dr-amy-abernethy-joins-flatiron-health-as-chief-medical-officer-and-svp-of-oncology2024-03-27https://resources.flatiron.com/clinical-research/the-opportunity-projecthttps://flatiron.com/hubfs/Imported_Blog_Media/Image-from-iOS-8-8-3.jpgImagefromiOS883ImagefromiOS883https://flatiron.com/hubfs/Imported_Blog_Media/Government-illustration_1028X880-1.jpgGovernmentillustration1028X8801Governmentillustration1028X8801https://flatiron.com/hubfs/Imported_Blog_Media/ot-top-health-3.pngottophealth3ottophealth3https://flatiron.com/hubfs/Imported_Blog_Media/Image_from_iOS_32_1_edited-3.jpgImagefromiOS321edited3ImagefromiOS321edited3https://flatiron.com/hubfs/Imported_Blog_Media/IMG_9098_edited-3.jpgIMG9098edited3IMG9098edited32024-04-02https://resources.flatiron.com/publications/use-and-outcomes-following-blinatumomab-rechallenge-in-adolescents-and-young-adults-and-adults-with-b-cell-acute-lymphoblastic-leukemia2025-11-03https://resources.flatiron.com/press/flatiron-health-triples-global-oncology-research-network-unlocking-multinational-evidence-generationhttps://flatiron.com/hubfs/flatiron-press-release-multinational-network-1.pngflatironpressreleasemultinationalnetwork1flatironpressreleasemultinationalnetwork12025-07-23https://resources.flatiron.com/press/natera-integrates-with-flatiron-healths-oncoemr-platform2025-11-12https://resources.flatiron.com/flatiron-stories/using-machine-learning-to-reimagine-the-infrastructure-of-cancer-carehttps://flatiron.com/hubfs/Imported_Blog_Media/21301198-Blue-2.jpg21301198Blue221301198Blue22024-03-29https://resources.flatiron.com/real-world-evidence/asco-2023-key-takeaways-from-improved-oncology-clinical-trials-to-aihttps://flatiron.com/hubfs/1687372158992-1.png16873721589921168737215899212024-04-16https://resources.flatiron.com/publications/development-of-oncology-ehr-derived-real-world-data-in-europe-and-japan2024-10-22https://resources.flatiron.com/publications/real-world-mortality-endpointhttps://flatiron.com/hubfs/Imported_Blog_Media/RM_openaccessarticle_thumb_01-4-2.jpgRMopenaccessarticlethumb0142RMopenaccessarticlethumb01422024-03-27https://resources.flatiron.com/press/press-release/foundation-medicine-and-flatiron-health-announce-first-of-its-kind-integration-of-genomic-profiling-into-oncoemr2024-03-27https://resources.flatiron.com/point-of-care/interview-with-dr.-ted-arrowsmithhttps://flatiron.com/hubfs/_Website%20Files/Resource%20Hub%20-%20Headshots/Interview-with-Ted-Arrowsmith-Tennessee-Oncology.pngInterviewwithTedArrowsmithTennesseeOncologyInterviewwithTedArrowsmithTennesseeOncology2024-04-02https://resources.flatiron.com/publications/assessing-contribution-scanned-outside-documents-completeness-real-world-data-abstraction2024-03-26https://resources.flatiron.com/real-world-evidence/flatiron-health-at-the-fdas-pdufa-public-meeting-july-23-2020https://flatiron.com/hubfs/Imported_Blog_Media/Press_Release_Sample2-2.jpgPressReleaseSample22PressReleaseSample222024-03-29https://resources.flatiron.com/point-of-care/making-oncologists-good-neighbors2024-04-02https://resources.flatiron.com/publications/maintenance-immunotherapy-upstream-treatment-selection-urothelial-cancerhttps://flatiron.com/hubfs/_Website%20Files/Resource%20Hub%20-%20Press%20Releases/flatiron-press-release-4.pngflatironpressrelease4flatironpressrelease42024-03-26https://resources.flatiron.com/point-of-care/ensuring-equity-expanding-precision-medicine-in-cancer-carehttps://flatiron.com/hubfs/takeaways-from-clinical-pathways-congress-3of3.pngtakeawaysfromclinicalpathwayscongress3of3takeawaysfromclinicalpathwayscongress3of32024-04-09https://resources.flatiron.com/publications/racial-disparities-telemedicine-uptake-covid19-hematologic-malignancies2024-05-09https://resources.flatiron.com/flatiron-stories/oncocloud-17-thats-a-wraphttps://flatiron.com/hubfs/Imported_Blog_Media/nat-oc17.pngnatoc17natoc172024-03-29https://resources.flatiron.com/press/press-release/flatiron-health-and-vector-oncology-to-offer-patient-reported-outcomes-at-the-point-of-care2024-04-18https://resources.flatiron.com/publications/an-evaluation-of-patient-activity-definitions-and-informative-censoring-in-analyses-of-real-world-overall-survival-in-electronic-health-recordshttps://flatiron.com/hubfs/_Website%20Files/Resource%20Hub%20-%20Defaults/resource-hub-6.pngresourcehub6resourcehub62024-10-30https://resources.flatiron.com/press/flatiron-health-enters-new-five-year-research-collaboration-with-fda-on-real-world-datahttps://flatiron.com/hubfs/FH_FDA_ResourceHubThumbnails_PressReleases.pngFHFDAResourceHubThumbnailsPressReleasesFHFDAResourceHubThumbnailsPressReleases2024-07-09https://resources.flatiron.com/publications/ras-amplification-anti-egfr-mcchttps://flatiron.com/hubfs/Imported_Blog_Media/RM_openaccessarticle_thumb_02-Mar-06-2023-06-50-48-1238-AM-Mar-10-2023-04-48-18-1912-AM.jpgRMopenaccessarticlethumb02Mar0620230650481238AMMar1020230448181912AMRMopenaccessarticlethumb02Mar0620230650481238AMMar1020230448181912AM2024-03-26https://resources.flatiron.com/publications/using-large-language-models-to-extract-pd-l1-biomarker-data-from-electronic-health-records2025-02-13https://resources.flatiron.com/publications/evaluating-real-world-overall-survival-rwos-across-oncology-data-sources-friends-of-cancer-research-non-small-cell-lung-cancer-pilot-study2024-03-26https://resources.flatiron.com/point-of-care/scaling-research-operations-at-community-oncology-practiceshttps://flatiron.com/hubfs/Kathy%20Oubre.pngKathyOubreKathyOubre2024-09-16https://resources.flatiron.com/publications/ctdna-testing-patterns-biomarker-metastasis-colorectal-cancer2024-05-23https://resources.flatiron.com/flatiron-stories/the-human-behind-the-cellhttps://flatiron.com/hubfs/Imported_Blog_Media/Flatiron_Blog_Rana_171025_DArtboard-1-copy-2@2x-8.pngFlatironBlogRana171025DArtboard1copy22x8FlatironBlogRana171025DArtboard1copy22x82024-03-29https://resources.flatiron.com/publications/assessing-real-world-biomarker-testing-rates-in-metastatic-colon-cancer2024-03-26https://resources.flatiron.com/press/press-release/caris-life-sciences-and-flatiron-health-partner-to-vastly-increase-access-to-most-comprehensive-molecular-testing-availablehttps://flatiron.com/hubfs/_Website%20Files/Resource%20Hub%20-%20Partner%20Logos/caris-life-sciences-flatiron.pngcarislifesciencesflatironcarislifesciencesflatiron2024-03-27https://resources.flatiron.com/publications/real-world-insights-into-diffuse-large-b-cell-lymphoma-from-ehr-derived-data-in-germany-and-the-united-kingdom2025-11-03https://resources.flatiron.com/press/press-release/northwest-medical-specialties-select-flatiron-healths-oncoemr-to-accelerate-clinical-transformation2024-03-27https://resources.flatiron.com/press/press-release/stephanie-reisinger-to-lead-flatiron-healths-real-world-evidence-businesshttps://flatiron.com/hubfs/_Website%20Files/Resource%20Hub%20-%20Defaults/resource-hub-9.pngresourcehub9resourcehub92024-04-26https://resources.flatiron.com/publications/real-world-treatment-profiles-in-patients-with-breast-cancer-in-japan2025-11-13https://resources.flatiron.com/publications/real-world-insights-into-multiple-myeloma-management-an-analysis-of-ehr-derived-data-in-the-uk-and-germany2025-11-03https://resources.flatiron.com/publications/patient-characteristics-and-treatment-patterns-in-extensive-stage-small-cell-lung-cancer-es-sclc2025-04-17https://resources.flatiron.com/point-of-care/a-redesigned-dose-calculation-workflow-increased-safety-and-efficiencyhttps://flatiron.com/hubfs/Imported_Blog_Media/Dose-Calc-blog-2.jpgDoseCalcblog2DoseCalcblog22024-04-02https://resources.flatiron.com/publications/biomarker-status-as-a-mediator-of-age-related-overall-survival-os-in-advanced-non-small-cell-lung-cancer-ansclc2024-03-26https://resources.flatiron.com/flatiron-stories/meet-our-changemakers-melissa-estevez-director-research-scienceshttps://flatiron.com/hubfs/_Website%20Files/Resource%20Hub%20-%20Changemakers/Melissa%20Estevez%20May%202024.pngMelissaEstevezMay2024MelissaEstevezMay20242024-12-10https://resources.flatiron.com/press/press-release/flatiron-health-awarded-as-technology-pioneer-by-world-economic-forum2024-03-27https://resources.flatiron.com/publications/machine-learning-high-risk-patients2024-03-26https://resources.flatiron.com/real-world-evidence/tmb-h-overall-survival-solid-tumors-rwdhttps://flatiron.com/hubfs/Imported_Blog_Media/season2_panTumor_clip_chelseaShao_01.jpgseason2panTumorclipchelseaShao01season2panTumorclipchelseaShao012024-09-16https://resources.flatiron.com/flatiron-stories/puerto-rico-supporthttps://flatiron.com/hubfs/Imported_Blog_Media/Flatiron_Blog_CSTeam-2.pngFlatironBlogCSTeam2FlatironBlogCSTeam2https://flatiron.com/hubfs/Imported_Blog_Media/Flatiron_Blog_PuertoRico_Data-2.pngFlatironBlogPuertoRicoData2FlatironBlogPuertoRicoData2https://flatiron.com/hubfs/Flatiron_Blog_PuertoRico_Header.pngFlatironBlogPuertoRicoHeaderFlatironBlogPuertoRicoHeader2024-03-29https://resources.flatiron.com/publications/real-world-outcomes-of-acute-myeloid-leukemia-patients-undergoing-treatment-with-tyrosine-kinase-inhibitor2024-11-06https://resources.flatiron.com/publications/optimizing-data-collection-assessing-ehr-to-edc-data-transfer-potential-across-structured-and-unstructured-data2025-03-13https://resources.flatiron.com/point-of-care/can-custom-oncology-pathways-fill-gaps-in-clinical-decision-supporthttps://flatiron.com/hubfs/122448-flatironhe-blogheroimage-D05.jpg122448flatironheblogheroimageD05122448flatironheblogheroimageD052024-04-18https://resources.flatiron.com/publications/real-world-response-endpointhttps://flatiron.com/hubfs/Imported_Blog_Media/RM_openaccessarticle_thumb_01-4-2.jpgRMopenaccessarticlethumb0142RMopenaccessarticlethumb01422024-03-26https://resources.flatiron.com/press/press-release/flatiron-health-ranked-the-top-end-to-end-oncology-technology-solution-by-black-book-research2024-03-27https://resources.flatiron.com/press/deepscribe-and-flatiron-health-announce-partnership-to-bring-oncology-specific-ambient-ai-to-flatirons-4200-providershttps://flatiron.com/hubfs/partnership-announcement-flatiron-and-deepscribe.pngpartnershipannouncementflatironanddeepscribepartnershipannouncementflatironanddeepscribe2025-01-22https://resources.flatiron.com/publications/postprediction-interference-clinical-characteristics-machine-learninghttps://flatiron.com/hubfs/_Website%20Files/Resource%20Hub%20-%20Press%20Releases/flatiron-press-release-4.pngflatironpressrelease4flatironpressrelease42024-03-26https://resources.flatiron.com/publications/development-of-a-derived-induction-failure-and-relapse-variable-for-acute-myeloid-leukemia-using-real-world-data-from-an-electronic-health-record-derived-databasehttps://flatiron.com/hubfs/_Website%20Files/Resource%20Hub%20-%20Press%20Releases/flatiron-press-release-4.pngflatironpressrelease4flatironpressrelease42024-03-26https://resources.flatiron.com/flatiron-stories/5-things-i-learned-from-transitioning-into-software-engineeringhttps://flatiron.com/hubfs/Imported_Blog_Media/5_things_I_learned_blog_image-2.png5thingsIlearnedblogimage25thingsIlearnedblogimage22024-03-29https://resources.flatiron.com/clinical-research/research-goal-trial-eligibility-criteria-and-diversity-among-patients-with-advanced-nsclchttps://flatiron.com/hubfs/Learnings%20Trial%20eligibility%20criteria%20and%20diversity%20among%20patients%20with%20advanced%20NSCLC.pngLearningsTrialeligibilitycriteriaanddiversityamongpatientswithadvancedNSCLCLearningsTrialeligibilitycriteriaanddiversityamongpatientswithadvancedNSCLC2024-09-16https://resources.flatiron.com/publications/diffusion-of-innovation-in-oncology-a-case-study-of-immuno-oncology-io-adoption-for-advanced-non-small-lung-cancer-ansclc-patients-across-practices-in-the-us2024-03-26https://resources.flatiron.com/press/press-release/flatiron-health-announces-research-to-be-presented-at-international-society-for-pharmacoeconomics-and-outcomes-research-europe-2022-annual-meetinghttps://flatiron.com/hubfs/Imported%20sitepage%20images/News-ISPOR.jpgNewsISPORNewsISPOR2024-04-26https://resources.flatiron.com/press/press-release/the-american-cancer-society-and-flatiron-health-announce-recipients-of-real-world-data-impact-awardhttps://flatiron.com/hubfs/_Website%20Files/Resource%20Hub%20-%20Partner%20Logos/real-world-data-impact-awards-acs-flatiron.pngrealworlddataimpactawardsacsflatironrealworlddataimpactawardsacsflatiron2024-03-27https://resources.flatiron.com/press/press-release/alabama-oncology-selects-flatiron-health-oncoemr-to-support-clinical-workflow-and-delivery-of-patient-care2024-03-27https://resources.flatiron.com/publications/harnessing-the-power-of-real-world-evidence-rwe-a-checklist-to-ensure-regulatory-grade-data-quality2024-03-27https://resources.flatiron.com/press/abbott-expands-access-to-precision-oncology-portfolio-through-integration-with-flatirons-oncoemr-platformhttps://flatiron.com/hubfs/press-release-3%20(1).pngpressrelease31pressrelease312026-03-30https://resources.flatiron.com/clinical-research/clinical-research-innovationhttps://flatiron.com/hubfs/_Website%20Files/Resource%20Hub%20-%20ResearchX/ResearchX-thumbnail-4.jpgResearchXthumbnail4ResearchXthumbnail42024-09-16https://resources.flatiron.com/publications/retrospective-analysis-of-real-world-clinico-genomic-data-for-clinical-impact-of-genomic-profiling-of-ctdna-in-nsclc2024-03-26https://resources.flatiron.com/publications/crossing-borders-the-need-for-empirical-evidence-of-real-world-evidence-transportability-in-oncology2025-07-17https://resources.flatiron.com/press/the-medical-university-of-south-carolina-and-flatiron-health-announce-collaboration-to-drive-more-standardized-efficient-and-effective-cancer-carehttps://flatiron.com/hubfs/FH_MUSC_PressReleases_flatiron-press-release-4.pngFHMUSCPressReleasesflatironpressrelease4FHMUSCPressReleasesflatironpressrelease42024-07-31https://resources.flatiron.com/real-world-evidence/sitc-symposium-a-new-era-of-precision-immuno-oncology-research-fueled-by-omics-based-technology-testing-and-linked-rwdhttps://flatiron.com/hubfs/_Website%20Files/SITC-2024-recap.pngSITC2024recapSITC2024recaphttps://flatiron.com/hubfs/image-png-3.pngimagepng3imagepng3https://flatiron.com/hubfs/image-png-4.pngimagepng4imagepng42024-12-17https://resources.flatiron.com/point-of-care/does-ehr-embedded-clinical-decision-support-reduce-care-variation-signs-point-to-yeshttps://flatiron.com/hubfs/Rebecca%20Maniago%20Poster.pngRebeccaManiagoPosterRebeccaManiagoPosterhttps://flatiron.com/hubfs/new%20research%20indicates%20EHR-embedded%20clinical%20decision%20support%20does%20reduce%20care%20variation.jpgnewresearchindicatesEHRembeddedclinicaldecisionsupportdoesreducecarevariationnewresearchindicatesEHRembeddedclinicaldecisionsupportdoesreducecarevariation2024-04-02https://resources.flatiron.com/publications/real-world-clinical-characteristics-and-treatment-patterns-in-patients-with-colorectal-cancer-crc-in-japan2026-03-30https://resources.flatiron.com/flatiron-stories/manager-therapy-for-engineers2024-03-29https://resources.flatiron.com/press/press-release/flatiron-health-celebrates-three-year-anniversary-with-new-san-francisco-office2024-03-27https://resources.flatiron.com/publications/a-real-world-rw-evidence-study-quantifying-the-clinical-value-of-multi-gene-testing-in-early-stage-lung-adenocarcinoma-luad2024-03-26https://resources.flatiron.com/flatiron-stories/on-biostatistics-alan-alda-and-being-mission-drivenhttps://flatiron.com/hubfs/Imported_Blog_Media/Flatiron_Blog_SGriffith_footer_180125.jpgFlatironBlogSGriffithfooter180125FlatironBlogSGriffithfooter1801252024-03-29https://resources.flatiron.com/press/flatiron-health-names-new-chief-business-technology-and-product-leadershttps://flatiron.com/hubfs/ET-2026%20(2).pngET20262ET202622026-02-11https://resources.flatiron.com/publications/exposure-to-us-cancer-drugs-lack-confirmed-benefit-after-us-fda-accelerated-approval2024-03-26https://resources.flatiron.com/publications/influence-of-prognostic-factors-on-outcomes-among-metastatic-breast-cancer-patients-treated-with-cdk46-inhibitors-in-routine-clinical-practice2024-03-26https://resources.flatiron.com/clinical-research/how-does-flatiron-help-sponsors-make-decisions-on-what-data-to-use-in-a-pmc-pmr-studyhttps://flatiron.com/hubfs/How%20does%20Flatiron%20help%20sponsors%20make%20decisions%20on%20what%20data%20to%20use%20in%20a%20PMC%20study.pngHowdoesFlatironhelpsponsorsmakedecisionsonwhatdatatouseinaPMCstudyHowdoesFlatironhelpsponsorsmakedecisionsonwhatdatatouseinaPMCstudy2024-09-16https://resources.flatiron.com/press/press-release/flatiron-health-unveils-new-features-and-enhancements-to-the-oncologycloud-software-platform2024-03-27https://resources.flatiron.com/publications/real-world-treatment-patterns-and-outcomes-in-us-patients-with-neurotrophic-tyrosine-receptor-kinase-positive-solid-tumors2025-10-13https://resources.flatiron.com/real-world-evidence/is-the-cancer-better-or-worsehttps://flatiron.com/hubfs/Imported_Blog_Media/Real_world_progression_1028X880.jpgRealworldprogression1028X880Realworldprogression1028X8802024-03-29https://resources.flatiron.com/flatiron-stories/scavenging-for-data-insights-with-quantitative-sciences-at-flatiron-healthhttps://flatiron.com/hubfs/Imported_Blog_Media/magnifying_glass.jpgmagnifyingglassmagnifyingglasshttps://flatiron.com/hubfs/Imported_Blog_Media/Growth-of-Quant-Sci-team-2.pngGrowthofQuantSciteam2GrowthofQuantSciteam22024-03-29https://resources.flatiron.com/publications/sociodemographic-inequities-telemedicine-community-cancer-centers2024-03-26https://resources.flatiron.com/publications/a-multi-modal-ehr-based-approach-to-screen-patients-for-oncology-clinical-trialshttps://flatiron.com/hubfs/publication-summary-are-community-oncology-practices-with-without-clinical-research-programs-different%20(1).pngpublicationsummaryarecommunityoncologypracticeswithwithoutclinicalresearchprogramsdifferent1publicationsummaryarecommunityoncologypracticeswithwithoutclinicalresearchprogramsdifferent12024-11-04https://resources.flatiron.com/real-world-evidence/scaling-insights-in-cancer-care-with-machine-learninghttps://flatiron.com/hubfs/_Website%20Files/Resource%20Hub%20-%20ResearchX/ResearchX-thumbnail-4.jpgResearchXthumbnail4ResearchXthumbnail4https://flatiron.com/hubfs/RXE02.pngRXE02RXE022025-03-05https://resources.flatiron.com/clinical-research/flatiron-clinical-research-customer-testimonialshttps://flatiron.com/hubfs/_Website%20Files/Resource%20Hub%20-%20Videos/Without%20Play%20Button/George-Clinical-video-thumb.jpgGeorgeClinicalvideothumbGeorgeClinicalvideothumbhttps://flatiron.com/hubfs/_Website%20Files/Resource%20Hub%20-%20Defaults/resource-hub-6.pngresourcehub6resourcehub62024-09-16https://resources.flatiron.com/flatiron-stories/onboarding-before-there-was-onboarding2024-04-18https://resources.flatiron.com/real-world-evidence/new-dosing-regiment-cetuximab-rwdhttps://flatiron.com/hubfs/_Website%20Files/Resource%20Hub%20-%20ResearchX/ResearchX-thumbnail-5.jpgResearchXthumbnail5ResearchXthumbnail5https://flatiron.com/hubfs/Imported_Blog_Media/Kristin.pngKristinKristin2024-09-16https://resources.flatiron.com/press/press-release/michael-kolodziej-m-d-a-leader-in-oncology-value-based-care-joins-flatiron-health-to-lead-managed-care-strategy2024-03-27https://resources.flatiron.com/press/press-release/keystone-urology-adopts-flatiron-health-revenue-cycle-management-serviceshttps://flatiron.com/hubfs/_Website%20Files/Resource%20Hub%20-%20Defaults/resource-hub-7.pngresourcehub7resourcehub72024-03-29https://resources.flatiron.comhttps://flatiron.com/hubfs/publication-summary.pngpublicationsummarypublicationsummaryhttps://flatiron.com/hubfs/PMWC_REcap_KateEstep_26.pngPMWCREcapKateEstep26PMWCREcapKateEstep26https://flatiron.com/hubfs/ASCO%20GU%20Blog%20Post-2.pngASCOGUBlogPost2ASCOGUBlogPost2https://flatiron.com/hubfs/ascogu26-1.pngascogu261ascogu261https://flatiron.com/hubfs/index-bg.pngindexbgindexbghttps://flatiron.com/hubfs/_Website%20Files/Resource%20Hub%20-%20Press%20Releases/flatiron-press-release-4.pngflatironpressrelease4flatironpressrelease42025-07-15https://resources.flatiron.com/real-world-evidence/lines-of-therapy-across-geographies-bridging-the-gap-between-clinical-practice-real-world-datahttps://flatiron.com/hubfs/Global%20LOT%20blog.pngGlobalLOTblogGlobalLOTblog2025-12-02https://resources.flatiron.com/publications/structural-racism-and-inequities-in-real-world-treatment-and-survival-among-patients-with-four-solid-tumor-cancershttps://flatiron.com/hubfs/_Website%20Files/Resource%20Hub%20-%20Defaults/resource-hub-7.pngresourcehub7resourcehub72024-03-26https://resources.flatiron.com/publications/personalized-acquired-cdk4/6i-resistance-associations-with-baseline-characteristics-like-obesity-in-real-world-clinical-multiomics-datahttps://flatiron.com/hubfs/Savill_March2026_CMDB_edited_x110.mp4/medium.jpgSavill_March2026_CMDB_edited_x110Savill_March2026_CMDB_edited_x110https://flatiron.com/hubfs/Savill_March2026_CMDB_edited_x110.mp4174nono2026-03-17https://resources.flatiron.com/point-of-care/top-four-takeaways-from-the-enhancing-oncology-modelhttps://flatiron.com/hubfs/Imported_Blog_Media/top-four-takeaways-for-eom.pngtopfourtakeawaysforeomtopfourtakeawaysforeom2024-04-02https://resources.flatiron.com/publications/evaluating-the-impact-of-oncology-care-model-reporting-requirements-on-biomarker-testing-and-treatment2024-03-26https://resources.flatiron.com/publications/characterization-of-novel-longitudinal-oncology-real-world-datasetshttps://flatiron.com/hubfs/_Website%20Files/Resource%20Hub%20-%20Defaults/resource-hub-6.pngresourcehub6resourcehub62024-10-30https://resources.flatiron.com/publications/evaluating-reasons-for-differences-in-real-world-clinical-outcomes-among-patients-with-relapsed/refractory-mantle-cell-lymphoma-on-covalent-btk-inhibitors2024-11-06https://resources.flatiron.com/point-of-care/what-we-know-so-far-about-the-enhancing-oncology-modelhttps://flatiron.com/hubfs/Imported_Blog_Media/what-we-know-so-far-enhancing-oncology-model.pngwhatweknowsofarenhancingoncologymodelwhatweknowsofarenhancingoncologymodel2024-04-02https://resources.flatiron.com/real-world-evidence/achieving-the-impossible-for-rare-populationshttps://flatiron.com/hubfs/Imported_Blog_Media/Blog_image_-ASH__120722-2.jpegBlogimageASH1207222BlogimageASH12072222024-03-29https://resources.flatiron.com/publications/co-occurrence-of-ntrk-fusions-with-other-genomic-biomarkers-in-cancer-patients2024-03-26https://resources.flatiron.com/publications/disparities-in-cardiovascular-disease-mortality-after-breast-cancer-treatment-methodological-considerations-using-real-world-data2024-03-26https://resources.flatiron.com/publications/reduce-uncertainty-health-technology-appraisals-retrospective-cohort2024-03-26https://resources.flatiron.com/clinical-research/how-flatiron-clinical-pipe-is-evolvinghttps://flatiron.com/hubfs/How%20is%20Flatiron%20Clinical%20Pipe%20evolving%20in%202023-%20thumbnail.pngHowisFlatironClinicalPipeevolvingin2023thumbnailHowisFlatironClinicalPipeevolvingin2023thumbnail2024-09-16https://resources.flatiron.com/publications/treatment-patterns-and-survival-outcomes-among-lutetium-177-experienced-patients-with-metastatic-castration-resistant-prostate-cancer2026-02-23https://resources.flatiron.com/real-world-evidence/flatiron-health-at-the-reagan-udall-foundations-2021-public-annual-meetinghttps://flatiron.com/hubfs/Imported_Blog_Media/Irene-blog-image-2.jpegIreneblogimage2Ireneblogimage22024-03-29https://resources.flatiron.com/press/press-release/flatiron-health-presents-research-at-ispor-europehttps://flatiron.com/hubfs/Imported%20sitepage%20images/News-ISPOR.jpgNewsISPORNewsISPOR2024-04-26https://resources.flatiron.com/flatiron-stories/designing-to-actually-improve-liveshttps://flatiron.com/hubfs/Imported_Blog_Media/FH_blog_mainarticle_180609_2120x1064-2.jpgFHblogmainarticle1806092120x10642FHblogmainarticle1806092120x106422024-03-29https://resources.flatiron.com/publications/prevalence-and-prognostic-effect-of-high-tumor-mutation-burden-tmb-h-across-multiple-less-common-solid-cancers-using-a-real-world-dataset2024-03-26https://resources.flatiron.com/publications/clinical-outcomes-of-perioperative-immunotherapy-in-resectable-non-small-cell-lung-cancer2025-07-01https://resources.flatiron.com/real-world-evidence/label-update-rwd-case-studyhttps://flatiron.com/hubfs/Imported_Blog_Media/season1_clip_thibautSanglier_02.jpgseason1clipthibautSanglier02season1clipthibautSanglier022024-12-06https://resources.flatiron.com/real-world-evidence/using-rwd-natural-history-regulatoryhttps://flatiron.com/hubfs/Imported_Blog_Media/Pranav.pngPranavPranav2024-09-16https://resources.flatiron.com/press/press-release/flatiron-health-raises-8-million-from-google-ventures-first-round-capital-and-labcorp2024-03-27https://resources.flatiron.com/real-world-evidence/oncology-case-studies-real-world-evidencehttps://flatiron.com/hubfs/Endpoints.pngEndpointsEndpoints2024-09-16https://resources.flatiron.com/publications/a-retrospective-real-world-study-of-first-line-pd-l1-inhibitor-use-in-patients-with-metastatic-non-small-cell-lung-cancer-mnsclc2025-06-17https://resources.flatiron.com/publications/trends-in-diagnosis-and-treatment-of-early-breast-cancer-ebc-in-the-united-states-us-during-the-covid-19-era2024-03-26https://resources.flatiron.com/publications/analysis-of-real-world-progression-and-insufficient-response-variables-and-related-endpoints-among-patients-with-non-hodgkin-lymphoma2025-04-07https://resources.flatiron.com/flatiron-stories/the-big-chttps://flatiron.com/hubfs/Imported_Blog_Media/image-2.pngimage2image22024-03-29https://resources.flatiron.com/publicationshttps://flatiron.com/hubfs/publication-summary-analysis-of-real-world-progression-with-insufficient-response-variables-and-related-endpoints-among-patients-with-non-hodgkin-lymphoma.pngpublicationsummaryanalysisofrealworldprogressionwithinsufficientresponsevariablesandrelatedendpointsamongpatientswithnonhodgkinlymphomapublicationsummaryanalysisofrealworldprogressionwithinsufficientresponsevariablesandrelatedendpointsamongpatientswithnonhodgkinlymphomahttps://flatiron.com/hubfs/_Website%20Files/Resource%20Hub%20-%20Defaults/resource-hub-4.pngresourcehub4resourcehub42024-04-17https://resources.flatiron.com/publications/impact-of-renal-function-eligibility-criteria-in-clinical-trials-and-real-world-survival-outcomes-among-patients-with-metastatic-renal-cell-carcinoma2025-06-06https://resources.flatiron.com/publications/chemotherapy-use-near-end-of-life-eol-measuring-real-world-benchmarks2024-03-27https://resources.flatiron.com/point-of-care/why-oncologists-need-technology-to-succeed-in-alternative-payment-models2024-04-02https://resources.flatiron.com/real-world-evidence/how-advances-in-molecular-profiling-technology-and-linked-real-world-clinico-omics-data-are-launching-a-new-era-of-precision-oncologyhttps://flatiron.com/hubfs/_Website%20Files/Resource%20Hub%20-%20Illustrations/How-advances-in-molecular-profiling-and-linked-real-world-clinico-omics-data-are-launching-a-new-era-of-precision-oncology.jpgHowadvancesinmolecularprofilingandlinkedrealworldclinicoomicsdataarelaunchinganeweraofprecisiononcologyHowadvancesinmolecularprofilingandlinkedrealworldclinicoomicsdataarelaunchinganeweraofprecisiononcology2025-04-24https://resources.flatiron.com/real-world-evidence/real-world-data-in-real-time-early-lessons-from-the-covid-19-pandemichttps://flatiron.com/hubfs/Imported_Blog_Media/ASCO-cancer-blog-small-image-2.jpegASCOcancerblogsmallimage2ASCOcancerblogsmallimage22024-03-29https://resources.flatiron.com/press/transforming-cancer-care-flatiron-health-uk-partners-with-university-hospitals-of-leicester-nhs-trust-to-advance-cancer-research-and-patient-impacthttps://flatiron.com/hubfs/_Website%20Files/Resource%20Hub%20-%20Press%20Releases/partnership-announcement-flatiron-health-uk-nhs-university-hospitals-of-leicester.pngpartnershipannouncementflatironhealthuknhsuniversityhospitalsofleicesterpartnershipannouncementflatironhealthuknhsuniversityhospitalsofleicester2024-10-07https://resources.flatiron.com/publications/real-world-treatment-patterns-and-clinical-outcomes-in-high-risk-mantle-cell-lymphoma-a-retrospective-analysis2025-11-03https://resources.flatiron.com/point-of-care/interview-with-olivia-barretthttps://flatiron.com/hubfs/_Website%20Files/Resource%20Hub%20-%20Headshots/Interview-with-Olivia-Barrett-Hematology-Oncology-Associates-of-Central-NY.pngInterviewwithOliviaBarrettHematologyOncologyAssociatesofCentralNYInterviewwithOliviaBarrettHematologyOncologyAssociatesofCentralNY2024-04-02https://resources.flatiron.com/publications/real-world-overall-survival-and-time-to-therapy-discontinuation-of-patients-with-mcrpc-treated-with-second-generation-novel-hormonal-therapies-associated-with-tis2024-03-26https://resources.flatiron.com/publications/practice-and-provider-level-inequities-in-next-generation-sequencinghttps://flatiron.com/hubfs/_Website%20Files/Resource%20Hub%20-%20Press%20Releases/flatiron-press-release-4.pngflatironpressrelease4flatironpressrelease42024-03-26https://resources.flatiron.com/real-world-evidence/racial-ethnic-disparities-rwehttps://flatiron.com/hubfs/Imported_Blog_Media/Recentlypublished-flatironpodcast.jpgRecentlypublishedflatironpodcastRecentlypublishedflatironpodcast2024-03-29https://resources.flatiron.com/flatiron-stories/for-dhttps://flatiron.com/hubfs/Imported_Blog_Media/IMG_4450-2.jpgIMG44502IMG44502https://flatiron.com/hubfs/Imported_Blog_Media/FH_Blog_AC_180319-4.jpgFHBlogAC1803194FHBlogAC18031942024-03-29https://resources.flatiron.com/publications/the-adoption-of-immune-checkpoint-inhibitors-and-patterns-of-care-at-the-end-of-life2024-03-26https://resources.flatiron.com/publications/real-world-patient-characteristics-treatment-patterns-and-overall-survival-os-in-metastatic-hormone-sensitive-prostate-cancer-mhspc-insights-by-pten-status2025-05-22https://resources.flatiron.com/publications/disease-burden-and-rwpfs-as-a-surrogate-endpoint-for-rwos-in-ntrk-nsclc-and-other-advanced/metastatic-solid-tumor2025-08-13https://resources.flatiron.com/publications/association-of-broad-based-genomic-sequencing-with-survival-among-patients-with-advanced-non-small-cell-lung-cancer-in-the-community-setting2024-03-26https://resources.flatiron.com/flatiron-stories/envisioning-the-future-of-electronic-health-recordshttps://flatiron.com/hubfs/Imported_Blog_Media/ASCO_blog_053118-2.jpgASCOblog0531182ASCOblog05311822024-03-29https://resources.flatiron.com/publications/bridging-the-divide-between-clinical-research-and-clinical-care-in-oncology-an-integrated-real-world-evidence-generation-platform2024-03-26https://resources.flatiron.com/publications/erbb2-copy-number-cn-as-a-quantitative-biomarker-for-real-world-rw-outcomes-to-anti-her2-therapy-in-advanced-gastroesophageal-adenocarcinoma-adv-gea2024-03-26https://resources.flatiron.com/publications/treatment-patterns-outcomes-mismatch-repair-microsatellite-instability-advanced-endometrial-cancer2024-05-23https://resources.flatiron.com/publications/real-world-bortezomib-usage-patterns-among-patients-with-relapsed/refractory-multiple-myeloma2024-03-27https://resources.flatiron.com/point-of-care/strategies-for-patient-navigationhttps://flatiron.com/hubfs/takeaways-from-clinical-pathways-congress-2024-3of3%20(1).pngtakeawaysfromclinicalpathwayscongress20243of31takeawaysfromclinicalpathwayscongress20243of312024-11-12https://resources.flatiron.com/publications/low-socioeconomic-overall-survival-acute-myeloid-leukemia2024-03-26https://resources.flatiron.com/real-world-evidence/case-study-early-onset-cancer-trends-in-japan-and-the-ushttps://flatiron.com/hubfs/_Website%20Files/Resource%20Hub%20-%20Illustrations/early-onset-cancers-in-Japan.jpgearlyonsetcancersinJapanearlyonsetcancersinJapanhttps://flatiron.com/hubfs/International%20data%20curation.pngInternationaldatacurationInternationaldatacuration2024-11-21https://resources.flatiron.com/publications/from-data-to-decisions-the-role-of-real-world-evidence-in-recent-multiple-myeloma-drug-approvals-in-the-us-and-eu2025-04-17https://resources.flatiron.com/point-of-care/case-study-research-documentationhttps://flatiron.com/hubfs/Imported%20sitepage%20images/oncology-consultants-houston-1-632x632.jpgoncologyconsultantshouston1632x632oncologyconsultantshouston1632x632https://flatiron.com/hubfs/_Website%20Files/Resource%20Hub%20-%20Defaults/resource-hub-7.pngresourcehub7resourcehub7https://flatiron.com/hubfs/Imported%20sitepage%20images/OncoEMR_AdverseEvents_ResearchDocumentation.jpgOncoEMRAdverseEventsResearchDocumentationOncoEMRAdverseEventsResearchDocumentation2024-04-09https://resources.flatiron.com/publications/cost-effectiveness-of-multigene-panel-sequencing-for-patients-with-advanced-non-small-cell-lung-cancer2024-03-26https://resources.flatiron.com/flatiron-stories/how-we-run-hackathons-at-flatironhttps://flatiron.com/hubfs/Imported_Blog_Media/elijah-3.jpgelijah3elijah3https://flatiron.com/hubfs/trophy.jpegtrophytrophyhttps://flatiron.com/hubfs/Imported_Blog_Media/The-Greens-3.pngTheGreens3TheGreens3https://flatiron.com/hubfs/Imported_Blog_Media/hack-cal-3.pnghackcal3hackcal32024-03-29https://resources.flatiron.com/publications/advancing-colorectal-cancer-research-with-real-world-evidence-insights-from-electronic-health-record-derived-data-in-germany2025-11-10https://resources.flatiron.com/point-of-care/give-patients-access-to-clinical-trialshttps://flatiron.com/hubfs/Imported_Blog_Media/FH-OncoCloudVirtual-session-thumbnail_give-patients-access-to-clinical-trials.pngFHOncoCloudVirtualsessionthumbnailgivepatientsaccesstoclinicaltrialsFHOncoCloudVirtualsessionthumbnailgivepatientsaccesstoclinicaltrialshttps://flatiron.com/hubfs/FH-OncoCloudVirtual-session-thumbnail_give-patients-access-to-clinical-trials.pngFHOncoCloudVirtualsessionthumbnailgivepatientsaccesstoclinicaltrialsFHOncoCloudVirtualsessionthumbnailgivepatientsaccesstoclinicaltrials2024-09-16https://resources.flatiron.com/publications/the-impact-of-structural-racism-and-social-determinants-of-health-on-fluorescence-in-situ-hybridization-testing-among-patients-with-multiple-myeloma2024-11-06https://resources.flatiron.com/publications/broadening-eligibility-criteria-diversity-clinical-trials2024-05-06https://resources.flatiron.com/point-of-care/five-ways-artificial-intelligence-is-poised-to-revolutionize-cancer-carehttps://flatiron.com/hubfs/takeaways-from-clinical-pathways-congress-2024-2of3-1.pngtakeawaysfromclinicalpathwayscongress20242of31takeawaysfromclinicalpathwayscongress20242of312024-10-02https://resources.flatiron.com/publications/analysis-of-real-world-data-rwd-for-metastatic-breast-cancer-mbc-patients-pts-without-germline-brca-gbrca-alterations-treated-with-parp-inhibitors-parpi2024-03-27https://resources.flatiron.com/clinical-research/what-role-do-services-play-in-pmc-pmr-studies-supported-by-flatironhttps://flatiron.com/hubfs/_Website%20Files/Resource%20Hub%20-%20Defaults/resource-hub-9.pngresourcehub9resourcehub9https://flatiron.com/hubfs/What%20role%20do%20services%20play%20in%20PMCPMR%20studies%2c%20supported%20by%20Flatiron.pngWhatroledoservicesplayinPMCPMRstudiessupportedbyFlatironWhatroledoservicesplayinPMCPMRstudiessupportedbyFlatiron2024-09-16https://resources.flatiron.com/publications/incidence-of-neutropenia-adverse-events-identified-in-electronic-health-care-records-among-initiators-of-cdk4/6-inhibitors-with-advanced-breast-cancer-in-the-uk2025-10-22https://resources.flatiron.com/real-world-evidence/clinicogenomic-rwd-regulatoryhttps://flatiron.com/hubfs/_Website%20Files/Resource%20Hub%20-%20ResearchX/ResearchX-thumbnail-2.jpgResearchXthumbnail2ResearchXthumbnail22024-09-16https://resources.flatiron.com/point-of-care/interview-with-kailee-hawkinshttps://flatiron.com/hubfs/_Website%20Files/Resource%20Hub%20-%20Headshots/Interview-with-Kailee-Hawkins-Alabama-Oncology.pngInterviewwithKaileeHawkinsAlabamaOncologyInterviewwithKaileeHawkinsAlabamaOncology2024-04-16https://resources.flatiron.com/real-world-evidence/powering-a-new-era-of-treatment-with-real-world-insights-on-26k-people-with-ovarian-cancerhttps://flatiron.com/hubfs/ovarian%201%20-100.jpgovarian1100ovarian11002026-04-03https://resources.flatiron.com/clinical-research/reducing-burden-and-filling-evidence-generation-gaps-with-flatiron-trialshttps://flatiron.com/hubfs/Resource%20Hub%20-%20Reducing%20burden%20and%20filling%20gaps%20in%20oncology%20evidence%20generation%20with%20prospective%20real-world%20studies.pngResourceHubReducingburdenandfillinggapsinoncologyevidencegenerationwithprospectiverealworldstudiesResourceHubReducingburdenandfillinggapsinoncologyevidencegenerationwithprospectiverealworldstudies2025-06-13https://resources.flatiron.com/flatiron-stories/asking-the-hard-questionshttps://flatiron.com/hubfs/Imported_Blog_Media/phone-2.jpgphone2phone22024-03-29https://resources.flatiron.com/publications/real-world-data-on-her2-positive-metastatic-colorectal-cancer-from-a-clinical-genomic-database2025-03-12https://resources.flatiron.com/real-world-evidence/real-world-data-missing-mortalityhttps://flatiron.com/hubfs/Imported_Blog_Media/Mortality%20LinkedIn.jpgMortalityLinkedInMortalityLinkedInhttps://flatiron.com/hubfs/Flatiron_Mortality_Variable_OD-mobile-02.jpgFlatironMortalityVariableODmobile02FlatironMortalityVariableODmobile02https://flatiron.com/hubfs/Flatiron_Mortality_Variable_combo-mobile-02.jpgFlatironMortalityVariablecombomobile02FlatironMortalityVariablecombomobile02https://flatiron.com/hubfs/Flatiron_Mortality_Variable_NDI-mobile-03.jpgFlatironMortalityVariableNDImobile03FlatironMortalityVariableNDImobile03https://flatiron.com/hubfs/Flatiron_Mortality_Variable_SSDI-mobile-04.jpgFlatironMortalityVariableSSDImobile04FlatironMortalityVariableSSDImobile04https://flatiron.com/hubfs/Flatiron_Mortality_Variable_EHR-mobile-02.jpgFlatironMortalityVariableEHRmobile02FlatironMortalityVariableEHRmobile022024-04-17https://resources.flatiron.com/press/flatiron-health-research-on-ai-driven-cancer-progression-extraction-presented-at-aacr-special-conference-in-cancer-research-artificial-intelligencehttps://flatiron.com/hubfs/flatiron-press-release-AACR.pngflatironpressreleaseAACRflatironpressreleaseAACR2026-03-17https://resources.flatiron.com/publications/racial-and-socioeconomic-disparities-in-telemedicine-use-among-us-patients-initiating-cancer-treatment-during-the-covid-19-pandemic2024-03-26https://resources.flatiron.com/publications/emulating-randomized-controlled-trials-hybrid-control-arms-oncology-case-studyhttps://flatiron.com/hubfs/Imported_Blog_Media/RM_openaccessarticle_thumb_02-Mar-06-2023-06-50-48-1238-AM-Mar-10-2023-04-50-59-7386-AM.jpgRMopenaccessarticlethumb02Mar0620230650481238AMMar1020230450597386AMRMopenaccessarticlethumb02Mar0620230650481238AMMar1020230450597386AM2024-03-26https://resources.flatiron.com/flatiron-stories/using-inductive-bias-as-a-guide-for-effective-machine-learning-prototypinghttps://flatiron.com/hubfs/Imported_Blog_Media/wheels-2.jpgwheels2wheels22024-03-29https://resources.flatiron.com/publications/comparative-effectiveness-of-carboplatin/pemetrexed-with-versus-without-bevacizumab-for-advanced-nonsquamous-non-small-cell-lung-cancer2024-03-26https://resources.flatiron.com/publications/medicaid-expansion-and-racial-inequities-in-next-generation-sequencing-testing-in-oncology2024-03-27https://resources.flatiron.com/publications/autologous-stem-cell-transplantation-t-cell-therapy-multiple-myeloma2024-03-26https://resources.flatiron.com/publications/understanding-racial-and-ethnic-inequities-in-uptake-and-outcomes-following-multigene-prognostic-testing-in-early-breast-cancer-the-promise-of-real-world-data2024-03-26https://resources.flatiron.com/flatiron-stories/learning-teaching-and-growinghttps://flatiron.com/hubfs/Imported_Blog_Media/08_Learn-teach-and-grow.jpg08Learnteachandgrow08Learnteachandgrow2024-03-29https://resources.flatiron.com/point-of-care/debunking-the-myths-of-artificial-intelligence-in-cancer-carehttps://flatiron.com/hubfs/takeaways-from-clinical-pathways-congress-1of3.pngtakeawaysfromclinicalpathwayscongress1of3takeawaysfromclinicalpathwayscongress1of32024-04-09https://resources.flatiron.com/publications/progress-in-the-application-of-machine-learning-algorithms-to-cancer-research-and-care2024-03-26https://resources.flatiron.com/publications/bridging-the-gap-between-oncologists-and-payers-impact-of-an-ehr-embedded-cds-tool-in-oncology-clinical-pathway-adherencehttps://flatiron.com/hubfs/_Website%20Files/Background%20Video%20Stills/02_HC_A04_16x9.jpg02HCA0416x902HCA0416x92024-08-29https://resources.flatiron.com/publications/emergent-renal-and-hepatic-dysfunction-dys-in-a-real-world-cohort-of-advanced-melanoma-amel-patients-pts-receiving-first-line-1l-immune-checkpoint-inhibitors-icis2024-03-26https://resources.flatiron.com/real-world-evidence/real-world-evidence-bolsters-breast-cancer-research-at-every-step-of-the-development-life-cyclehttps://flatiron.com/hubfs/_Website%20Files/Resource%20Hub%20-%20Illustrations/RWE-Bolsters-Breast-Cancer-Research-at-Every-Stage-of-the-Development-Cycle-2.jpgRWEBolstersBreastCancerResearchatEveryStageoftheDevelopmentCycle2RWEBolstersBreastCancerResearchatEveryStageoftheDevelopmentCycle22024-10-18https://resources.flatiron.com/real-world-evidence/applying-real-world-data-use-cases-and-fda-guidancehttps://flatiron.com/hubfs/applying%20RWD.pngapplyingRWDapplyingRWD2024-05-01https://resources.flatiron.com/real-world-evidence/heres-why-were-linking-claims-with-our-ehr-datahttps://flatiron.com/hubfs/Imported_Blog_Media/claims-linked-ehr.pngclaimslinkedehrclaimslinkedehr2024-03-29https://resources.flatiron.com/publications/imaging-surveillance-bias-rwdhttps://flatiron.com/hubfs/Imported_Blog_Media/RM_openaccessarticle_thumb_02-Mar-06-2023-06-50-48-1238-AM-Mar-10-2023-04-48-18-1912-AM.jpgRMopenaccessarticlethumb02Mar0620230650481238AMMar1020230448181912AMRMopenaccessarticlethumb02Mar0620230650481238AMMar1020230448181912AM2024-03-26https://resources.flatiron.com/press/press-release/foundation-medicine-and-flatiron-health-collaborate-to-develop-first-in-class-data-platform-to-accelerate-precision-medicine-for-cancer2024-03-27https://resources.flatiron.com/flatiron-stories/dont-cancel-the-retrospective2024-03-29https://resources.flatiron.com/publications/performance-assessment-disease-agnostic-treatment-heurisitc-tumor-mutational-board-status2024-04-16https://resources.flatiron.com/publications/bevacizumab-first-line-chemotherapy-ovarian-cancer-clinical-trial-findings2024-05-23https://resources.flatiron.com/publications/a-multi-stakeholder-platform-to-prospectively-link-longitudinal-real-world-clinico-genomic-imaging-and-outcomes-data-for-patients-with-metastatic-lung-cancer2024-03-26https://resources.flatiron.com/real-world-evidence/informing-global-evidence-strategies-with-real-world-data-across-multiple-geographieshttps://flatiron.com/hubfs/Arun%20thumbnail-1.jpgArunthumbnail1Arunthumbnail12026-01-29https://resources.flatiron.com/publications/real-world-data-of-palbociclib-in-combination-with-endocrine-therapy-for-the-treatment-of-metastatic-breast-cancer-in-men2024-03-26https://resources.flatiron.com/flatiron-stories/liberal-arts-studies-pay-off-for-flatiron-engineershttps://flatiron.com/hubfs/Imported_Blog_Media/StephBlogPost-2.jpgStephBlogPost2StephBlogPost22024-03-29https://resources.flatiron.com/flatiron-stories/meet-our-changemakers-ivy-altomare-md-head-of-research-oncology-clinical-research2024-04-17https://resources.flatiron.com/clinical-research/why-is-patient-enrollment-challenging-for-pmc-pmr-studieshttps://flatiron.com/hubfs/Why%20is%20patient%20enrollment%20challenging%20for%20PMCPMR%20studies.pngWhyispatientenrollmentchallengingforPMCPMRstudiesWhyispatientenrollmentchallengingforPMCPMRstudies2024-09-16https://resources.flatiron.com/flatiron-stories/navigating-software-engineering-pathways-how-new-grads-can-grow-through-learninghttps://flatiron.com/hubfs/Navigating%20software%20engineering%20pathways.jpegNavigatingsoftwareengineeringpathwaysNavigatingsoftwareengineeringpathways2024-04-17https://resources.flatiron.com/publications/concordance-of-response-based-clinical-trial-and-machine-learning-generated-real-world-end-points2025-05-30https://resources.flatiron.com/publications/real-world-data-missing-deaths-oshttps://flatiron.com/hubfs/Imported_Blog_Media/RM_openaccessarticle_thumb_02-Mar-06-2023-06-50-48-1238-AM-Mar-10-2023-04-50-59-7386-AM.jpgRMopenaccessarticlethumb02Mar0620230650481238AMMar1020230450597386AMRMopenaccessarticlethumb02Mar0620230650481238AMMar1020230450597386AM2024-03-27https://resources.flatiron.com/flatiron-stories/why-metrics-matter-when-inheriting-code-a-case-studyhttps://flatiron.com/hubfs/Imported_Blog_Media/1_btfqy12a2GGLo41vzOEhyw-2.jpeg1btfqy12a2GGLo41vzOEhyw21btfqy12a2GGLo41vzOEhyw2https://flatiron.com/hubfs/Imported_Blog_Media/1_iwNYDWbg7lIC4FH604krcA.jpeg1iwNYDWbg7lIC4FH604krcA1iwNYDWbg7lIC4FH604krcAhttps://flatiron.com/hubfs/Imported_Blog_Media/1_BFo4s7g8o6fddPAfH-MGBA-2.jpeg1BFo4s7g8o6fddPAfHMGBA21BFo4s7g8o6fddPAfHMGBA22024-03-29https://resources.flatiron.com/publications/comparative-efficacy-analysis-between-entrectinib-trial-and-crizotinib-real-world-ros1-fusion-positive-ros1-nsclc-patients2024-03-26https://resources.flatiron.com/publications/real-world-time-on-treatment-with-immuno-oncology-therapy-in-recurrent/metastatic-head-and-neck-squamous-cell-carcinoma2024-03-26https://resources.flatiron.com/real-world-evidence/biotechs-accelerate-pipeline-rwdhttps://flatiron.com/hubfs/Imported_Blog_Media/Biotech%20real-world%20data.jpgBiotechrealworlddataBiotechrealworlddata2024-03-29https://resources.flatiron.com/publications/retrospective-analysis-of-real-world-data-to-determine-clinical-outcomes-of-patients-with-advanced-non-small-cell-lung-cancer-following-cell-free-circulating-tumo2024-03-26https://resources.flatiron.com/publications/mediators-of-racial-and-ethnic-inequities-in-access-to-front-line-therapies-for-chronic-lymphocytic-leukemia-in-the-united-states-a-real-world-evidence-study2025-11-03https://resources.flatiron.com/real-world-evidence/covid-19-real-world-data-health-policy-oncologyhttps://flatiron.com/hubfs/Imported_Blog_Media/podcast-1-hero-cover.jpgpodcast1herocoverpodcast1herocover2024-03-29https://resources.flatiron.com/publications/building-control-arms-for-cancer-clinical-trials-from-real-world-data2024-03-26https://resources.flatiron.com/publications/identifying-the-prognostic-significance-of-genomic-alterations-in-a-real-world-ehr-derived-clinico-genomic-database-cgdb2024-03-26https://resources.flatiron.com/press/press-release/flatiron-healths-oncoemr-earns-onc-health-it-certification-from-drummond-group-llc2024-03-27https://resources.flatiron.com/publications/applying-big-data-to-address-the-social-determinants-of-health-in-oncology-proceedings-of-a-workshop2024-03-26https://resources.flatiron.com/real-world-evidence/answering-hematologys-hardest-questions-takeaways-from-a-panel-of-rwe-expertshttps://flatiron.com/hubfs/Blog%20Image%20-%20Article%20with%20Author%201.pngBlogImageArticlewithAuthor1BlogImageArticlewithAuthor12026-03-23https://resources.flatiron.com/clinical-research/how-to-incorporate-pragmatic-design-elements-into-your-clinical-studieshttps://flatiron.com/hubfs/How%20to%20incorporate%20pragmatic%20design%20elements%20into%20your%20clinical%20studies.mp4/medium.jpgHow to incorporate pragmatic design elements into your clinical studiesHow to incorporate pragmatic design elements into your clinical studieshttps://flatiron.com/hubfs/How%20to%20incorporate%20pragmatic%20design%20elements%20into%20your%20clinical%20studies.mp43437nonohttps://flatiron.com/hubfs/webinar-1.pngwebinar1webinar1https://flatiron.com/hubfs/how-to-incorporate-pragmatic-design-elements-into-your-clinical-studies.pnghowtoincorporatepragmaticdesignelementsintoyourclinicalstudieshowtoincorporatepragmaticdesignelementsintoyourclinicalstudies2025-05-15https://resources.flatiron.com/publications/epidermal-growth-factor-inhibitors-early-onset-metastatic-colorectal-cancer2024-03-26https://resources.flatiron.com/press/flatiron-health-redefines-real-world-evidence-pioneering-scientific-innovations-move-beyond-what-is-to-uncover-why-and-predict-what-will-behttps://flatiron.com/hubfs/press-release-1.pngpressrelease1pressrelease12026-03-17https://resources.flatiron.com/publications/approach-to-machine-learning-for-extraction-of-real-world-data-variables-from-electronic-health-recordshttps://flatiron.com/hubfs/Figure-5-Machine-Learning-Adamson-2023-2.jpgFigure5MachineLearningAdamson20232Figure5MachineLearningAdamson20232https://flatiron.com/hubfs/Figure%205%20Machine%20Learning%20Adamson%202023.jpgFigure5MachineLearningAdamson2023Figure5MachineLearningAdamson20232024-03-26https://resources.flatiron.com/publications/framework-clinical-artificial-intelligence-ground-truth-annotations-sudo2024-03-26https://resources.flatiron.com/publications/exploring-the-potential-for-ehr-derived-real-world-data-to-reduce-uncertainty-in-hta-decision-making-a-case-study-of-long-term-survival-outcomes2024-03-26https://resources.flatiron.com/publications/racial/ethnic-inequities-in-access-to-novel-therapies-and-outcomes-in-triple-negative-breast-cancer2025-12-01https://resources.flatiron.com/publications/real-world-outcomes-for-advanced-non-small-cell-lung-cancer-patients-with-egfr-exon-19-deletions-stratified-by-deletion-size2024-03-26https://resources.flatiron.com/publications/advancing-breast-cancer-research-in-japan-using-ehr-derived-real-world-data2025-04-17https://resources.flatiron.com/press/press-release/flatiron-health-and-the-fda-embark-on-cancer-research-collaboration2024-03-27https://resources.flatiron.com/point-of-care/how-user-research-helps-improve-the-electronic-health-recordhttps://flatiron.com/hubfs/Imported_Blog_Media/User_research_632X396.jpgUserresearch632X396Userresearch632X396https://flatiron.com/hubfs/Imported_Blog_Media/flatiron-blog-regimen-selection-old-2.pngflatironblogregimenselectionold2flatironblogregimenselectionold2https://flatiron.com/hubfs/Imported_Blog_Media/flatiron-blog-new-orders-old-2.pngflatironblognewordersold2flatironblognewordersold2https://flatiron.com/hubfs/Imported_Blog_Media/flatiron-blog-regimen-selection-new-2.gifflatironblogregimenselectionnew2flatironblogregimenselectionnew2https://flatiron.com/hubfs/Imported_Blog_Media/flatiron-blog-new-orders-workflow-2.pngflatironblognewordersworkflow2flatironblognewordersworkflow22024-04-02https://resources.flatiron.com/flatiron-stories/evolving-the-flatiron-brandhttps://flatiron.com/hubfs/_Website%20Files/Background%20Videos/Mobile/02_HC_A04_1x1.mp4/medium.jpg02_HC_A04_1x102_HC_A04_1x1https://flatiron.com/hubfs/_Website%20Files/Background%20Videos/Mobile/02_HC_A04_1x1.mp44nonohttps://flatiron.com/hubfs/_Website%20Files/Blog%20inline%20images/brand-refresh-collateral.jpgbrandrefreshcollateralbrandrefreshcollateralhttps://flatiron.com/hubfs/_Website%20Files/Animated%20gifs/flatiron-bumper-web.gifflatironbumperwebflatironbumperwebhttps://flatiron.com/hubfs/_Website%20Files/Background%20Videos/Stills/flatiron-brand-refresh-diamonds.jpgflatironbrandrefreshdiamondsflatironbrandrefreshdiamondshttps://flatiron.com/hubfs/_Website%20Files/Resource%20Hub%20-%20Illustrations/flatiron-health-brand-refresh.jpgflatironhealthbrandrefreshflatironhealthbrandrefresh2024-03-29https://resources.flatiron.com/publications/real-world-first-line-osimertinib-treatment-in-epidermal-growth-factor-receptor-mutation-positive-egfrm-advanced-nsclc2024-03-26https://resources.flatiron.com/real-world-evidence/fda-and-flatiron-healths-collaborative-study-to-evaluate-real-world-outcomes-in-patients-with-organ-impairmenthttps://flatiron.com/hubfs/Table%202.pngTable2Table2https://flatiron.com/hubfs/Table%201.pngTable1Table1https://flatiron.com/hubfs/publications-fda.pngpublicationsfdapublicationsfda2024-04-17https://resources.flatiron.com/flatiron-stories/how-to-fixit-keep-it-simple-take-a-day-make-it-funhttps://flatiron.com/hubfs/Imported_Blog_Media/fixit_cat-4.pngfixitcat4fixitcat4https://flatiron.com/hubfs/Imported_Blog_Media/fixit_cat-Mar-10-2023-03-33-05-2305-PM.pngfixitcatMar1020230333052305PMfixitcatMar1020230333052305PM2024-03-29https://resources.flatiron.com/real-world-evidence/learned-adapting-rwe-regulatory-guidance-experiencehttps://flatiron.com/hubfs/_Website%20Files/Resource%20Hub%20-%20ResearchX/ResearchX-thumbnail-2.jpgResearchXthumbnail2ResearchXthumbnail22024-09-16https://resources.flatiron.com/publications/association-of-patient-characteristics-and-tumor-genomics-with-clinical-outcomes-among-patients-with-non-small-cell-lung-cancer-using-a-clinicogenomic-database2024-03-26https://resources.flatiron.com/press/flatiron-health-announces-research-to-be-presented-at-american-society-of-clinical-oncology-2024-annual-meetinghttps://flatiron.com/hubfs/FH_Website_ResourceHubThumbnails_PressReleases_ASCO_2024-02.pngFHWebsiteResourceHubThumbnailsPressReleasesASCO202402FHWebsiteResourceHubThumbnailsPressReleasesASCO2024022025-05-01https://resources.flatiron.com/publications/racialized-economic-segregation-inequities-metastatic-breast-cancer2024-05-17https://resources.flatiron.com/publications/transportability-of-overall-survival-estimates-from-the-us-to-england-in-metastatic-breast-cancer-using-nationally-representative-data-sources2024-10-22https://resources.flatiron.com/real-world-evidence/best-leverage-rwe-2021https://flatiron.com/hubfs/basics_earlyAdopters_01.jpgbasicsearlyAdopters01basicsearlyAdopters01https://flatiron.com/hubfs/_Website%20Files/Resource%20Hub%20-%20ResearchX/ResearchX-thumbnail-1.jpgResearchXthumbnail1ResearchXthumbnail12024-09-16https://resources.flatiron.com/press/press-release/west-cancer-center-chooses-flatiron-healths-oncoemr-and-oncoanalytics-to-support-high-quality-patient-care2024-03-27https://resources.flatiron.com/publications/an-automated-ehr-based-tool-for-identification-of-patients-with-metastatic-disease-to-facilitate-clinical-trial-patient-ascertainment2024-03-26https://resources.flatiron.com/publications/real-world-progression-overall-survivalhttps://flatiron.com/hubfs/Imported_Blog_Media/RM_openaccessarticle_thumb_01-4-Mar-10-2023-04-50-59-3127-AM.jpgRMopenaccessarticlethumb014Mar1020230450593127AMRMopenaccessarticlethumb014Mar1020230450593127AM2024-03-27https://resources.flatiron.com/point-of-care/part-2-community-oncology-financial-counselors-get-creative-to-help-patients-manage-the-cost-of-carehttps://flatiron.com/hubfs/Imported_Blog_Media/advisor_2120x1064-2.jpgadvisor2120x10642advisor2120x106422024-04-02https://resources.flatiron.com/real-world-evidence/our-journey-to-integrating-real-world-clinical-outcomes-and-genomicshttps://flatiron.com/hubfs/Imported_Blog_Media/JAMA-paper_1028X880.jpgJAMApaper1028X880JAMApaper1028X8802024-04-18https://resources.flatiron.com/press/flatiron-health-announces-research-to-be-presented-at-ispor-2025https://flatiron.com/hubfs/ISPOR-2025-overview.pngISPOR2025overviewISPOR2025overview2025-06-05https://resources.flatiron.com/publications/plasma-circulating-tumor-dna-ctdna-fraction-and-real-world-overall-survival-rwos-in-metastatic-castration-resistant-prostate-cancer-mcrpc2024-03-26https://resources.flatiron.com/point-of-care/panel-discussion-the-enhancing-oncology-modelhttps://flatiron.com/hubfs/_Website%20Files/Resource%20Hub%20-%20Videos/Without%20Play%20Button/EOM-Panel-video-thumb.jpgEOMPanelvideothumbEOMPanelvideothumb2024-09-16https://resources.flatiron.com/real-world-evidence/the-potential-of-real-world-evidence-key-learnings-from-ispor-2023https://flatiron.com/hubfs/_Website%20Files/Resource%20Hub%20-%20Illustrations/ISPOR%202023.pngISPOR2023ISPOR20232024-04-09https://resources.flatiron.com/publications/optimization-of-natural-language-processing-supported-comorbidity-classification-algorithms-in-electronic-health-records2024-03-26https://resources.flatiron.com/publications/methodological-considerations-for-real-world-data-derived-progression-free-survival-in-multiple-myeloma2024-11-06https://resources.flatiron.com/publications/impact-of-social-determinants-of-health-on-mortality-in-diffuse-large-b-cell-lymphoma-dlbcl-using-real-world-data2025-06-17https://resources.flatiron.com/clinical-researchhttps://flatiron.com/hubfs/partnership-announcement-flatiron-and-veeva.pngpartnershipannouncementflatironandveevapartnershipannouncementflatironandveevahttps://flatiron.com/hubfs/ASCO-2025-overview.pngASCO2025overviewASCO2025overviewhttps://flatiron.com/hubfs/collaboration-announcement-MassiveBio.pngcollaborationannouncementMassiveBiocollaborationannouncementMassiveBiohttps://flatiron.com/hubfs/DPharm%202025%20Webinar_Clinical%20Pipe_90%25-1.svgDPharm2025WebinarClinicalPipe901DPharm2025WebinarClinicalPipe901https://flatiron.com/hubfs/_Website%20Files/Resource%20Hub%20-%20Defaults/resource-hub-7.pngresourcehub7resourcehub7https://flatiron.com/hubfs/blog-neal-meropol-asco-2025-recap.pngblognealmeropolasco2025recapblognealmeropolasco2025recaphttps://flatiron.com/hubfs/webinar-1.pngwebinar1webinar12024-04-17https://resources.flatiron.com/clinical-research/mechanisms-for-transferring-structured-and-unstructured-data-from-the-ehr-at-the-point-of-care-into-study-edc-systemshttps://flatiron.com/hubfs/Mechanisms%20for%20transferring%20structured%20and%20unstructured%20data%20from%20the%20EHR%20at%20the%20point%20of%20care%20into%20study%20EDC%20systems.pngMechanismsfortransferringstructuredandunstructureddatafromtheEHRatthepointofcareintostudyEDCsystemsMechanismsfortransferringstructuredandunstructureddatafromtheEHRatthepointofcareintostudyEDCsystemshttps://flatiron.com/hubfs/_Website%20Files/Resource%20Hub%20-%20Defaults/resource-hub-3.pngresourcehub3resourcehub32024-09-16https://resources.flatiron.com/point-of-care/cms-confirms-flatiron-assist-clinical-guidelines-meet-eom-requirementshttps://flatiron.com/hubfs/_Website%20Files/Resource%20Hub%20-%20Press%20Releases/flatiron-assist-press-release.pngflatironassistpressreleaseflatironassistpressrelease2024-04-09https://resources.flatiron.com/real-world-evidence/genitourinary-cancer-research-is-incredibly-promising-and-real-world-evidence-is-a-key-part-of-ithttps://flatiron.com/hubfs/genitourinary%203-100.jpggenitourinary3100genitourinary31002025-07-13https://resources.flatiron.com/publications/use-of-electronic-health-record-data-for-quality-reporting2024-03-27https://resources.flatiron.com/publications/real-time-assessment-of-resource-utilization-and-subsequent-cost-analysis-in-cancer-patients-pts-near-the-end-of-life-eol2024-03-26https://resources.flatiron.com/publications/quality-metrics-electronic-health-records2024-03-26https://resources.flatiron.com/press/flatiron-health-announces-research-to-be-presented-at-international-conference-of-pharmacoepidemiology-2023-annual-meetinghttps://flatiron.com/hubfs/126269_PressRelease.png126269PressRelease126269PressRelease2024-04-26https://resources.flatiron.com/publications/immune-checkpoint-inhibitor-ici-treatment-in-advanced-melanoma-amel-patients-pts-with-renal-or-hepatic-dysfunction-dysf-real-world-patient-characteristics-and-out2024-03-26https://resources.flatiron.com/press/press-release/flatiron-health-and-via-oncology-announce-availability-of-via-pathways-for-medical-oncology-in-oncoemr2024-03-27https://resources.flatiron.com/publications/quantifying-the-number-of-events-borrowed-from-external-data-for-time-to-event-outcomes-in-hybrid-control-arms2024-03-26https://resources.flatiron.com/point-of-care/are-you-ready-to-take-downside-riskhttps://flatiron.com/hubfs/Imported_Blog_Media/DSR_5.pngDSR5DSR52024-04-02https://resources.flatiron.com/press/press-release/flatiron-health-announces-research-to-be-presented-at-american-society-of-clinical-oncology-2019-annual-meeting2024-03-27https://resources.flatiron.com/press/flatiron-health-announces-research-to-be-presented-at-american-society-of-clinical-oncology-genitourinary-cancers-symposiumhttps://flatiron.com/hubfs/ASCOGU-2025-overview.pngASCOGU2025overviewASCOGU2025overview2025-03-19https://resources.flatiron.com/publications/racial-ethnic-inequities-ngs-ansclc-us-patients2024-04-02https://resources.flatiron.com/publications/evaluating-external-validity-oncology-biosimilar-safety-health-equityhttps://flatiron.com/hubfs/_Website%20Files/Resource%20Hub%20-%20Press%20Releases/flatiron-press-release-4.pngflatironpressrelease4flatironpressrelease42024-03-26https://resources.flatiron.com/publications/cost-effectiveness-of-multi-gene-panel-sequencing-for-patients-with-advanced-melanoma2024-03-26https://resources.flatiron.com/real-world-evidence/medicare-drug-price-negotiation-oncology-applications-real-world-evidencehttps://flatiron.com/hubfs/_Website%20Files/Resource%20Hub%20-%20Illustrations/Navigating%20Medicare%20Drug%20Price%20Negotiation%20in%20Oncology-%20Applications%20for%20Real-World%20Evidence.jpgNavigatingMedicareDrugPriceNegotiationinOncologyApplicationsforRealWorldEvidenceNavigatingMedicareDrugPriceNegotiationinOncologyApplicationsforRealWorldEvidence2024-04-17https://resources.flatiron.com/flatiron-stories/if-youre-growing-a-company-and-its-talent-dont-forget-to-grow-up2024-03-29https://resources.flatiron.com/publications/affordable-care-act-medicaid-expansion-impact-on-racial-disparities-in-time-to-cancer-treatment2024-03-26https://resources.flatiron.com/publications/using-real-world-cohorts-to-assess-the-generalizability-and-relevance-of-randomized-clinical-trials2024-03-26https://resources.flatiron.com/publications/natural-language-processing-algorithm-improve-ecog-performance-statushttps://flatiron.com/hubfs/_Website%20Files/Resource%20Hub%20-%20Press%20Releases/flatiron-press-release-4.pngflatironpressrelease4flatironpressrelease42024-03-26https://resources.flatiron.com/publications/estimand-target-trial-frameworks-external-control-analyses2024-03-26https://resources.flatiron.com/real-world-evidence/how-does-flatirons-data-empathy-or-deep-expertise-in-real-world-data-drive-cutting-edge-oncology-solutionshttps://flatiron.com/hubfs/_Website%20Files/Resource%20Hub%20-%20Videos/Without%20Play%20Button/How-does-Flatirons-data-empathy%2c-or-deep-expertise-in-real-world-data%2c-drive-cutting-edge-oncology-solutions-.jpgHowdoesFlatironsdataempathyordeepexpertiseinrealworlddatadrivecuttingedgeoncologysolutionsHowdoesFlatironsdataempathyordeepexpertiseinrealworlddatadrivecuttingedgeoncologysolutions2024-09-16https://resources.flatiron.com/publications/survival-prediction-in-advanced-nsclc-ansclc-amid-evolving-standards-of-care-soc-digital-twin-modeling-incorporating-llm-extracted-clinical-context2025-11-06https://resources.flatiron.com/clinical-research/creating-focus-through-technologyhttps://flatiron.com/hubfs/Creating%20focus%20through%20technology.pngCreatingfocusthroughtechnologyCreatingfocusthroughtechnology2024-09-16https://resources.flatiron.com/real-world-evidence/rwe-for-hta-decision-makinghttps://flatiron.com/hubfs/Imported_Blog_Media/season2_videoThumbs_02research%20x.jpgseason2videoThumbs02researchxseason2videoThumbs02researchxhttps://flatiron.com/hubfs/_Website%20Files/Resource%20Hub%20-%20ResearchX/ResearchX-thumbnail-2.jpgResearchXthumbnail2ResearchXthumbnail22025-03-05https://resources.flatiron.com/publications/niraparib-as-first-line-maintenance-therapy-in-patients-with-stage-iii-ovarian-cancer-and-no-visible-residual-disease-ar1ze-real-world-study2025-01-29https://resources.flatiron.com/point-of-care/how-will-ai-impact-the-future-of-clinical-decision-supporthttps://flatiron.com/hubfs/_Website%20Files/Resource%20Hub%20-%20Illustrations/how-will-AI-impact-the-future-of-clinical-decision-support.jpghowwillAIimpactthefutureofclinicaldecisionsupporthowwillAIimpactthefutureofclinicaldecisionsupport2024-04-02https://resources.flatiron.com/publications/racial-inequities-treatment-survival-breast-cancer2024-03-26https://resources.flatiron.com/publications/systemic-anticancer-therapy-end-of-life-usage-immunotherapy-era2024-03-26https://resources.flatiron.com/press/press-release/frost-sullivan-award2024-03-27https://resources.flatiron.com/publications/real-world-treatment-patterns-and-outcomes-of-abemaciclib-for-the-treatment-of-hr-her2-metastatic-breast-cancer2024-03-26https://resources.flatiron.com/point-of-care/how-to-build-your-own-pathway-programhttps://flatiron.com/hubfs/takeaways-from-clinical-pathways-congress-2024-1of3-1.pngtakeawaysfromclinicalpathwayscongress20241of31takeawaysfromclinicalpathwayscongress20241of312024-09-25https://resources.flatiron.com/publications/a-platform-to-prospectively-link-real-world-clinico-genomic-imaging-and-outcomes-data-for-patients-with-lung-cancer2024-03-26https://resources.flatiron.com/real-world-evidence/a-geyser-of-biomarkers-extracting-data-from-ngs-reportshttps://flatiron.com/hubfs/article-ngs-testing-reports.pngarticlengstestingreportsarticlengstestingreports2025-07-13https://resources.flatiron.com/flatiron-stories/rochehttps://flatiron.com/hubfs/Imported_Blog_Media/Blog_150215.jpgBlog150215Blog150215https://flatiron.com/hubfs/Imported_Blog_Media/Blog_milesstones_150215_B-2.jpgBlogmilesstones150215B2Blogmilesstones150215B22024-03-29https://resources.flatiron.com/publications/cell-of-origin-coo-association-with-high-body-mass-index-bmi-and-overall-survival-os-in-patients-with-diffuse-large-b-cell-lymphoma-dlbcl2024-03-26https://resources.flatiron.com/real-world-evidence/flatiron-partners-with-friends-of-cancer-research-to-advance-the-use-of-real-world-response-endpointshttps://flatiron.com/hubfs/_Website%20Files/Resource%20Hub%20-%20Illustrations/Flatiron%20partners%20with%20FoCR%20to%20advance%20the%20use%20of%20rwr%20endpoints.jpgFlatironpartnerswithFoCRtoadvancetheuseofrwrendpointsFlatironpartnerswithFoCRtoadvancetheuseofrwrendpoints2024-04-17https://resources.flatiron.com/publications/comparator-cohort-single-arm-trial-simulation-study-heterogeneity2024-03-26https://resources.flatiron.com/press/flatiron-health-announces-12-abstracts-accepted-to-be-presented-at-ispor-europe-2025https://flatiron.com/hubfs/Isporeurope.pngIsporeuropeIsporeurope2025-10-23https://resources.flatiron.com/flatiron-stories/when-it-comes-to-cancer-big-data-is-so-small-its-familyhttps://flatiron.com/hubfs/Imported_Blog_Media/erin-2.jpgerin2erin22024-03-29https://resources.flatiron.com/press/press-release/bristol-myers-squibb-and-flatiron-health-expand-collaboration-with-a-three-year-agreement2024-03-27https://resources.flatiron.com/flatiron-stories/fighting-cancerhttps://flatiron.com/hubfs/Imported_Blog_Media/Flatiron_Blog_Jillian.pngFlatironBlogJillianFlatironBlogJillian2024-03-29https://resources.flatiron.com/point-of-care/putting-an-oncology-pharmacist-in-your-pocket-with-flatiron-assisthttps://flatiron.com/hubfs/putting-an-oncology-pharmacist-in-your-pocket-with-Flatiron-Assist.pngputtinganoncologypharmacistinyourpocketwithFlatironAssistputtinganoncologypharmacistinyourpocketwithFlatironAssist2024-04-16https://resources.flatiron.com/publications/augmenting-race-and-ethnicity-in-a-real-world-oncology-cohort-using-the-bayesian-improved-surname-geocoding-methodology2025-04-17https://resources.flatiron.com/point-of-care/interview-with-heather-baker-from-alabama-oncologyhttps://flatiron.com/hubfs/_Website%20Files/Resource%20Hub%20-%20Headshots/Interview-with-Heather-Baker-from-Alabama-Oncology.pngInterviewwithHeatherBakerfromAlabamaOncologyInterviewwithHeatherBakerfromAlabamaOncology2024-04-16https://resources.flatiron.com/publications/are-community-oncology-practices-with/without-clinical-research-programs-different-a-comparison-of-patient-and-practice-characteristicshttps://flatiron.com/hubfs/_Website%20Files/Resource%20Hub%20-%20Publications/publication-2.pngpublication2publication22024-07-31https://resources.flatiron.com/publications/rwd-comparative-effectiveness-researchhttps://flatiron.com/hubfs/Imported_Blog_Media/RM_openaccessarticle_thumb_02-Mar-06-2023-06-50-48-1238-AM-Mar-10-2023-04-48-18-1912-AM.jpgRMopenaccessarticlethumb02Mar0620230650481238AMMar1020230448181912AMRMopenaccessarticlethumb02Mar0620230650481238AMMar1020230448181912AM2024-03-26https://resources.flatiron.com/real-world-evidence/how-real-world-clinico-genomic-data-is-delivering-new-cancer-insightshttps://flatiron.com/hubfs/Imported_Blog_Media/Blog_image_-_Blog_image_-_ESMO_CGDB_blog_post_092121-scaled-2.jpgBlogimageBlogimageESMOCGDBblogpost092121scaled2BlogimageBlogimageESMOCGDBblogpost092121scaled22024-04-18https://resources.flatiron.com/flatiron-stories/patrick-gonzaleshttps://flatiron.com/hubfs/Imported_Blog_Media/patrickgonzales-2.jpgpatrickgonzales2patrickgonzales22024-03-29https://resources.flatiron.com/real-world-evidence/real-world-evidence-for-regulatory-usehttps://flatiron.com/hubfs/Imported_Blog_Media/leveraging-real-world-endpoints-for-regulatory-use.jpgleveragingrealworldendpointsforregulatoryuseleveragingrealworldendpointsforregulatoryuse2024-09-16https://resources.flatiron.com/press/flatiron-health-expands-beyond-real-world-data-providing-end-to-end-evidence-solutions-for-oncologyhttps://flatiron.com/hubfs/flatiron-press-release-standard.webpflatironpressreleasestandardflatironpressreleasestandard2024-03-27https://resources.flatiron.com/publications/clinical-pathways-innovation-a-lesson-on-the-value-of-clinician-based-feedback-and-collaboration-with-flatiron-healthhttps://flatiron.com/hubfs/_Website%20Files/Resource%20Hub%20-%20Press%20Releases/flatiron-press-release-4.pngflatironpressrelease4flatironpressrelease42024-04-16https://resources.flatiron.com/publications/quality-measurement-in-cancer-care-a-review-and-endorsement-of-high-impact-measures-and-concepts2024-03-26https://resources.flatiron.com/publications/rwd-hta-case-studyhttps://flatiron.com/hubfs/Imported_Blog_Media/RM_openaccessarticle_thumb_01-4-2.jpgRMopenaccessarticlethumb0142RMopenaccessarticlethumb0142https://flatiron.com/hubfs/Screen%20Shot%202024-03-26%20at%203.08.17%20PM.pngScreenShot20240326at30817PMScreenShot20240326at30817PM2024-03-26https://resources.flatiron.com/publications/racial-ethnic-inequities-in-oncology-clinical-trial-participationhttps://flatiron.com/hubfs/_Website%20Files/Resource%20Hub%20-%20Press%20Releases/flatiron-press-release-4.pngflatironpressrelease4flatironpressrelease42024-03-26https://resources.flatiron.com/real-world-evidence/filling-critical-evidence-generation-gaps-with-global-oncology-real-world-datahttps://flatiron.com/hubfs/_Website%20Files/Video%20Thumbnails%20-%20Large/Filling%20critical%20evidence%20generation%20gaps%20with%20global%20oncology%20real-world%20data.pngFillingcriticalevidencegenerationgapswithglobaloncologyrealworlddataFillingcriticalevidencegenerationgapswithglobaloncologyrealworlddata2024-09-16https://resources.flatiron.com/publications/treatment-sequencing-patterns-costs-breast-cancer-2011-20212024-03-26https://resources.flatiron.com/publications/japanese-language-ehr-llm-extraction-of-longitudinal-unstructured-ecog-performance-status2026-03-30https://resources.flatiron.com/flatiron-stories/crisis-driven-development-part-2-the-good-partshttps://flatiron.com/hubfs/Imported_Blog_Media/FH_EngBlog_180227-edit.jpgFHEngBlog180227editFHEngBlog180227edit2024-03-29https://resources.flatiron.com/flatiron-stories/why-do-i-keep-going-back-to-grace-hopperhttps://flatiron.com/hubfs/Imported_Blog_Media/20181005_balloons.jpg20181005balloons20181005balloons2024-03-29https://resources.flatiron.com/point-of-care/oncs-interoperability-rule-is-good-for-patients-and-innovationhttps://flatiron.com/hubfs/Imported_Blog_Media/Interoperability_1028X880.jpgInteroperability1028X880Interoperability1028X8802024-04-02https://resources.flatiron.com/publications/pik3ca-akt1-pten-alterations-testing-patterns-prevalence-breast-cancer2024-05-23https://resources.flatiron.com/publications/real-world-safety-of-first-line-therapies-for-locally-advanced-or-metastatic-urothelial-cancer-in-the-us2025-02-10https://resources.flatiron.com/publications/transportability-overall-survival-advanced-non-small-cell-lung-cancer2024-03-26https://resources.flatiron.com/publications/beyond-the-trial-real-world-crs-icans-and-healthcare-burden-of-car-t-cell-therapy-across-us-oncology-practices2025-11-03https://resources.flatiron.com/publications/retrospective-observational-analysis-of-real-world-safety-outcomes-in-sacituzumab-govitecan-treated-patients-with-locally-advanced-metastatic-urothelial-cancer2025-02-10https://resources.flatiron.com/publications/prevalence-of-microsatellite-instability-and-association-with-pembrolizumab-p-usage-in-a-real-world-clinico-genomic-database2024-03-26https://resources.flatiron.com/publications/assessing-value-commercial-mortality-data-public-data-nononcology-research2024-04-16https://resources.flatiron.com/publications/real-world-progression-free-survival-of-cdk4/6-inhibitors-plus-an-aromatase-inhibitor-in-hr-positive/her2-negative-metastatic-breast-cancer-in-unite-17579607292542025-09-15https://resources.flatiron.com/real-world-evidence/patient-discussion-rwehttps://flatiron.com/hubfs/_Website%20Files/Resource%20Hub%20-%20ResearchX/ResearchX-thumbnail-6.jpgResearchXthumbnail6ResearchXthumbnail62025-03-04https://resources.flatiron.com/publications/real-world-surgical-and-treatment-patterns-after-neoadjuvant-checkpoint-inhibition-in-us-patients-with-stage-ii/iii-non-small-cell-lung-cancer2025-05-22https://resources.flatiron.com/real-world-evidence/novel-methodologies-analytics-powering-integrated-evidencehttps://flatiron.com/hubfs/_Website%20Files/Resource%20Hub%20-%20ResearchX/ResearchX-thumbnail-4.jpgResearchXthumbnail4ResearchXthumbnail42024-09-16https://resources.flatiron.com/publications/opportunities-for-precision-oncology-real-world-patterns-and-disparities-in-fgfr3-testing-among-us-patients-with-locally-advanced/metastatic-urothelial-cancer2026-02-23https://resources.flatiron.com/point-of-care/value-based-care-in-oncology-moving-the-needle-on-quality-and-costshttps://flatiron.com/hubfs/Beckers%20OVS.pngBeckersOVSBeckersOVS2024-04-09https://resources.flatiron.com/publications/real-world-evidence-on-prostate-cancer-management-in-germany-a-retrospective-analysis-of-electronic-health-records-to-investigate-clinical-characterics2025-11-10https://resources.flatiron.com/publications/fit-for-purpose-real-world-data-lessons-from-fda-qcard-and-ema-data-quality-framework2025-10-22https://resources.flatiron.com/press/press-release/flatiron-health-achieves-hitrust-csf-certification2024-03-27https://resources.flatiron.com/publications/evaluating-generalizability-of-practice-changing-randomized-clinical-trials-in-non-small-cell-lung-cancer-using-machine-learning-based-in-silico-trialshttps://flatiron.com/hubfs/_Website%20Files/Resource%20Hub%20-%20Press%20Releases/flatiron-press-release-4.pngflatironpressrelease4flatironpressrelease42024-03-26https://resources.flatiron.com/publications/generalizable-machine-learning-framework-for-predictive-modeling-of-patient-outcomes-using-oncology-electronic-health-records2024-03-26https://resources.flatiron.com/press/flatiron-health-joins-veevas-product-partner-program-to-accelerate-oncology-clinical-researchhttps://flatiron.com/hubfs/partnership-announcement-flatiron-and-veeva.pngpartnershipannouncementflatironandveevapartnershipannouncementflatironandveeva2025-04-16https://resources.flatiron.com/point-of-carehttps://flatiron.com/hubfs/collaboration-announcement-Adaptive.pngcollaborationannouncementAdaptivecollaborationannouncementAdaptivehttps://flatiron.com/hubfs/collaboration-announcement-Tempus-MPI.pngcollaborationannouncementTempusMPIcollaborationannouncementTempusMPIhttps://flatiron.com/hubfs/partnership-announcement-flatiron-and-willowglade-1.pngpartnershipannouncementflatironandwillowglade1partnershipannouncementflatironandwillowglade1https://flatiron.com/hubfs/_Website%20Files/Resource%20Hub%20-%20Interviews/oncology-trials-interview-with-anosheh-afghahi.pngoncologytrialsinterviewwithanoshehafghahioncologytrialsinterviewwithanoshehafghahihttps://flatiron.com/hubfs/_Website%20Files/Resource%20Hub%20-%20Defaults/resource-hub-9.pngresourcehub9resourcehub9https://flatiron.com/hubfs/takeaways-from-clinical-pathways-congress-2024-3of3%20(1).pngtakeawaysfromclinicalpathwayscongress20243of31takeawaysfromclinicalpathwayscongress20243of31https://flatiron.com/hubfs/press-release-2%20(1).pngpressrelease21pressrelease21https://flatiron.com/hubfs/Paradigm%20Health-1.pngParadigmHealth1ParadigmHealth1https://flatiron.com/hubfs/onco%20blog%20graphic_f.jpgoncobloggraphicfoncobloggraphicfhttps://flatiron.com/hubfs/partnership-announcement-flatiron-and-deepscribe.pngpartnershipannouncementflatironanddeepscribepartnershipannouncementflatironanddeepscribe2024-04-17https://resources.flatiron.com/point-of-care/interview-with-rachel-de-la-rosahttps://flatiron.com/hubfs/_Website%20Files/Resource%20Hub%20-%20Headshots/Interview-with-Rachel-De-La-Rosa-Sarah-Cannon-Research-Institute.pngInterviewwithRachelDeLaRosaSarahCannonResearchInstituteInterviewwithRachelDeLaRosaSarahCannonResearchInstitute2024-04-02https://resources.flatiron.com/publications/carboplatin-based-chemotherapy-versus-immunotherapy-in-metastatic-urothelial-carcinoma2024-03-26https://resources.flatiron.com/publications/development-and-initial-validation-of-a-prognostic-score-based-on-structured-data-from-ehrs2024-03-26https://resources.flatiron.com/publications/validation-of-composite-mortality-data-in-electronic-health-records-derived-data-in-germany-comparison-to-a-german-cancer-registry2026-03-10https://resources.flatiron.com/flatiron-stories/durham-101-a-candidates-guide-to-flatirons-life-sciences-officehttps://flatiron.com/hubfs/durham-101.jpgdurham101durham1012025-12-01https://resources.flatiron.com/real-world-evidence/advancing-the-use-of-real-world-evidence-with-a-noteworthy-industry-collaborative-pilot-projecthttps://flatiron.com/hubfs/Imported_Blog_Media/FH_blog__180801_copy-2.jpgFHblog180801copy2FHblog180801copy22024-03-29https://resources.flatiron.com/press/press-release/the-fda-and-flatiron-health-expand-real-world-data-cancer-research-collaboration2024-03-27https://resources.flatiron.com/point-of-care/ingredient-drug-substitution-for-505b2-with-tennessee-oncologyhttps://flatiron.com/hubfs/onco%20blog%20graphic_f.jpgoncobloggraphicfoncobloggraphicfhttps://flatiron.com/hubfs/usage%20by%20drug%202x-1.jpgusagebydrug2x1usagebydrug2x1https://flatiron.com/hubfs/count%20of%20505b2%202x.jpgcountof505b22xcountof505b22x2025-01-15https://resources.flatiron.com/publications/real-world-response-imaginghttps://flatiron.com/hubfs/_Website%20Files/Resource%20Hub%20-%20Publications/jama-network-open-flatiron-publication.pngjamanetworkopenflatironpublicationjamanetworkopenflatironpublication2024-03-26https://resources.flatiron.com/press/flatiron-health-announces-research-to-be-presented-at-the-2025-european-society-for-medical-oncology-ai-digital-oncology-congresshttps://flatiron.com/hubfs/esmoai25.pngesmoai25esmoai252025-12-18https://resources.flatiron.com/press/flatiron-health-announces-research-to-be-presented-at-the-2025-american-society-of-hematologys-annual-meeting-expositionhttps://flatiron.com/hubfs/ASH-2025.pngASH2025ASH20252025-11-03https://resources.flatiron.com/press/press-release/south-carolina-oncology-associates-choose-flatiron-health-oncoemr2024-03-27https://resources.flatiron.com/publications/characteristics-of-real-world-metastatic-non-small-cell-lung-cancer-patients-treated-with-nivolumab-and-pembrolizumab-during-the-year-following-approval2024-03-27https://resources.flatiron.com/publications/cancer-immunotherapy-use-and-effectiveness-in-real-world-patients-living-with-hiv2024-03-26https://resources.flatiron.com/press/press-release/roche2024-03-27https://resources.flatiron.com/publications/analytical-approaches-to-estimate-medication-persistence-from-ehr-data-a-study-of-tkis-in-patients-with-egfr-advanced-nsclc2025-04-17https://resources.flatiron.com/press/press-release/flatiron-health-announces-former-groupon-and-google-executive-jason-harinstein-to-join-as-chief-financial-officer2024-03-27https://resources.flatiron.com/flatiron-stories/viennahttps://flatiron.com/hubfs/Imported_Blog_Media/blog-post-screenshot-2.pngblogpostscreenshot2blogpostscreenshot2https://flatiron.com/hubfs/Imported_Blog_Media/Ignaz-Semmelweis-2.jpgIgnazSemmelweis2IgnazSemmelweis2https://flatiron.com/hubfs/Imported_Blog_Media/Worst_Product_Rollout_Ever_171025_632X396.pngWorstProductRolloutEver171025632X396WorstProductRolloutEver171025632X3962024-03-29https://resources.flatiron.com/publications/real-world-first-line-treatment-and-overall-survival-in-non-small-cell-lung-cancer-without-known-egfr-mutations-or-alk-rearrangements-in-us-community-oncology-set2024-03-27https://resources.flatiron.com/press/press-release/dr-robert-j-green-a-leader-in-community-oncology-joins-flatiron-health-as-vice-president-of-oncology2024-03-27https://resources.flatiron.com/publications/clinical-and-genomic-characteristics-of-small-cell-lung-cancer-in-never-smokers2024-03-26https://resources.flatiron.com/publications/control-arms-rwd2024-03-26https://resources.flatiron.com/press/press-release/nccn-and-flatiron-health-announce-collaboration-to-launch-novel-oncology-outcomes-database2024-03-27https://resources.flatiron.com/publications/comparison-of-population-characteristics-in-real-world-clinical-oncology-databases-in-the-us-flatiron-health-seer-and-npcr2024-03-26https://resources.flatiron.com/real-world-evidence/flatiron-health-comment-on-pdufa-vii-commitment-letterhttps://flatiron.com/hubfs/Imported_Blog_Media/PDUFA-Blog-Image-2.jpegPDUFABlogImage2PDUFABlogImage22024-03-29https://resources.flatiron.com/publications/comparison-real-world-clinical-oncology-databases-flatiron-foundation-research-national-cancer-seerhttps://flatiron.com/hubfs/Imported_Blog_Media/RM_openaccessarticle_thumb_02-Mar-06-2023-06-50-48-1238-AM-Mar-10-2023-04-50-59-7386-AM.jpgRMopenaccessarticlethumb02Mar0620230650481238AMMar1020230450597386AMRMopenaccessarticlethumb02Mar0620230650481238AMMar1020230450597386AM2024-03-26https://resources.flatiron.com/publications/association-of-brca-alteration-type-with-real-world-outcomes-to-parp-inhibitors-in-patients-with-metastatic-castrate-resistant-prostate-cancer2024-03-26https://resources.flatiron.com/publications/survival-analysis-of-patients-treated-at-oncology-practices-with-more-aggressive-end-of-life-practice-patternshttps://flatiron.com/hubfs/_Website%20Files/Resource%20Hub%20-%20Press%20Releases/flatiron-press-release-4.pngflatironpressrelease4flatironpressrelease42024-03-26https://resources.flatiron.com/press/flatiron-health-launches-new-strategic-collaboration-to-advance-health-insights-and-equity-of-cancer-carehttps://flatiron.com/hubfs/FH_PennPartnership_PressReleases.pngFHPennPartnershipPressReleasesFHPennPartnershipPressReleases2024-04-26https://resources.flatiron.com/point-of-care/practice-transformation-through-value-based-analytics-insights-from-the-avbcc-summithttps://flatiron.com/hubfs/insights-from-avbcc-summit-2023%20(1).pnginsightsfromavbccsummit20231insightsfromavbccsummit202312024-09-16https://resources.flatiron.com/real-world-evidence/tumor-site-agnostic-drug-developmenthttps://flatiron.com/hubfs/Imported_Blog_Media/season2_clip_jeffV_01.jpgseason2clipjeffV01season2clipjeffV012024-09-16https://resources.flatiron.com/press/press-release/flatiron-health-announces-three-additions-to-research-oncology-team2024-03-27https://resources.flatiron.com/real-world-evidence/flatirons-inaugural-research-summithttps://flatiron.com/hubfs/Imported_Blog_Media/image2-3.pngimage23image23https://flatiron.com/hubfs/Imported_Blog_Media/amy-abernethy-rick-pazdur-flatiron-research-summit-2018-3.jpgamyabernethyrickpazdurflatironresearchsummit20183amyabernethyrickpazdurflatironresearchsummit20183https://flatiron.com/hubfs/Imported_Blog_Media/flatiron-research-summit-abstraction-lab-3.jpgflatironresearchsummitabstractionlab3flatironresearchsummitabstractionlab3https://flatiron.com/hubfs/Imported_Blog_Media/flatiron-research-summit-2018.jpgflatironresearchsummit2018flatironresearchsummit2018https://flatiron.com/hubfs/Imported_Blog_Media/sean-khozin-flatiron-research-summit-3.jpgseankhozinflatironresearchsummit3seankhozinflatironresearchsummit32024-03-29https://resources.flatiron.com/real-world-evidence/icpe-2023-key-takeawayshttps://flatiron.com/hubfs/ICPE%202023.pngICPE2023ICPE20232024-04-17https://resources.flatiron.com/publications/statistical-methods-for-pantumor-analysis-models-to-account-for-tumor-level-heterogeneity2024-03-26https://resources.flatiron.com/publications/real-world-overall-survival-with-palbociclib-plus-an-aromatase-inhibitor-in-patients-with-hr/her2-metastatic-breast-cancer-who-are-overweight/obese2025-12-01https://resources.flatiron.com/real-world-evidence/three-key-takeaways-from-esmo-ai-2025https://flatiron.com/hubfs/ESMO-AI-takeaways.pngESMOAItakeawaysESMOAItakeaways2026-02-25https://resources.flatiron.com/publications/icd-coded-information-on-sites-of-metastasis-in-oncology-real-world-data-is-specific-but-not-sensitive2024-03-27https://resources.flatiron.com/point-of-care/eight-reasons-not-to-miss-oncocloud17https://flatiron.com/hubfs/Imported_Blog_Media/blog-oncocloud-2.jpgblogoncocloud2blogoncocloud22024-04-02https://resources.flatiron.com/press/flatiron-health-announces-new-partnership-in-the-ukhttps://flatiron.com/hubfs/flatiron-press-release-LTHTannouncement_US.pngflatironpressreleaseLTHTannouncementUSflatironpressreleaseLTHTannouncementUS2024-03-27https://resources.flatiron.com/publications/overall-survival-in-non-small-cell-lung-cancer-patients-with-comorbidities-treated-with-frontline-chemotherapy-or-immunotherapy-a-real-world-data-collaboration2024-03-26https://resources.flatiron.com/publications/replication-real-world-evidence-oncology-ehr-machine-learning2024-03-26https://resources.flatiron.com/publications/real-world-neoadjuvant-therapy-utilization-and-outcomes-in-patients-with-muscle-invasive-bladder-cancer-ineligible-for-cisplatin-treatment2026-02-23https://resources.flatiron.com/publications/emulating-control-arms-for-cancer-clinical-trials-using-external-cohorts-created-from-electronic-health-record-derived-real-world-data2024-03-26https://resources.flatiron.com/point-of-care/getting-to-the-point-of-care-with-machine-learninghttps://flatiron.com/hubfs/Imported_Blog_Media/i6yXL3uTNKos2tqncoEw_nature%20health%20figure%202%20adamson%20lakhtakia-2.pngi6yXL3uTNKos2tqncoEwnaturehealthfigure2adamsonlakhtakia2i6yXL3uTNKos2tqncoEwnaturehealthfigure2adamsonlakhtakia2https://flatiron.com/hubfs/Imported_Blog_Media/Hands-working-Yellow-2.jpgHandsworkingYellow2HandsworkingYellow2https://flatiron.com/hubfs/Imported_Blog_Media/plzNiUicQKSljdOQywZ5_nature%20health%20figure%201%20adamson%20lakhtakia-2.pngplzNiUicQKSljdOQywZ5naturehealthfigure1adamsonlakhtakia2plzNiUicQKSljdOQywZ5naturehealthfigure1adamsonlakhtakia22024-04-02https://resources.flatiron.com/publications/advancing-real-world-evidence-in-diffuse-large-b-cell-lymphoma-insights-from-ehr-derived-data-in-the-uk2025-11-10https://resources.flatiron.com/real-world-evidence/how-real-world-research-can-streamline-post-marketing-studies-in-oncologyhttps://flatiron.com/hubfs/How-real-world-research-can-streamline-post-marketing-studies-in-oncology.jpgHowrealworldresearchcanstreamlinepostmarketingstudiesinoncologyHowrealworldresearchcanstreamlinepostmarketingstudiesinoncology2025-05-27https://resources.flatiron.com/publications/advancing-colorectal-cancer-research-in-japan-insights-from-electronic-health-record-ehr-derived-data-in-japan2025-10-23https://resources.flatiron.com/publications/primary-tumor-location-and-survival-in-colorectal-cancer-a-retrospective-cohort-study2024-03-26https://resources.flatiron.com/publications/inequities-endometrical-cancer-survival-2017-2022-sdoh2024-04-16https://resources.flatiron.com/point-of-care/thinking-about-the-ocf-heres-how-you-can-start-preparinghttps://flatiron.com/hubfs/Imported_Blog_Media/OCF_part_2_1028X880-2.jpgOCFpart21028X8802OCFpart21028X88022024-04-18https://resources.flatiron.com/real-world-evidence/real-world-data-hta-market-accesshttps://flatiron.com/hubfs/_Website%20Files/Resource%20Hub%20-%20Defaults/resource-hub-9.pngresourcehub9resourcehub9https://flatiron.com/hubfs/basics_hta_05.jpgbasicshta05basicshta052024-09-16https://resources.flatiron.com/press/press-release/brilliant-black-mindshttps://flatiron.com/hubfs/_Website%20Files/Resource%20Hub%20-%20Partner%20Logos/karat-brilliant-black-minds-flatiron.pngkaratbrilliantblackmindsflatironkaratbrilliantblackmindsflatiron2024-03-27https://resources.flatiron.com/publications/survival-outcomes-of-erbb2-amplified-metastatic-colorectal-cancer-treated-with-first-line-chemotherapy2025-12-15https://resources.flatiron.com/publications/impact-of-dose-reductions-on-clinical-outcomes-among-patients-pts-with-metastatic-pancreatic-cancer-mpc-treated-with-liposomal-irinotecan-nal-iri-in-oncology-clin2024-03-26https://resources.flatiron.com/real-world-evidence/behind-the-research-an-exploration-of-real-world-datas-ability-to-support-adverse-event-surveillance-at-ispor-europehttps://flatiron.com/hubfs/real-world-data-adverse-event-surviellence.pngrealworlddataadverseeventsurviellencerealworlddataadverseeventsurviellence2025-10-29https://resources.flatiron.com/publications/clinical-application-artificial-intelligence-genomics2024-03-26https://resources.flatiron.com/publications/real-world-insights-into-non-small-cell-lung-cancer-in-germany-using-electronic-health-record-derived-data2025-11-10https://resources.flatiron.com/publications/real-world-characteristics-and-distant-metastasis-free-survival-of-patients-with-early-nsclchttps://flatiron.com/hubfs/_Website%20Files/Resource%20Hub%20-%20Defaults/resource-hub-6.pngresourcehub6resourcehub62024-08-16https://resources.flatiron.com/publications/ensuring-reliability-of-curated-ehr-derived-data-the-validation-of-accuracy-for-llm/ml-extracted-information-and-data-valid-frameworkhttps://flatiron.com/hubfs/publication-summary.pngpublicationsummarypublicationsummary2026-03-17https://resources.flatiron.com/publications/association-between-post-treatment-alpha-fetoprotein-reduction-and-outcomes-in-real-world-us-patients-with-advanced-hepatocellular-carcinoma2024-03-26https://resources.flatiron.com/publications/real-world-enrollment-for-a-prospective-clinico-genomic-database-using-a-pragmatic-technology-enabled-platform2025-02-20https://resources.flatiron.com/press/press-release/real-world-progression-20192024-03-27https://resources.flatiron.com/point-of-care/using-provider-feedback-to-improve-efficiency-and-utilization-of-the-flatiron-assist-emr-based-pathways-toolhttps://flatiron.com/hubfs/dr-avella-interview-journal-of-clinical-pathways.pngdravellainterviewjournalofclinicalpathwaysdravellainterviewjournalofclinicalpathwayshttps://flatiron.com/hubfs/Christopher%20DAvella.pngChristopherDAvellaChristopherDAvella2024-09-16https://resources.flatiron.com/publications/real-world-biomarker-testing-and-treatment-initiation-in-patients-with-resected-early-stage-nsclc-ensclc-in-the-us-and-uk2025-08-13https://resources.flatiron.com/real-world-evidence/identify-new-opportunities-in-lung-cancer-research-with-rwehttps://flatiron.com/hubfs/_Website%20Files/Resource%20Hub%20-%20Illustrations/Harnessing%20the%20power%20of%20RWE%20across%20the%20NSCLC%20drug%20development%20lifecycle.jpgHarnessingthepowerofRWEacrosstheNSCLCdrugdevelopmentlifecycleHarnessingthepowerofRWEacrosstheNSCLCdrugdevelopmentlifecycle2024-11-08https://resources.flatiron.com/press/flatiron-health-announces-research-to-be-presented-at-the-2025-san-antonio-breast-cancer-symposiumhttps://flatiron.com/hubfs/SABCS-2025-overview.pngSABCS2025overviewSABCS2025overview2025-12-01https://resources.flatiron.com/publications/evaluating-transportability-of-overall-survival-estimates-from-us-to-uk-populations-receiving-first-line-treatment-for-advanced-non-small-cell-lung2024-12-10https://resources.flatiron.com/flatiron-stories/seasonal-annual-review-stress-these-4-steps-will-get-you-throughhttps://flatiron.com/hubfs/Imported_Blog_Media/BLOG_IMAGEHow_I_Trick_Myself_into_Feedback_1028X880-2.jpgBLOGIMAGEHowITrickMyselfintoFeedback1028X8802BLOGIMAGEHowITrickMyselfintoFeedback1028X88022024-03-29https://resources.flatiron.com/press/flatiron-health-announces-upcoming-research-presentations-at-the-san-antonio-breast-cancer-symposium-2024https://flatiron.com/hubfs/flatiron-press-release-SABCS.pngflatironpressreleaseSABCSflatironpressreleaseSABCS2024-12-04https://resources.flatiron.com/press/tempus-molecular-profiling-integration-now-available-through-flatirons-oncoemrhttps://flatiron.com/hubfs/collaboration-announcement-Tempus-MPI.pngcollaborationannouncementTempusMPIcollaborationannouncementTempusMPI2025-02-06https://resources.flatiron.com/press/press-release/virginia-cancer-institute-selects-flatiron-health-oncoemr-to-enhance-patient-care2024-03-27https://resources.flatiron.com/publications/barriers-and-bridges-real-world-car-t-delivery-across-us-oncology-practices2025-11-03https://resources.flatiron.com/real-world-evidence/bigger-deeper-faster-real-world-data-opens-new-horizons-in-hematologic-oncology-researchhttps://flatiron.com/hubfs/blog-melissa-estevez-data-quality%20(1).pngblogmelissaestevezdataquality1blogmelissaestevezdataquality12025-12-18https://resources.flatiron.com/flatiron-stories/meet-our-changemakers-megan-hildner-senior-data-insights-engineerhttps://flatiron.com/hubfs/Megan%20Hildner.pngMeganHildnerMeganHildner2024-07-11https://resources.flatiron.com/press/press-release/flatiron-health-raises-130-million-series-b-round-led-by-google-ventures-and-agrees-to-acquire-leading-cloud-based-emr-company-altos-solutions2024-03-27https://resources.flatiron.com/publications/use-of-cancer-immunotherapies-in-the-real-world-in-the-setting-of-microsatellite-instability2024-03-27https://resources.flatiron.com/publications/real-world-use-of-radiation-brain-lung-cancer-02024-03-26https://resources.flatiron.com/publications/initial-real-world-treatment-patterns-and-outcomes-of-abemaciclib-for-the-treatment-of-hrher2-metastatic-breast-cancer2024-03-26https://resources.flatiron.com/point-of-care/precision-medical-ecosystem-panelhttps://flatiron.com/hubfs/Imported_Blog_Media/precision-medicine-blog%20(2).pngprecisionmedicineblog2precisionmedicineblog22024-04-02https://resources.flatiron.com/publications/changes-over-time-in-real-world-next-generation-sequencing-test-use-in-patients-with-advanced-non-small-cell-lung-cancer2024-03-26https://resources.flatiron.com/flatiron-stories/thank-you-amyhttps://flatiron.com/hubfs/Imported_Blog_Media/EC7A0058-FF85-45F4-9CCD-775424EB0F46-2.jpegEC7A0058FF8545F49CCD775424EB0F462EC7A0058FF8545F49CCD775424EB0F4622024-03-29https://resources.flatiron.com/real-world-evidence/introducing-the-prostate-cancer-panoramic-dataset2025-11-17https://resources.flatiron.com/publications/racialized-economic-segregation-and-inequities-in-survival-among-patients-with-multiple-myelomahttps://flatiron.com/hubfs/_Website%20Files/Resource%20Hub%20-%20Press%20Releases/flatiron-press-release-4.pngflatironpressrelease4flatironpressrelease42024-03-26https://resources.flatiron.com/press/press-release/foundation-medicine-and-flatiron-health-publish-validation-of-clinico-genomic-database-as-a-platform-to-advance-oncology-therapeutics-development-an2024-03-27https://resources.flatiron.com/publications/biallelic-tp53-alterations-predict-poorer-survival-in-mantle-cell-lymphoma-insights-from-a-national-real-world-cohort2025-11-03https://resources.flatiron.com/clinical-research/webinar-overcoming-ehr-to-edc-implementation-challenges-in-oncology-trialshttps://flatiron.com/hubfs/DPharm%202025%20Webinar_Clinical%20Pipe_90%25-1.svgDPharm2025WebinarClinicalPipe901DPharm2025WebinarClinicalPipe901https://flatiron.com/hubfs/DPharm%202025%20Webinar_Clinical%20Pipe_90%25.svgDPharm2025WebinarClinicalPipe90DPharm2025WebinarClinicalPipe902025-07-24https://resources.flatiron.com/press/press-release/flatiron-health-unveils-the-next-version-of-its-oncology-software-suite-oncocloud2024-03-27https://resources.flatiron.com/publications/extrapolation-long-term-survival-rwehttps://flatiron.com/hubfs/Imported_Blog_Media/RM_openaccessarticle_thumb_02-Mar-06-2023-06-50-48-1238-AM-Mar-10-2023-04-50-59-7386-AM.jpgRMopenaccessarticlethumb02Mar0620230650481238AMMar1020230450597386AMRMopenaccessarticlethumb02Mar0620230650481238AMMar1020230450597386AM2024-03-26https://resources.flatiron.com/press/unicancer-and-flatiron-health-partner-to-accelerate-regulatory-grade-evidence-generation-from-international-real-world-datahttps://flatiron.com/hubfs/flatiron-press-release-unicancer.pngflatironpressreleaseunicancerflatironpressreleaseunicancer2025-02-05https://resources.flatiron.com/flatiron-stories/working-with-oncologists-flatiron-healthhttps://flatiron.com/hubfs/Imported_Blog_Media/figure_A-Mar-10-2023-03-31-30-2012-PM.pngfigureAMar1020230331302012PMfigureAMar1020230331302012PMhttps://flatiron.com/hubfs/_Website%20Files/Resource%20Hub%20-%20Defaults/resource-hub-9.pngresourcehub9resourcehub92024-03-29https://resources.flatiron.com/real-world-evidence/accelerate-postmarketing-studieshttps://flatiron.com/hubfs/Fig2.pngFig2Fig2https://flatiron.com/hubfs/Fig1.pngFig1Fig1https://flatiron.com/hubfs/_Website%20Files/Resource%20Hub%20-%20Illustrations/New-analysis-shows-real-world-evidence-could-streamline-and-accelerate-at-least-one-in-four-postmarketing-studies.jpgNewanalysisshowsrealworldevidencecouldstreamlineandaccelerateatleastoneinfourpostmarketingstudiesNewanalysisshowsrealworldevidencecouldstreamlineandaccelerateatleastoneinfourpostmarketingstudies2024-07-09https://resources.flatiron.com/point-of-care/pharmacists-perspective-technology-podcasthttps://flatiron.com/hubfs/Imported_Blog_Media/110693-flatironhc-beckerhealthcare-10.png110693flatironhcbeckerhealthcare10110693flatironhcbeckerhealthcare102024-04-02https://resources.flatiron.com/publications/machine-learning-based-predictive-model-of-5-year-survival-in-multiple-myeloma-autologous-transplant-patients2024-03-26https://resources.flatiron.com/clinical-research/enabling-new-processes-through-technologyhttps://flatiron.com/hubfs/OncoBay.pngOncoBayOncoBay2024-09-16https://resources.flatiron.com/publications/unlocking-the-patient-journey-comparing-machine-learning-ml-based-natural-language-processing-nlp-and-expert-abstraction-in-understanding-treatment-patternshttps://flatiron.com/hubfs/_Website%20Files/Resource%20Hub%20-%20Defaults/resource-hub-6.pngresourcehub6resourcehub62024-03-26https://resources.flatiron.com/publications/systemic-anticancer-overall-survival-advanced-solid-tumors2024-05-20https://resources.flatiron.com/flatiron-stories/building-an-effective-engineering-culture-from-startup-to-acquisitionhttps://flatiron.com/hubfs/Imported_Blog_Media/FH_blog_180627-1030x532-2.jpgFHblog1806271030x5322FHblog1806271030x53222024-03-29https://resources.flatiron.com/press/lifebit-and-flatiron-health-bring-cutting-edge-research-technology-to-japan-advancing-global-cancer-care-through-real-world-datahttps://flatiron.com/hubfs/flatiron-press-release-nccn-collaboration.pngflatironpressreleasenccncollaborationflatironpressreleasenccncollaboration2024-10-08https://resources.flatiron.com/publications/evolving-treatment-patterns-in-early-stage-non-small-cell-lung-cancer-in-the-us2025-08-13https://resources.flatiron.com/point-of-care/what-happens-when-cancer-centers-use-site-specific-preferred-treatment-pathwayshttps://flatiron.com/hubfs/takeaways-from-clinical-pathways-congress-2of3.pngtakeawaysfromclinicalpathwayscongress2of3takeawaysfromclinicalpathwayscongress2of32024-04-09https://resources.flatiron.com/publications/opportunities-and-challenges-in-leveraging-electronic-health-record-data-in-oncology2024-03-27https://resources.flatiron.com/publications/transportability-comparative-effectiveness-considerations-health-technology-assessmenthttps://flatiron.com/hubfs/Blythe%20BTR.pngBlytheBTRBlytheBTR2024-09-23https://resources.flatiron.com/publications/implementing-an-electronic-end-of-life-chemotherapy-utilization-measure2024-03-26https://resources.flatiron.com/flatiron-stories/per-mio-padrehttps://flatiron.com/hubfs/Imported_Blog_Media/Carrie-Bennettes-1028x880.jpgCarrieBennettes1028x880CarrieBennettes1028x8802024-03-29https://resources.flatiron.com/press/press-release/tennessee-oncology-and-flatiron-health-partner-to-advance-the-development-of-value-based-care-products-and-services2024-03-27https://resources.flatiron.com/publications/the-fda-oncology-center-of-excellence-and-precision-medicine2024-03-27https://resources.flatiron.com/real-world-evidence/precision-oncology-how-rwd-is-advancing-clinico-genomic-researchhttps://flatiron.com/hubfs/_Website%20Files/Resource%20Hub%20-%20ResearchX/ResearchX-thumbnail-2.jpgResearchXthumbnail2ResearchXthumbnail22024-09-16https://resources.flatiron.com/publications/real-world-data-as-an-evidence-source-in-nuclear-medicine2024-03-26https://resources.flatiron.com/publications/real-world-overall-survival-using-oncology-electronic-health-record-data-friends-of-cancer-research-pilot2024-03-26https://resources.flatiron.com/publications/substitute-biosimilars-improve-practice-efficiency-financial-health2024-03-26https://resources.flatiron.com/publications/socioeconomic-status-inequities-treatment-initiation-overall-survival-2011-20222024-03-26https://resources.flatiron.com/publications/complementary-roles-for-tissue-and-blood-based-comprehensive-genomic-profiling-for-detection-of-actionable-driver-alterations-in-advanced-nsclc2024-03-26https://resources.flatiron.com/real-world-evidence/data-you-can-trust-setting-the-bar-for-mlllm-extracted-rwdhttps://flatiron.com/hubfs/Screenshot%202025-09-25%20at%202.36.16%20PM%20(2).pngScreenshot20250925at23616PM2Screenshot20250925at23616PM22025-09-25https://resources.flatiron.com/point-of-care/ocm-turns-2-lets-retrohttps://flatiron.com/hubfs/FH_blog_180621-1030x532.jpegFHblog1806211030x532FHblog1806211030x5322024-04-02https://resources.flatiron.com/publications/effectiveness-of-first-line-immune-checkpoint-blockade-versus-carboplatin-based-chemotherapy-for-metastatic-urothelial-cancer2024-03-26https://resources.flatiron.com/point-of-care/state-of-the-unionhttps://flatiron.com/hubfs/Imported_Blog_Media/FH-OncoCloudVirtual-session-thumbnail_state-of-the-union-1.pngFHOncoCloudVirtualsessionthumbnailstateoftheunion1FHOncoCloudVirtualsessionthumbnailstateoftheunion1https://flatiron.com/hubfs/Imported_Blog_Media/FH-OncoCloudVirtual-session-thumbnail_state-of-the-union.pngFHOncoCloudVirtualsessionthumbnailstateoftheunionFHOncoCloudVirtualsessionthumbnailstateoftheunion2024-09-16https://resources.flatiron.com/publications/sequencing-of-ramucirumab-ram-and-immune-checkpoint-inhibitors-icis-in-platinum-pt-treated-real-world-patients-pts-with-advanced-non-small-cell-lung-cancer-ansclc2024-03-26https://resources.flatiron.com/publications/association-of-programmed-cell-death-1-pd-1-inhibitor-therapy-with-overall-survival-os-in-stage-iv-melanoma-treated-with-targeted-therapies2024-03-26https://resources.flatiron.com/publications/generating-real-world-external-comparators-rwecs-for-randomized-clinical-trials-rcts-in-metastatic-breast-cancer-mbc-using-electronic-health-records-ehrs2024-03-26https://resources.flatiron.com/clinical-research/challenging-the-status-quothe-future-of-oncology-research-is-more-efficient-and-inclusivehttps://flatiron.com/hubfs/The%20future%20of%20oncology.pngThefutureofoncologyThefutureofoncology2024-09-16https://resources.flatiron.com/flatiron-stories/machine-learning-and-cancers-n-of-onehttps://flatiron.com/hubfs/Imported_Blog_Media/Carolyn-blog-illustration-2.jpegCarolynblogillustration2Carolynblogillustration22024-03-29https://resources.flatiron.com/real-world-evidence/from-obligation-to-opportunityhttps://flatiron.com/hubfs/Resource%20Hub%20-%20Reducing%20burden%20and%20filling%20gaps%20in%20oncology%20evidence%20generation%20with%20prospective%20real-world%20studies.pngResourceHubReducingburdenandfillinggapsinoncologyevidencegenerationwithprospectiverealworldstudiesResourceHubReducingburdenandfillinggapsinoncologyevidencegenerationwithprospectiverealworldstudies2025-09-25https://resources.flatiron.com/flatiron-stories/this-matrix-helps-growing-teams-make-great-decisionshttps://flatiron.com/hubfs/IMG_4387.jpegIMG4387IMG43872024-03-29https://resources.flatiron.com/publications/a-pan-tumor-and-pan-country-approach-to-llm-based-extraction-of-systemic-therapies-from-the-electronic-health-record2025-11-06https://resources.flatiron.com/publications/impact-of-oncology-care-model-reporting-requirements-on-quality-of-care2024-03-27https://resources.flatiron.com/flatiron-stories/using-machine-learning-models-to-unlock-insights-into-castleman-diseasehttps://flatiron.com/hubfs/Using%20machine%20learning.jpegUsingmachinelearningUsingmachinelearning2024-04-17https://resources.flatiron.com/press/the-university-of-colorado-cancer-center-and-flatiron-health-announce-collaboration-to-drive-more-efficient-clinical-trialshttps://flatiron.com/hubfs/collaboration-announcement-CU.pngcollaborationannouncementCUcollaborationannouncementCU2025-03-05https://resources.flatiron.com/publications/a-roadmap-for-developing-study-endpoints-in-real-world-settings2024-03-26https://resources.flatiron.com/publications/extracting-non-small-cell-lung-cancer-nsclc-diagnosis-and-diagnosis-dates-from-electronic-health-record-ehr-text-using-a-deep-learning-algorithm2024-03-26https://resources.flatiron.com/publications/technology-enabled-clinical-trials-transforming-medical-evidence-generation2024-03-26https://resources.flatiron.com/publications/real-world-evidence-label-expansionhttps://flatiron.com/hubfs/Imported_Blog_Media/RM_openaccessarticle_thumb_02-Mar-06-2023-06-50-48-1238-AM-Mar-10-2023-04-48-18-1912-AM.jpgRMopenaccessarticlethumb02Mar0620230650481238AMMar1020230448181912AMRMopenaccessarticlethumb02Mar0620230650481238AMMar1020230448181912AM2024-03-26https://resources.flatiron.com/press/press-release/oncology-consultants-selects-flatiron-health-oncoemr2024-03-27https://resources.flatiron.com/press/flatiron-health-launches-six-new-hematology-ai-powered-longitudinal-datasetshttps://flatiron.com/hubfs/press-release-2.pngpressrelease2pressrelease22025-10-29https://resources.flatiron.com/flatiron-stories/from-flintstones-to-the-full-stack-how-precision-care-and-consumerization-will-modernize-healthcare-deliveryhttps://flatiron.com/hubfs/Imported_Blog_Media/FH_blog_181003_2120x1064-2.jpgFHblog1810032120x10642FHblog1810032120x106422024-03-29https://resources.flatiron.com/publications/do-the-characteristics-of-the-site-of-care-influence-outcomeshttps://flatiron.com/hubfs/_Website%20Files/Resource%20Hub%20-%20Press%20Releases/flatiron-press-release-4.pngflatironpressrelease4flatironpressrelease42024-03-26https://resources.flatiron.com/publications/comprehensive-genomic-profiling-in-breast-cancer-patterns-and-results-from-a-clinico-genomic-database2024-03-26https://resources.flatiron.com/press/press-release/flatiron-health-expands-leadership-team-with-two-new-executive-hireshttps://flatiron.com/hubfs/_Website%20Files/Resource%20Hub%20-%20Headshots/Flatiron-Health-Expands-Leadership-Team-with-Two-New-Executive-Hires.pngFlatironHealthExpandsLeadershipTeamwithTwoNewExecutiveHiresFlatironHealthExpandsLeadershipTeamwithTwoNewExecutiveHires2024-03-27https://resources.flatiron.com/publications/clinical-characteristics-treatment-patterns-and-overall-survival-of-real-world-patients-with-idiopathic-multicentric-castleman-disease2024-03-26https://resources.flatiron.com/point-of-care/health-equity-what-are-leading-cancer-centers-doing-to-reduce-health-disparitieshttps://flatiron.com/hubfs/What%20are%20leading%20cancer%20centers%20doing%20to%20reduce%20health%20disparities.pngWhatareleadingcancercentersdoingtoreducehealthdisparitiesWhatareleadingcancercentersdoingtoreducehealthdisparities2024-09-16https://resources.flatiron.com/real-world-evidence/nsclc-prognostic-biomarkers2024-04-17https://resources.flatiron.com/publications/real-world-evidence-fda-alertshttps://flatiron.com/hubfs/Imported_Blog_Media/RM_openaccessarticle_thumb_02-Mar-06-2023-06-50-48-1238-AM-Mar-10-2023-04-48-18-1912-AM.jpgRMopenaccessarticlethumb02Mar0620230650481238AMMar1020230448181912AMRMopenaccessarticlethumb02Mar0620230650481238AMMar1020230448181912AM2024-03-27https://resources.flatiron.com/flatiron-stories/you-dont-have-to-be-an-expert-in-medicine-to-be-a-good-designer-in-healthcarehttps://flatiron.com/hubfs/Imported%20sitepage%20images/FH_blog_design_180926_2120x1064.jpgFHblogdesign1809262120x1064FHblogdesign1809262120x10642024-03-29https://resources.flatiron.com/publications/impact-of-real-world-response-to-first-line-immunotherapy-and-chemotherapy-on-subsequent-treatment-outcomes-in-patients-with-advanced-or-metastatic-17725699883442026-03-03https://resources.flatiron.com/publications/accrual-of-racially-and-ethnically-underrepresented-populations-with-multiple-myeloma-associated-with-centralized-patient-screening-in-a-multicenter-study2025-05-30https://resources.flatiron.com/real-world-evidence/how-scaled-real-world-evidence-insights-advance-breast-cancer-researchhttps://flatiron.com/hubfs/How%20scaled%20real-world%20evidence%20insights%20advance%20breast%20cancer%20research.pngHowscaledrealworldevidenceinsightsadvancebreastcancerresearchHowscaledrealworldevidenceinsightsadvancebreastcancerresearch2025-04-18https://resources.flatiron.com/flatiron-stories/nursing-beyond-the-bedsidehttps://flatiron.com/hubfs/Imported_Blog_Media/shirts_1030x532-2.jpgshirts1030x5322shirts1030x53222024-03-29https://resources.flatiron.com/press/flatiron-health-research-highlights-power-of-real-world-oncology-data-at-ispor-2023https://flatiron.com/hubfs/FH_ISPOR_PressReleases.pngFHISPORPressReleasesFHISPORPressReleases2024-03-27https://resources.flatiron.com/press/press-release/flatiron-health-to-incorporate-nccn-chemotherapy-order-templates-into-oncoemr2024-03-27https://resources.flatiron.com/press/flatiron-health-announces-research-to-be-presented-at-american-society-of-hematology-2023-annual-meetinghttps://flatiron.com/hubfs/FH_Website_ResourceHubThumbnails_ASHPressRelease.pngFHWebsiteResourceHubThumbnailsASHPressReleaseFHWebsiteResourceHubThumbnailsASHPressRelease2024-04-26https://resources.flatiron.com/clinical-research/how-does-flatiron-reduce-the-burden-of-pmc-pmr-studies-for-sponsors-sites-and-patientshttps://flatiron.com/hubfs/How%20does%20Flatiron%20reduce%20the%20burden%20of%20PMCPMR%20studies%20for%20sponsors%2c%20sites%2c%20and%20patients.pngHowdoesFlatironreducetheburdenofPMCPMRstudiesforsponsorssitesandpatientsHowdoesFlatironreducetheburdenofPMCPMRstudiesforsponsorssitesandpatients2024-09-16https://resources.flatiron.com/point-of-care/the-wall-street-journal-clinical-drug-trials-may-be-coming-to-your-doctors-officehttps://flatiron.com/hubfs/Imported_Blog_Media/press-clinical-drug-trials.jpgpressclinicaldrugtrialspressclinicaldrugtrials2024-04-02https://resources.flatiron.com/press/press-release/nina-chavez2024-03-27